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 Abstract 
 
All classes of leukocytes must be able to move from the circulation into tissue to 
carry out their protective functions. To achieve this transfer, the flowing cells must 
adhere to the endothelium and migrate through the vessel wall. Though this process 
follows common stages during recruitment in different organs, there is also 
specialisation in underlying molecular mechanisms. The main aim was to further 
elucidate these organ specific phenotypic differences and relate them to the 
functional ability of EC to recruit subsets and total leukocytes from flow. Murine 
models of human disease are an incredibly useful experimental tool allowing 
investigation of whole diseases to the effect of one gene on a disease outcome. 
Isolation of primary human endothelial cell populations is well-defined 
(hLSEC/HUVEC) however obtaining and culturing the murine counterparts is more 
challenging. Primary mLSEC were isolated from murine livers using ɑ-CD146 
magnetic beads and the phenotype compared to immortalised cell lines from heart 
(mUCEC-1), skin (s.END) and brain (b.End.5). The expression of a number of 
adhesion molecules and endothelial markers varied within cell type in response to 
pro-inflammatory insult (Endoglin, CD34, CD31). Some artefacts of immortalisation 
were also apparent (VCAM-1 expression in mUCEC-1 and LYVE-1 in s.END). 
Functional assays indicated small differences in cell types and further microarray 
analysis elucidated further candidates, including chemokines, which could be 
involved in regulating leukocyte recruitment processes in the different organs 
examined. 
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1.1 Inflammation and inflammatory mediators 
 
The Romans originally defined inflammation in the first century as heat (calor), pain 
(dolor), redness (rubor) and swelling (tumour). It is the response of the immune 
system to physical tissue damage or the presence of a pathogen or foreign antigen. 
Inflammation occurs in three distinct phases. Almost immediately, a physical barrier 
is formed by clots of fibrinogen, minimising the movement of fluids and spread of 
infection. Acute inflammation is transient, blood flow in the effected area is increased 
as vessels dilate, reducing velocity resulting in heat and redness. Endothelial cells 
(EC) aid vascular permeability by altering the properties of cellular junctions allowing 
fluid and proteins to exit the general circulation and accumulate in the tissue leading 
to swelling and pain. In the sub-acute phase the pattern of EC adhesion molecule 
expression changes to recruit circulating leukocytes. Initial neutrophilic infiltration is 
followed by monocytes, eosinophils and lymphocytes. Additional effector molecules 
and cells are delivered to the site of infection enhancing the eradication of invading 
pathogens by tissue resident macrophages. This then progresses to a chronic 
proliferative stage leading to fibrosis and tissue degeneration (Parkin et al. 2001).  
 
Inflammation is mediated by a number of different substances both exogenous and 
endogenous including nitric oxide (NO), interleukins, serotonin and endotoxins. In 
acute inflammation macrophages produce prostaglandins, leukotrienes, eicosanoids 
and platelet activating factor (PAF), in response to the identification of pathogens. 
These lipid-derived mediators are generated by the metabolism of phospholipid 
membranes. Complement is also involved here; products from dying cells contribute 
to this enzymatic cascade system attracting neutrophils, leading to mast cell 
degranulation and release of histamine and opsonisation of bacteria. In addition, pro-
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inflammatory cytokines such as TNF-α (Tumour necrosis factor-alpha), IL-1 
(Interleukin-1) and IL-6 (Interleukin-6) are produced to perpetuate inflammation 
(Parkin et al. 2001). 
 
Cytokines are produced by almost all cells of the body and have a wide range of 
functions including cell activation, proliferation and apoptosis. These small molecular 
weight molecules act in an autocrine, paracrine and endocrine manner sending 
signals by binding to specific cell surface receptors. Their role is to regulate the 
direction, amplitude and duration of the inflammatory response (Moser et al. 2004). 
Chemokines are chemotactic cytokines; produced in response to pro-inflammatory 
stimuli, and they play an important role in leukocyte migration. Grouped according to 
the location of two cysteine (C) residues within a number of different amino acids (X) 
there are CXC (α-chemokines) and CC (β-chemokines). Exceptions exist, such as 
CXXXC (Fractalkine) and C (Lymphotactin). Chemokines can cause prolonged 
effects as they bind to glycosaminoglycans (GAG’s) on the surface of cells and extra-
cellular matrix leading to leukocyte activation and migration (Murdoch et al. 2000).  
 
Inflammation is mediated by several substances, in this project I used a number of 
different pro-inflammatory stimuli to activate endothelial cell populations, including 
the cytokines TNF-α, IFN-γ (Interferon-gamma), IL-1β and bacterial product LPS 
(Lipopolysaccharide). Cytokines are small molecular substances allowing cells to 
communicate. These messengers send signals by binding specific cell-surface 
receptors leading to changes in cellular behaviour (Parkin et al. 2001). TNF-α is 
produced rapidly by all inflammatory cells, particularly activated mast cells. TNF-α is 
a member of a group of cytokines that stimulate the acute phase reaction produced 
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in response to LPS and IL-1. The TNF-receptor is expressed on all inflammatory cells 
which when stimulated are activated to synthesise more TNF-α, amplifying the 
response via a positive feedback loop.  
 
IFN-γ originally called macrophage-activating factor, is produced by T-Cells and 
Natural Killer Cells, activating macrophage and neutrophil intracellular killing, 
enhancing NKT (Natural Killer Cell) function and antigen presentation by upregulating 
MHC II (Major Histocompatibility Complex) receptor expression on Antigen 
Presenting Cells (APC’s) via a different receptor to class 1 interferons. γ-interferon is 
used therapeutically in patients with congenital neutrophil defects, macrophage 
based infections and those with defects in the production of the cytokine itself or 
receptor (Parkin et al. 2001). 
 
Interleukins are cytokines produced by leukocytes, in particular macrophages and 
monocytes. IL-1 was one of the first cytokines to be described, also known as 
lymphocyte activating factor, it was only in 1984-85 that it was discovered to be 
composed of two subunits (α andβ), which act in a similar fashion. IL-1 is an 
endogenous pyrogen inducing fever (via prostaglandins), lowering blood pressure, 
activating T-Cells and producing additional interleukins.   
 
LPS or Lipopolysaccharide is an endotoxin and a component of the outer membrane 
of gram-negative bacteria. Essential for bacterial structural integrity it protects the 
membrane from chemical attack. Endotoxins mediate acute inflammation via Toll 
Like Receptor 4 (TLR 4) (Ley et al. 2007;Parkin et al. 2001).  
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1.2 Role of Lymphocytes 
 
Adaptive immunity depends on lymphocytes, providing life-long protection following 
disease or vaccination. This immunological memory enables familiar pathogens to be 
overcome if the innate immune system is ineffective (Delves et al. 2000).  
Lymphocytes arise from a common lymphoid progenitor in the bone marrow, which 
can develop into either B-Cells, which have the capacity to differentiate into antibody 
producing plasma cells when activated, or T-Cells. Lymphocytes are housed in the 
lymphatic system and lymphoid tissues. These organs can be broadly categorised 
into primary (thymus) or secondary lymphoid organs (Spleen, Peyers Patches), 
where lymphocytes are generated or maintained respectively. Both groups of 
lymphocytes originate in the bone marrow but only B-Cells mature there, whereas T-
Cells migrate to the thymus as thymocytes. Post maturation both cell types enter the 
general circulation before migrating to secondary lymphoid organs. In order to 
contribute to a fully functioning immune system, T-Cells need to acquire antigen 
specificity. This rearrangement and splicing of random DNA segments coding for 
antigen binding areas of receptors (complimentarity determining sequences) 
produces over 108 T-Cell receptors, enough to accommodate all the antigens 
encountered in a lifetime (Arstila et al. 1999). After gene rearrangement these cells 
are still considered ‘naïve’ as they have not yet encountered their specific antigen as 
part of an immune response. These cells then go on to populate secondary lymphoid 
organs such as the spleen, tonsils, lymph nodes and mucosa associated lymphatic 
tissues (e.g. Peyers Patches). Cells of the lymphatics can move throughout the 
lymphatic system as tissues provide an ordered expression of adhesion molecules 
allowing T and B cells to review various tissues searching for antigens in immune 
surveillance.  
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Figure 1. 1: The role of T and B Cells in specific immunity (Parkin et al. 2001) 	  
Representative schematic diagram of T and B-Cell development in the bone marrow 
and thymus.  
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1.2.1 T-Cell Development: CD4+/CD8+ 
 
As mentioned previously naïve cells are primed to respond to their defined antigen 
inducing an immune response. However, this process needs to be tightly regulated in 
order to prevent responses to self-antigens. To combat this T-Cells undergo a 
process of positive and negative selection in the thymus (Fig.1.1). When T-Cells 
enter the thymus they are double negative expressing neither CD4+ nor CD8+. Cells 
that have a high avidity for self-peptides presented by MHC are negatively selected 
and deleted (clonal deletion). Those with low avidity are positively selected and 
become double positives. In the final stages, remaining single positive T-cells are 
selected for as they either bind self peptide/antigen via MHC class I (CD8+) or MHC 
class II (CD4+). Antigen can be presented to T-cells in one of two ways depending on 
their phenotype. MHC Class I displays endogenous antigens such as viral or tumour 
proteins, whereas, exogenous antigens which can be taken up by professional 
antigen presenting cells such as dendritic cells (DC’s) are presented via MHC Class 
II. This specificity allows targeted cytotoxic attack by CD8+ cells expressing viral 
proteins on their surface and induction of cytokine production by CD4+ cells in 
response to a local infection activating surrounding cells of the immune system. The 
two types of effector T-Cells are T-helper cells and T-cytotoxic cells expressing either 
CD4 or CD8 surface markers. Both are co-receptors acting in addition to the T-Cell 
Receptor (TCR) with corresponding MHC complexes.  
1.2.2 Role of neutrophils 
 
Neutrophils are an essential component of the protective innate immune response. 
To fulfil this crucial role they must be able to rapidly move from the circulation, 
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migrate through the endothelium lining the vasculature and phagocytose any 
invading pathogens. The recruitment of neutrophils must be highly regulated 
however, as neutrophils are double-edged swords. They utilise proteinases and 
reactive oxygen species (ROS) to neutralise the pathogen, but these substances can 
inflict tissue damage (Morgan et al. 2005). It is thought that neutrophils have a 
relatively short life span to avoid this possibility. If these harmful cells are allowed to 
accumulate in tissues as a result of unresolved inflammation or deregulated 
recruitment they could potentially cause damage for example in the synovium in 
Rheumatoid Arthritis (RA)  (Bostan et al. 2002).  
 
1.2.3 Development and fate of neutrophils 
 
Neutrophil development begins in the bone marrow where pluripotent myeloid stem 
cells are directed down the myeloblastic cell lineage by a number of specific growth 
factors and cytokines. The myeloid stem cell differentiates into granulocyte-monocyte 
progenitor in response to granulocyte-monocyte colony stimulating factor (GM-CSF), 
IL-3 and IL-6. Exposure to additional GM-CSF and G-CSF results in the production of 
fully functional segmented neutrophils (Pallister. 1998). The resulting mature 
neutrophils exit the bone marrow and enter the peripheral bloodstream. Here they 
either circulate freely in the blood, the circulating pool or enter the marginated pool. 
The marginated pool of neutrophils circulates slowly through the lungs and 
microcirculation and can be mobilised rapidly in response to stimuli, such as exercise 
(Adams et al. 2005). 
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In the absence of a pro-inflammatory stimulus, neutrophils circulate through the 
peripheral blood for 6-12 hours, after which they are thought to die by apoptosis and 
are removed by macrophages of the reticuloendothelial system (Brown et al. 1999). 
When neutrophils encounter pro-inflammatory cytokines, growth factors (Homburg et 
al. 1996) or signals transduced during migration they have been shown to survive for 
up to 48 hours (McGettrick et al. 2006). This increased lifespan is thought to allow 
neutrophils to carry out their protective functions in tissue. 
 
1.3 The role of endothelium 
 
1.3.1 Vascular endothelial cells and their function 
 
Endothelial cells line the whole of the vasculature and are highly heterogeneous. EC 
play a major role in leukocyte recruitment as well as haemostasis, regulation of 
vascular tone, angiogenesis and the control of movement of solutes between the 
vascular system and tissues (Johnson-Leger et al. 2000;Matharu et al. 2006;Springer 
1995). Endothelial phenotype has been shown to vary in both structure and function 
from organ to organ and throughout the vascular tree. EC are notoriously difficult to 
define, as no specific marker of EC exists. In addition any ‘endothelial-like’ markers 
such as CD31 or VE-Cadherin, or structural characteristics for example Weibel-
Palade bodies or fenestrations vary between subsets of EC and can also be present 
on additional cell types. For example fenestrated epithelial cells are found around the 
fenestrated capillaries of the glomerulus. In addition CD31 is also expressed on 
platelets, macrophages and subsets of T-Cells. 
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The structure of EC varies throughout the vasculature, although conventionally flat in 
vessels they are cuboidal in shape in high endothelial venules and their thickness 
varies from 0.1µm in capillaries to 1µm in the aorta (Girard et al. 1995). Vascular 
endothelium is either continuous or discontinuous and can be further categorised by 
the presence or absence of fenestrations respectively. Fenestrations are transcellular 
pores of approximately 70nm with a thin diaphragm across their opening in some 
cases, providing size selective filtration. Non-fenestrated continuous endothelium is 
present in the brain, skin, heart and lungs. Fenestrated endothelium occurs in exo 
and endocrine glands, gastrointestinal mucosa and glomeruli where substances are 
filtered or transported across the endothelium into tissues. Discontinuous 
endothelium is found in sinusoidal beds such as the liver, which lack a basement 
membrane and possess an increased number of larger fenestrations up to 100-
200nm in diameter (Aird 2007b;Braet et al. 2002). Vascular Endothelial Growth 
Factor (VEGF) is thought to play an important role in the presence and maintenance 
of intercellular gaps and fenestrations. The presence of exogenous VEGF has been 
shown to induce fenestrations in vascular beds of the skin and cremaster, where they 
are normally absent (Roberts et al. 1995). 
 
1.4 Leukocyte Recruitment 
 
The recruitment of leukocytes into tissues is highly regulated process involving 
complex interactions between leukocytes and endothelial cells. By modifying the 
expression of adhesion receptors and chemokines on their surface, EC can control 
the recruitment of leukocytes in response to locally produced inflammatory 
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substances, including TNF-α and IL-1β (Bahra et al. 1998;Mantovani et al. 1992). 
However, their location leads to the involvement of these cells in the pathology of 
several diseases due to deregulated or inappropriate leukocyte recruitment. The 
most relevant diseases in this context are chronic inflammatory diseases including 
atherosclerosis and acute diseases such as ischemia/reperfusion injury and early 
transplant rejection. The location of endothelial cells means they are ideally situated 
to interact with passing leukocytes in the circulation. There are thought to be 
differences in leukocyte recruitment due to variation of EC phenotype in different 
levels of the vascular tree and in different organs of the body (Berlin et al. 
1993;Picker 1992). For example CCL25 is thought to be important in attracting CCR9 
expressing CD8+ effector cells to the gut associated lymphoid tissues in the small 
intestine (Campbell et al. 2002). The homing receptor pair or addressing of L-Selectin 
and Peripheral Lymph Node Addressin (PNAd) is also thought to mediate lymphocyte 
adhesion to peripheral lymph node HEV (Garrood et al. 2006) 
 
Each tissue may provide a diverse cellular, physiological and rheological 
environment under which endothelial cells and leukocytes may respond differently. 
Study of these localised phenotypic differences may yield data, which could increase 
the level of understanding of mechanisms of inflammatory diseases in different 
organs. 
   
Leukocyte recruitment can be separated into two main types: (1) constitutive 
recruitment which takes place in high endothelial venules (HEV) for immune 
surveillance and (2), recruitment in response to trauma and infection, i.e. 
inflammation, which occurs mostly in post-capillary venules (PCV). Both of these 
processes are thought to be similar but utilise different specific adhesion molecules 
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and chemokines. α4β7 integrins and L-Selectin in particular have been shown to play 
a role in immune surveillance directing lymphocytes to peyers patches and 
mesenteric lymph nodes (Stoolman 1993). Chemokines also play an in important part 
here. They can be split into two categories, inflammatory and homeostatic, directing 
leukocytes in infection and tissue injury or to the bone marrow and thymus during 
haematopoiesis and initiation of the adaptive immune response respectively (Moser 
et al. 2004). In both types of recruitment, leukocytes must migrate into surrounding 
tissues from the bloodstream via a process known as extravasation. This highly 
regulated process occurs in the low shear stress environment of post-capillary and 
high endothelial venules (Anderson et al. 1993).  
 
A specific sequence of events has to occur in order for the leukocytes to migrate from 
the bloodstream into the surrounding tissues. Specialised adhesion molecules are 
essential in this capture process. These molecules are constitutively expressed on 
the endothelial cells present in high endothelial venules of lymph nodes, allowing 
continuous trafficking of lymphocytes into the lymphatics. In non-lymphoid tissue the 
endothelial cells in PCV are able to upregulate expression of such molecules in 
response to pro-inflammatory stimuli as a result of infection, directing leukocytes to 
the affected tissue (Parkin et al. 2001). 
 
In normal conditions leukocytes localise to the centre of venules where the flow is 
fastest; under inflammatory conditions the blood vessels dilate decreasing the rate of 
flow, increasing the frequency of complex interactions between the vascular 
endothelium and lymphocytes in the circulation. Immune surveillance differs, as 
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lymphocytes are constantly recruited from the bloodstream and home to their 
predisposed site. 
 
A number of cell surface receptors and adhesion molecules expressed on the both 
cell types are involved in regulating specific interactions between the lymphocytes 
and endothelial cells required for recruitment. A general paradigm of leukocyte 
recruitment exists (Fig. 1.2) and involves a defined sequence of events divided into 
several steps (Adams et al. 1994;Buckley et al. 2000;Springer 1994). Flowing 
leukocytes must make contact with the vessel wall. This comes about as a result of 
margination. The leukocytes are pushed towards the vessel wall by the central flow 
of red blood cells (Goldsmith et al. 1984). As a result of inflammation, substances 
such as histamine and prostaglandins trigger an increase in local blood flow and 
permeability. Protein rich fluids move from the general circulation into the 
surrounding tissues increasing the blood haematocrit and viscosity, resulting in 
slower blood flow. The increasing numbers of erythrocytes in post capillary venules 
gravitate towards the centre of the vein pushing circulating leukocytes outwards, thus 
facilitating more leukocyte endothelial interactions. On contact with the endothelium, 
weak, rapidly-reversible interactions are formed with Selectin receptors (Lawrence et 
al, 1991), leading to tethering and rolling along the vascular wall (Alon et al. 
2002;Bahra et al. 1998). Chemokines present on the surface of vascular endothelial 
cells initiate activation of the leukocyte leading to tight adhesion to the vascular 
surface via integrins and their receptors (Springer 1993). In the final stages, the 
leukocyte migrates through the endothelium to the surrounding tissue in response to 
a chemotactic gradient generated by endothelial or resident inflammatory cells. This 
multi-step process involving defined independent steps generates opportunities for 
regulation. Each step is mediated by distinct interactions between specific sets of 
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adhesion molecules, allowing targeted recruitment of different leukocyte subsets to 
specific tissues if the tissues provide the unique combination of receptors and 
chemokines (Springer 1994). 
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Figure 1. 2: Diagram of the leukocyte recruitment paradigm (Ley et al.  2007).  	  
Schematic of current outline of the leukocyte recruitment cascade from the circulation 
into surrounding tissues. Includes rolling, firm adhesion and transmigration through 
the endothelium. 	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1.5 Tissue specific recruitment 
 
An increasing amount of literature illustrates the use of unique adhesion molecules 
and chemokines, differentially expressed in a variety of tissues, to drive tissue-
specific leukocyte recruitment (Mackay 1993). This variation accommodates the 
different functions required by diverse tissues and systems.  
 
Mucosal addressin adhesion molecule-1 (MAdCAM-1) is expressed predominantly by 
intestinal lymphatic EC (Berlin et al. 1993). This binds to α4β7 and α4β1 integrins, 
which are expressed uniquely by a specific subset of T-lymphocytes displaying tissue 
tropism (Berg et al. 1993). A similar mechanism operates in the skin, where 
cutaneous lymphocyte antigen (CLA) mediates lymphocyte binding to dermal 
endothelium via its interactions with E-selectin (Picker 1992). Tissue specific 
endothelial cells produce these address codes. These EC are exposed to different 
stromal and haemodynamic environments depending on which organ they reside in. 
This unique location conditions the EC, which can result in varied phenotype, gene 
expression and signalling producing these unique address codes, leading to 
differential recruitment of leukocytes from the circulation. 
 
I have looked at several organs in this project, from the microvasculature of the skin, 
brain, heart and hepatic sinusoids. Each of these endothelial populations performs 
different functions and in particular play certain roles in the immune system. I will 
highlight in particular how these EC regulate leukocyte recruitment in the specific 
tissues. 
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In general the process of recruitment is the same in most tissue beds; however there 
are some differences, which I will highlight here. It must also be considered that 
much research was conducted in vitro to examine disease processes in the effected 
tissues and ‘normal’ conditions may not be directly physiologically relevant. In 
addition, in order to recapitulate certain in vivo systems in the absence of primary 
cells, immortalised cell lines have been used. 
 
1.5.1 Skin 
 
The skin acts as protective barrier for the internal organs from the external 
environment, combating toxins, pathogens and physical stresses. In order to protect 
the body the skin acts as an efficient immune organ containing a wide array of 
immune-competent cells and inflammatory mediators supplied by the circulation and 
lymphatics. Intercellular adhesion molecule-1 (ICAM-1) has many different effects in 
skin; it is constitutively expressed at low levels on EC, which increase in response to 
pro-inflammatory stimuli, IL-1, TNF-α and IFN-γ in particular. T-Cells can utilise 
ICAM-1: LFA-1 (Lymphocyte function antigen) interactions to adhere to EC’s and 
keratinocytes and migrate into the epidermis, in addition these interactions are 
essential for inducing T-Cell activation as a co-stimulatory signal. In B-Cells LFA-1 
binding to ICAM-1 is thought to reduce the amount of antigen needed to form the 
immunological synapse and activate B-Cells (Carrasco et al. 2004). Expression has 
been found in a number of diseases including cutaneous cancers. In a disease model 
of dermatitis, increased ICAM-1 expression on keratinocytes correlated with a 
mononuclear infiltration. IL-1 and TNF-α produced by keratinocytes can increase 
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ICAM-1 and MHC II expression on Langerhans cells (specialised dermal APC’s) 
having a positive effect on antigen presentation (Kupper 1990). In addition E-Selectin 
and CLA have been proposed as candidates for a ‘skin vascular addressin’ important 
for trafficking leukocytes to the skin (Picker 1992). E-Selectin is expressed on EC in 
inflamed tissues, but in particular in the skin where it is constitutively expressed 
allowing continuous surveillance and increasing in the presence of TNF-α. In addition 
the epithelial-expressed chemokine CCL27 is thought to be involved in homeostatic 
leukocyte recruitment (Kunkel et al. 2002). Neutrophils express the sLEx ligand for E-
Selectin (ELAM-1) and CLA is the suggested candidate on T-Cells. Expression of 
these receptor ligand pairs allows targeted recruitment or homing of specific subsets 
of cells (Henseleit et al. 1999). 
 
1.5.2 The Brain 	  
The human brain contains almost 98% of the body’s neural tissue and weighs 
approximately 1.4kg. Brain size varies between individuals and male brains are on 
average 10% larger compared to females. The brain is an extremely active organ 
requiring large amounts of glucose and oxygen continuously. Blood reaches the brain 
through the internal carotid arteries and vertebral arteries and leaves through the 
internal jugular veins. The most important structure of the brain in the context of the 
report is the BBB, which biochemical isolates the neural tissue from the general 
circulation. Composed of brain parenchymal microvascular endothelial cells, 
ensheathed by astrocytes, foot processes and pericytes, the endothelium of the 
cerebral vasculature contains a large number of tight junctions preventing the 
transport of materials between juxtaposed endothelial cells (Greenwood et al. 2002). 
Only lipid soluble substances such as oxygen and prostaglandins can diffuse across 
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the endothelium into the interstitial fluid of the central nervous system (CNS). Other 
water-soluble compounds and ions are either transported through channels in 
endothelial cell membranes or through active or passive transport. The selective 
permeability characteristic of the BBB is somewhat controlled by astrocytes which 
are in close contact with brain microvascular endothelial cells (BMEC). The 
substances they produce help regulate the functions of the BBB and if destroyed as a 
consequence of brain damage the integrity of the BBB is compromised. The 
cerebrospinal fluid that is responsible for transporting nutrients, chemical 
messengers and disposing of waste products is separate from the blood. In addition 
the ion concentrations and pH can differ vastly from that of the bloodstream. The 
properties of the brain can however be manipulated to administer drugs to treat brain 
disorders or trauma.  
 
Much research is being carried out to shed more light on the role of the BBB. In order 
to study its function many groups isolate cerebral cells including astrocytes and 
BMEC to study the system in vitro. Many methods involve isolating the small 
capillaries and microvasculature of the brain out of which endothelial cells are 
cultured. This has been attempted primarily using bovine brain. Most methods 
involve the removal of the meninges, homogenisation of the tissue, enzymatic 
digestion, followed by either gradient centrifugation or antibody selection/depletion 
(Audus et al. 1996). BMEC appear to retain many morphological and biochemical 
properties present in vivo including cobblestone morphology and the permeability 
properties of the BBB such as the transcellular passage of glucose (Audus et al. 
1996). However it must be considered that once isolated primary cells can begin to 
dedifferentiate in culture due to the absence of external stimuli or direct contact with 
additional cell types present in the physiological environment.  
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The brain is of interest in this context as the physiochemical environment of the brain 
microvasculature, like the liver sinusoid, differs in comparison to most organs. In 
contrast to the sinusoids, brain endothelial cells are exposed to high shear stress and 
are in close contact with surrounding astrocytes (Lui et al. 2003). Due to the varied 
microenvironment the recruitment of leukocytes to cerebral tissues, and the 
molecules involved in subsequent processes are different. In addition circulating 
leukocytes have to overcome the blood-brain barrier (BBB) in order to combat 
inflammation in the brain (Williams et al. 1995). A number of different adhesion 
molecules, ICAM-1, Vascular Cell Adhesion Molecule-1 (VCAM-1) and CD31 are 
involved in the recruitment and transport of leukocytes into the brain parenchyma. 
The function of ICAM-1/VCAM-2 has demonstrated on cytokine stimulated primary 
mouse, rat and human brain microvascular endothelial cells (BMEC) (Xiaoyan et al. 
2001) and inflammatory conditions such as Multiple Sclerosis (MS) including the 
experimental model Experimental Autoimmune Encephalomyelitis (EAE) (Lee et al. 
1999). In particular ICAM-1, CD31 and ICAM-2 are thought to be involved in 
downstream signalling events, via G-protein coupled receptors perpetuating further 
recruitment, due to the induction of cytoskeletal changes creating transmigratory 
cups (Greenwood et al. 2002). In addition experiments examining the effect of 
adenoviral vectors in naïve brain tissue, an issue to be considered in gene therapy, 
found that injection of 1x108 infective units (IU) into brain increased the levels of 
mRNA coding for IP-10, MCP-1 and RANTES, which play a role in the innate 
immune response (Zirger et al. 2006). 
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1.5.3 The Liver 
 
The liver receives blood from two sources, the hepatic artery and the hepatic portal 
vein. Portal blood contains numerous nutrients, waste products and metabolites 
absorbed and produced during digestion. The presence of nutrient-rich portal blood 
means that the liver is constantly exposed to gut derived antigens and particles of 
food and is in a favourable position to metabolise protein, ignore harmless food 
antigens and clear any harmful pathogens, which may enter the system. The liver is 
also an important immunological organ with a large resident population of rapidly 
responsive immune cells providing essential immune surveillance (Lalor and Adams 
2002;Lalor et al. 2002a;Lalor and Adams 1999). The liver contains a large number of 
resident lymphocytes, up to 108 (Racanelli et al. 2006) consisting of CD4+, CD8+, B-
Cells, NK and NKT cells. 
 
Hepatic sinusoidal endothelial cells (LSEC) are a variety of specialised endothelial 
cells that populate the low shear vascular bed of the liver. The most noted phenotypic 
differences are observed between the vascular endothelium in the portal vessels and 
the sinusoidal endothelial cells (Lalor & Adams 2002;Lalor et al. 2002b). In terms of 
leukocyte recruitment, adhesion in LSEC lacks an important rolling step required in 
all other organs. Selectins are not essential for recruitment, leukocytes were initially 
thought to become physically trapped in the small sinusoids but further studies have 
found ICAM-1 and VCAM-1 to be important. In addition adhesion can occur via 
integrin dependent or independent mechanisms such as the non-classical pathway 
involving Common Lymphatic Endothelial and Vascular Endothelial Receptor-1 
(CLEVER-1), the mannose receptor or CD44 and Vascular Adhesion Protein-1 (VAP-
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1) (Lee et al. 2008). Recruitment in portal and central venules of liver is similar to the 
standard paradigm. 
 
1.5.4 Heart 
 
The endothelium plays an important role in cardiac health, protecting the heart from 
infection and resolving inflammation (Hillis et al. 1998). However, EC also contribute 
to inflammatory disorders and atherosclerosis having adverse effects on the heart. In 
bacterial endocarditis, plasma levels of E-Selectin, VCAM-1 and ICAM-1 are elevated 
(B.Soderquist et al. 1999). It has been postulated that the increased levels of E-
Selectin released are related to the degree of vascular injury caused by sepsis. 
Increased levels of ICAM-1, VCAM-1, E-Selectin, CD34 and CD31 were found on 
inflamed, degenerated and florid heart valves suggesting adhesion molecule 
mediated leukocyte recruitment and activated endothelium implicating EC in disease 
pathogenesis and complications such as thromboembolism (Muller et al. 2000). 
However it cannot be distinguished whether this is a result of local adhesion 
molecule release at the site of disease or systemic infection. ICAM-1 and VCAM-1 
were also implicated in the infiltration of CD8+ T-Cells in the cardiac tissue of patients 
with severe cardiomyopathy (Haverslag et al. 2008). 
 
1.6 Modulation of EC responses by their environment 
 
There is growing evidence that functional responses of endothelial cells can be 
modulated by the local physiochemical environment (Nash et al. 2004). One aspect 
briefly considered in the current project is to examine the effect of haemodynamic 
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forces on the ability of EC to recruit leukocytes. These forces affect intra-cellular 
signalling, secretion, and protein and gene expression (Chien et al. 1998;Jalali et al. 
1998). In addition, underlying stromal cells and substrate can modify EC phenotype 
and their ability to recruit leukocytes (Aird 2003;Nash et al. 2004). In particular EC 
cultured with smooth muscle cells were shown to have an augmented response to 
oxidised LDL judged by the ability to bind monocytic cells (Kinard et al. 2001). In 
addition EC cultured with alveolar epithelium showed increased recruitment of 
leukocytes upon cytokine stimulation (Eghtesad et al. 2001). Interestingly the specific 
phenotype of endothelial cells isolated from different tissues may be retained in vitro 
for extended periods (Nash et al. 2004). For instance, isolated murine cardiac and 
lung EC, both supported adhesion of flowing T-cells, but were shown to use different 
mechanisms. Cardiac EC after stimulation with TNF-α were found to used VCAM-
1:VLA-4 and RANTES:CCR5 induced mechanisms, whereas in lung EC, ICAM-1, 
MIP-2 and MIP-1β were thought to be important (Lim et al. 2003).  
 
1.6.1 Modulation of EC responses by shear stress  
 
Vascular endothelium is exposed to a number of different haemodynamic forces. 
These include the frictional shear stress imposed by the bloodstream and hydrostatic 
pressure acting perpendicular to the vessel wall, which exerts compression and 
circumferential strain (Matharu et al. 2006). The most widely studied of these forces 
is shear stress (Lelkes 1999). Shear stress varies in different organs and throughout 
the vasculature, with arterial stress in the range of 1 to 4 Pa in comparison to 0.05 to 
2 Pa in the microcirculation, where leukocyte recruitment takes place. Variation in 
shear stress is dependent on local pressure gradients, flow rate and the diameter of 
the vessels (Matharu et al. 2006). The type of blood flow is also variable, with 
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undisturbed laminar flow (LF) present within the microcirculation and some straight 
larger vessels. Arterial blood flow is not only pulsatile as a result of the cardiac cycle 
but there are also some areas of disturbed flow due to curvature of the arteries or 
bifurcations (Caro et al. 1969;Cunningham et al. 2005;Libby et al. 2005). 
 
Endothelium responds to changes in haemodynamic forces by rapidly releasing a 
number of vasoactive substances including NO. Over time shear stress can also 
modify levels of expression of genes, a number of which are involved in leukocyte 
recruitment (Matharu et al. 2006). The altered expressions of some of these genes 
are too short lived to have a prolonged effect on leukocyte recruitment. The above 
supports the theory that initial exposure to shear or changes in shear cause transient 
responses, while prolonged exposure establishes a new phenotype with, for 
instance, altered response to pro-inflammatory cytokines. Studies have found that 
long-term exposure to shear inhibited TNF-α induced activation of NFkB and the 
associated upregulation of adhesion molecules and chemokines (IL-8 and Gro-α) in 
HUVEC (Sheikh et al. 2005). This is important because the ability of EC’s to alter 
their phenotype under varying shear stresses could be important in situations where 
blood flow is disturbed such as ischemia/reperfusion and altered flow as a result of 
surgery (Nash et al. 2004). 
 
1.7 The use of mouse models in research of human disease 
 
One of the main aims of this project was to create an effective murine flow model to 
examine leukocyte recruitment as a useful standard to which comparisons could be 
made to the behaviour of isolated primary cells in vitro. The question is, why use 
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mice, when the ultimate aim is to apply any data obtained to the human situation? 
Murine models are a useful experimental research tool. They provide a great amount 
of flexibility and allow you to model tissues that are difficult to access in humans or 
are not freely available for experimental analysis. Models also provide a controlled 
environment in which you can test various reagents and knockdown genes i.e. 
knockout mice. In addition in vitro culture systems can be exposed to conditions not 
subject to manipulation in a whole animal systems in for example, intra-vital 
microscopy. 
 
Several mouse models of human disease have been developed including cancer, 
neurodegenerative, neuromuscular, hearing and sight disorders and immunological 
and haematological disorders (Bedell et al. 1997b). Comparisons have been made 
between human and mouse genetic maps. These genetic and physical linkage maps 
enable identification of homologous genes and generation of mutants that closely 
resemble the human disease phenotype (Bedell et al. 1997a). In addition, the 
location of disease-associated genes discovered in mice can predict the location of 
the human locus. There are several different methods of creating mouse models 
including inbred, congenic and recombinant inbred strains allowing manipulation of 
several different parameters (Frankel et al. 1995). Transgenic mice were first 
developed in the 80’s by injecting foreign DNA into the germline of mice. The animals 
containing this human disease gene could be studied to track disease pathogenesis 
and effectiveness of treatment regimes. Scientists could examine the response of 
different strains and examine interactions of genes. However there are issues with 
transgenic strains as the gene may be located within introns, misexpressed or 
integrate into other genes disrupting function (Wilson et al. 2003). Knockout mice are 
a result of the introduction of specific mutations in endogenous genes that can 
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transmit through the germ line (Melton et al. 1994). Mutations are created via 
homologous recombination in embryonic stem cells (mES), which contribute to all cell 
lineages when injected into blastocyts, although many are embryonically lethal 
(Bedell et al. 1997a). Strain specificity can impact on disease phenotype as unlinked 
genes can have a dramatic effect on disease outcome. For example, null mutations 
in the epidermal growth factor receptor (EGFR) gene were found to cause defects 
including peri-implantation and juvenile lethality in mice from CF-1, 129/SvJ and 
C57BL/6 background (Threadgill et al. 1995).  
 
Although it is possible to create models where single specific genes are altered a 
number of the most important diseases such as cancer, diabetes and obesity are 
caused by the combination of several mutations in different loci. In addition some are 
genetically inherited but can be affected by somatically acquired mutations or 
environmental factors, called quantitative trait loci (QLT’s). Several QLT’s of human 
disease have been identified in mice, including atherosclerosis (Hyman et al. 1994), 
epilepsy (Frankel et al. 1994) and obesity (West et al. 1994). In the context of this 
research inflammatory and immune disorders are of particular relevance. Models of 
autoimmunity have helped to model diseases such as lupus, arthritis and diabetes 
(Bedell et al. 1997b). Studies on lymphoproliferation (lpr) and generalised 
lymphadenopathy (gld) have shown the importance of apoptosis in the maintenance 
of immune self-tolerance. Sufferers of autoimmune lymphoproliferative syndrome 
(ALPS) have been found to have mutations in the Fas gene. Fas Ligand was found to 
be mutated in gld mice (Fisher et al. 1995;Singer et al. 1994). In addition several 
models have been created to examine the role of Apoe and Ldlr in atherosclerosis. 
Homozygotes for the Apoe null mutations develop severe hypercholesterolemia and 
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atherosclerotic lesions at a young age, even when fed a low fat diet (Knecht et al. 
1995). 
 
Knockout mice can be used to examine the process of leukocyte recruitment and the 
role of each step in successful adhesion and migration. If functioning correctly, the 
recruitment of leukocytes is an essential mechanism for combating invading 
pathogens. If however, this process is modified or malfunctions in some way, as is 
the case in some autoimmune diseases, it can lead to undesirable consequences. If 
recruitment is ineffective it can increase the host’s susceptibility to infection leading to 
recurrent or persistent infections, which are never resolved effectively. In leukocyte 
adhesion deficiencies for example, functional defects in neutrophil adhesion 
molecules such P-selectin or β2 integrins lead to poor recruitment to the site of 
infection due to impaired neutrophil adherence (Resenzweig et al. 2002). Smith et al 
(Smith et al. 1988) showed that polymorphonuclear lymphocytes (PMN) from LAD-1 
patients could bind to activated human umbilical vein endothelial cells (HUVEC), but 
they couldn’t transmigrate. On the other hand if recruitment is uncontrolled it can 
result in adherent neutrophils releasing their lysosomal enzymes inappropriately for 
example in vasculitis (Calderwood et al. 2005). If clearance of tissue resident 
apoptosing neutrophils is deregulated it can lead to chronic inflammation and organ 
damage (Morgan et al. 2005). 
 
The advent of intravital microscopy has enabled researchers to examine leukocyte 
recruitment in real time in vivo. Although a remarkably useful experimental tool, it is 
difficult to examine tissue specific recruitment, as whole tissues are difficult to 
visualise microscopically. The majority of experiments manipulate parameters of 
recruitment in the mesentery and cremaster muscle as they are easily 
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transilluminated. Recruitment and transmigration can be investigated in liver 
(Zarbock et al. 2009). Due to the multi-lobular structure of rodent livers it is only 
possible to visualise recruitment in the edges of liver lobes and it is difficult to 
observe post-sinusoidal events. Multi-photon microscopy allows deeper tissue 
penetration and higher resolution.  
 
Intra vital systems are physiologically relevant as they are performed in vivo, 
however there are drawbacks as discussed above, for example factors affecting the 
physiochemical environment cannot be easily manipulated. Primary isolated 
endothelium and immortalised cell lines can be cultured in vitro easily treated and 
exposed to biological and physical stimuli. 
 
1.8 Isolating primary murine endothelial cells 
 
Tissue specific variation in leukocyte recruitment is a widely accepted idea. However 
direct comparisons and extrapolation linking phenotypic variations to functional 
differences has not been made. One of the ultimate aims of this research was to 
highlight tissue specific phenotypic and functional variations by examining endothelial 
cells from heart, skin, brain and liver sinusoids. Details of specialised recruitment 
have been discussed in previous sections. However, attempts were made to isolate 
primary endothelial cell populations from murine brain and liver discussed in more 
detail here. 
 
Several groups have published data detailing the isolation of primary murine 
endothelial cells from a number of different tissues, including, lung, heart, fat pad, 
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aortic rings (Marelli-Berg et al. 2000), liver (Katz et al. 2004) and brain (Wu et al. 
2003). These EC populations are used to study endocytosis (Smedsrod et al. 1985), 
immunological function (Knolle et al. 1999), EC marker expression, angiogenesis, 
metastasis and endothelial specific roles in complex pathologies such as 
atherosclerosis among others. Most methods involve dissociation of the tissue in 
question using physical or enzymatic techniques. Cells can be separated on the 
basis of size or buoyant density and further purified using negative or positive 
antibody selection methods. 
 
1.9 Isolating human endothelial cells 
 
Unlike isolating murine endothelium, there are well-defined methods for isolating 
primary human endothelial cells, in particular human umbilical vein endothelial cells 
(HUVEC) and human sinusoidal endothelial cells (hLSEC). Much research examining 
endothelial cell behaviour has been done using HUVEC due to availability of tissue 
and ease of isolation (Jaffe et al. 1973). The umbilical veins are cannulated and 
digested using proteolytic enzymes (collagenase) to release the endothelial layer, 
which is then washed out and cultured on collagen-coated tissue plastic in medium 
199 in the presence of human serum (Cooke et al. 1993). The isolation of hLSEC is 
more complicated, the tissue is dissociated and digested using collagenase, non-
parenchymal cells are separated on the basis of buoyant density on a Percoll 
gradient. Contaminating biliary epithelial cells are removed by negative magnetic 
bead selection using HEA-125 followed by positive endothelial cell selection using 
CD31. hLSEC are cultured in human basal endothelial cell medium, with PSG, 
human serum, Hepatocyte growth factor (HGF) and vascular endothelial cell growth 
factor (VEGF) (Lalor et al. 2000b;Lalor & Adams 1999).  
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Although research involving macrovascular endothelium has provided useful insights, 
more interest lies in the microvasculature as this is where disease processes tend to 
occur. Isolation methods here prove more challenging as it is not possible to use 
cannulation. The majority of methods use physical dissociation of whole tissue 
followed by enzymatic digestion. Initial isolation methods involved allowing isolated 
cells to adhere and identifying cells with cobblestone morphology. In addition to 
endothelial cells, there were also contaminating adherent cells including fibroblasts, 
which tend to outgrow other cell populations. EC also have the propensity to 
differentiate in culture in response to the composition of culture medium. In order to 
minimise contamination a variety of purification methods can be used, cell 
preparations can be separated by size with meshes or filters of varying pore sizes 
and/or buoyant density via density gradient purification (Percoll, Optiprep). The 
desired endothelial population can then be positively/negatively selected using 
endothelial markers such as acetylated low-density lipoprotein (AcLDL) with flow 
cytometry or magnetic bead selection with CD31/CD146.  
 
When the desired population of cells is obtained the challenge is then to maintain the 
phenotype of freshly isolated cells in vitro. Human cells require the presence of 
human serum in culture, whereas the inclusion of autologous serum in murine 
cultures is controversial, as serum has been shown to be toxic (Martinez et al. 2008). 
In both cases it is important however, to provide an artificial matrix to for the cells to 
adhere to, be it gelatin, collagen, fibronectin, vitronectin etc.  
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It is crucial to be able to phenotype and identify primary isolated cell populations. 
There are a number of characteristic endothelial cell features including CD31, CD34, 
and vWF (von Willebrand Factor) expression, uptake of ac-LDL, binding of lectins, 
‘cobblestone’ morphology and the propensity to form tubes in matrigel. Although 
largely present on populations of endothelial cells these features are not universal 
and are more than likely to vary temporally and spatially in vitro and in vivo and 
between cultures accounting for their marked heterogeneity. vWF has been reported 
in sections of human liver, whereas expression is variable in cultured hLSEC. Studies 
using rat LSEC found that shortly after isolation CD31 is expressed intracellularly but 
after prolonged culture when LSEC dedifferentiate and lose characteristic 
fenestrations CD31 is found on the surface as with most other endothelium. As I 
previously mentioned EC are highly endocytic a number of scavenger receptors can 
be used to identify LSEC including stabilin-2 and Lymphatic Vessel Hyaluronan 
Receptor-1 (LYVE-1).  
 
1.10 The Human Liver 
 
The liver is the one of the largest organs in the human body, weighing approximately 
1.4kg in women and 1.6 kg in men. Second in size only to the skin it is located in the 
right upper portion of the abdomen sitting underneath the diaphragm and protected 
by the rib cage. Consisting of two lobes, the larger right is separated from the left by 
the falciform ligament. The gall bladder, a pear shaped organ around 7-10 cm in 
length stores bile produced by hepatocytes is situated in a depression on the 
posterior surface of the liver. Bile is required to assist the digestion of fats by 
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emulsifying the fat into droplets, increasing the surface area upon which various 
lipases can hydrolyse the fat. 
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Figure 1. 3: Schematic of hepatic microvascular subunits and the portal triads.  	  
Schematic diagram demonstrating the finer structure of human liver. Each of the 
hexagonal microvascular subunits consists of plates of hepatocytes. At each corner 
are the portal triads made up of branches of the hepatic artery, hepatic portal vein 
and bile duct. Blood flows from here through the fine sinusoids and drains through 
the central vein. 
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The liver receives blood from two sources, the hepatic artery provides around one 
third, delivering oxygenated arterial blood from the general circulation. The remaining 
blood flow is supplied by the hepatic portal vein, which supplies deoxygenated blood 
directly from various points along the gastrointestinal tract. Portal blood contains 
numerous nutrients, waste products and metabolites absorbed and produced during 
digestion. Blood from both sources then flows through the liver tissue and out 
through branches of the central vein. 
 
Each of the liver lobes consists of many lobules or ‘hepatic microvascular’ subunits 
(Matsumoto et al. 1982). These lobules are the main functional unit of the liver (Fig. 
1.3) Separated by various blood vessels and connective tissues they have a 
characteristic hexagonal shape consisting of rows of hepatocytes radiating out from 
the central hepatic vein. Located at the corners of each lobule are portal triads, 
comprising of branches of the hepatic artery, hepatic portal vein and bile duct. 
Radiating out from the portal triad, forming an irregular vascular network throughout 
the hepatocytes are the blood filled liver sinusoids that create a connection to the 
central vein. Blood entering the liver flows through the sinusoids and over the rows of 
hepatocytes before collecting in the central vein (Sherlock et al. 1993). 
 
This characteristic dual blood supply enables the liver to perform its biological 
functions absorbing, metabolising, storing and detoxifying macromolecules and 
clearing foreign antigens from the blood. The presence of nutrient-rich portal blood 
means that the liver is constantly exposed to gut derived antigens and particles of 
food and is in a favourable position to metabolise protein, ignore harmless food 
antigens and clear any harmful pathogens, which may enter the system. The liver is 
also an important immunological organ with a large resident population of rapidly 
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responsive immune cells providing essential immune surveillance (Lalor & Adams 
2002;Lalor et al. 2002b;Lalor & Adams 1999). 
 
1.11 Immortalisation of cells 
 
Due to the difficulty of isolating primary cell populations immortalised cell lines have 
been developed to allow further research and understanding of endothelial cell 
function. Two methods of immortalisation have been developed utilising viral 
mechanisms to prevent senescence. Care must be taken when utilising cell lines as 
the immortalisation process can result in phenotypic changes or an altered response 
to cytokines. H-2KB-tsA58 transgenic mice express a thermolabile strain (tsA58) of 
the simian virus (SV40) large T-Antigen linked to an inducible major histocompatibility 
complex H-2K promoter. T-Ag expression is only apparent when cells are cultured at 
the lower temperature of 33°C and promoter activity can be up regulated by the 
addition of IFN-γ. I have utilised a cardiac endothelial cell population using this 
method. mUCEC-1 have been shown to rapidly expand in culture, respond to growth 
factors and cytokines (TNF-α, IL-1β and LPS) and express appropriate adhesion 
molecules involved in leukocyte recruitment including CD31, Endoglin, ICAM-1/2, 
and VCAM-1 (Lidington et al. 2002). In addition cells can be isolated from 
hemangiomas (vascular tumours) generated by a retroviral construct encoding 
polyoma middle-sized T-Ag from skin, heart, brain and whole embryos. The 
remaining s.End (Bussolino et al. 1991) and b.End.5 (Rohnelt et al. 1997) cells used 
in my project were immortalised using this method (Bussolino et al. 1992).  
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1.12 Genomic Analysis: Gene Array Technologies 
 
The use of array analysis in scientific research is ever increasing allowing the study 
of whole organism biology and how proteins, genes and other molecules interact to 
alter the behaviour of organisms. Several types of arrays exist from macro to micro 
investigating areas associated with proteomics, metabolomics and genomics 
(Hobman et al. 2007). 
 
DNA microarrays in particular allow genomic analysis of cells or organisms. This 
technology relies on detecting interactions between molecules immobilised to a solid 
substrate with a complex mix of nucleic acids in solution. Nucleic acids (DNA/RNA) 
bind to complimentary sequences under optimal salt concentrations in solution and 
temperatures. Comparisons can be made between treatment groups independently 
or in competition with each other to examine differentially expressed genes 
(transcriptional profiles) (Zheng et al. 2007). 
 
RNA samples are run on ‘in house’ or commercially available arrays, most of which 
consist of immobilised oligonucleotides. Fluorescently labelled nucleotides (cDNA) 
bind to the probes, images of which are obtained by scanning the array producing a 
map of spots to which opposing sequences have bound representing the level of 
transcription of that gene. Data is subjected to stringent statistical analysis to remove 
outliers and are then further selected on the basis of a fixed fold-change (Loos et al. 
2001). Gene lists can be used to generate graphical representations of expression to 
highlight differences between populations or treatment groups. Further pathway 
analysis can generate data indicating which biological pathways or processes 
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differentially expressed genes are involved in providing an interesting insight into the 
data obtained. 
 
A large amount of DNA microarray data is available, and some concerns mouse 
models of disease, in particular in this context inflammatory diseases such as 
atherosclerosis (Yuan et al. 2009) and psoriasis (Wolfram et al. 2009). Studies on 
endothelial cells from murine aortic walls in mice susceptible to atherosclerotic lesion 
formation showed between 590 and 1514 differentially expressed genes (Kobayashi 
et al. 2005). Subsequent pathway analysis suggested a role for calcium signalling in 
regulating atherosclerosis (Yuan et al. 2009). In addition genome wide analysis on 
skin from a murine model of scleroderma discovered differences in chemokine 
(CCL2, MIG etc), growth factor (VEGF-α, FGF-1) and adhesion molecule (VCAM-1 
and Selectins) expression consistent with inflammatory conditions (Zhou et al. 2006). 
The use of this experimental tool may expose useful therapeutic targets and provide 
insights into disease pathology allowing the progression of research. 
 
In the current study, broad phenotypic analysis was carried out using whole genome 
murine oligo gene arrays. However we selected specific genes from the whole array, 
in order to compare the phenotypes of the specific endothelial cells. We included a 
panel of common ‘endothelial phenotypic markers and adhesion markers which are 
described below.  
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1.13 Endothelial cell markers 
 
The expression patterns of a number of different endothelial cell markers were 
examined on endothelium from all organs.  
 
1.13.1 CD34 
 
CD34 is a 105-120 kDa type 1 transmembrane sialomucin protein expressed of 
haematopoietic precursors and on the vascular endothelium of several organs 
(Baumhueter et al. 1994). It has been discovered that peripheral blood cells positive 
for CD34 can differentiate into ECs. In humans this molecule is not normally found on 
the sinusoidal endothelium (Couvelard et al. 1993;Daneker et al. 1998), except 
during disease in a process known as ‘capillarisation’ (Cui et al. 1996;Frachon et al. 
2001). Although CD34 can be used as marker for sinusoidal neoangiogenesis in 
hepatocellular carcinoma in conjunction with VEGF (Ohmori et al. 2003). The 
expression of this molecule in rodent models has been studied by Baumhueter et al 
(Baumhueter et al. 1994) and was found that the global expression of murine CD34 
on vascular tissues and its ability to act as a ligand for L–selectin was dependent on 
various posttranslational carbohydrate modifications and that an appropriately 
glycosylated form of CD34 could mediate leukocyte trafficking to both lymphoid and 
non-lymphoid tissue. 
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1.13.2 Endoglin 
 
Endoglin or CD105 is a transmembrane glycoprotein of 658 amino acids residues 
that contains an extracellular domain, a single transmembrane domain and a short 
intracellular domain. Acting as a TGF-β type 3 auxiliary receptor (Cheifetz et al. 
1992), endoglin is normally expressed as homodimers on the cell surface linked by 
disulfide bridges, which has been observed on the surface of microvascular 
endothelial cells (ten Dijke et al. 2008). Endoglin is thought to be expressed on most 
endothelial cells to some extent with levels increasing in activated vascular 
endothelial cells at sites of angiogenesis, inflammation and wound healing (Goumans 
et al. 2008). Its involvement in vascular development, remodelling and angiogenesis 
(Duff et al. 2003;Fonsatti et al. 2004) and elevated levels of expression in cancerous 
tumours make it attractive as a potential therapeutic target (Carmeliet et al. 2000).  
 
1.14 Adhesion molecules involved in leukocyte binding to endothelial cells 
 
The pattern of adhesion molecule expression varies in the presence or absence of 
inflammation. This allows targeted recruitment and infiltration of specific leukocyte 
subsets to tissues providing the correct combination of molecules. These adhesion 
molecules can be grouped according to not only structure and function but also the 
stage of recruitment they are involved in. 
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1.14.1 The Selectins 
 
Selectins are a group of adhesion molecules involved in the intial tethering and rolling 
stages of leukocyte recruitment of which there are 3 types L, P and E-Selectin. These 
calcium dependent type 1 transmembrane glycoproteins are classified by the cell 
type in which they were discovered, leukocytes, platelets and endothelium 
respectively. Selectins consist of a common N-terminal lectin domain, an epidermal 
growth factor domain, a variable number of concensus repeats (CR), a single 
transmembrane domain and a short cytoplasmic tail. Variation in the number of CR’s 
and within the N-terminal domain accounts for differences in adhesion molecule 
function. If the number of CR’s is altered it can alter the ability of selectins to tether 
leukocytes (Patel et al. 1995). Both E and P-Selectin have been shown to be critical 
for leukocyte recruitment in intravital studies (Lawrence et al. 1991;Zimmerman et al. 
1991;Zimmerman et al. 1992), however more recent studies have shown that they 
are not essential as CD44, CD34 and VAP-1 can replace them.  E-Selectin 
(CD62E/ELAM-1) is expressed rapidly and synthesised de novo in activated 
endothelium in response to inflammatory mediators. During an inflammatory 
response P-Selectin is immediately trafficked to the cell surface from Weibel-Palade 
bodies, followed closely by E-Selectin leading to enhanced leukocyte recruitment and 
decreasing rolling velocity, increasing the chances of firm adhesion to the 
endothelium. Selectins bind to heavily glycosylated carbohydrate or mucin ligands 
including sialyl lewis and P-Selectin glycoprotein ligand (PSGL-1). E-Selectin binds 
both of these ligands, in addition to CD43, CD44 and E-Selectin ligand-1.   
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1.14.2 The Integrins 
 
Integrins are involved in tight adhesion of the leukocyte to the endothelium. 
Chemokines present on the vascular surface activated the leukocytes leading to high 
affinity adhesion through integrins and their receptors. 
 
1.14.2.1 ICAM-2 	  
ICAM-2 (intracellular adhesion molecule-2) is a member of the Ig gene superfamily 
which share a limited sequence similarity which conserves their tertiary structure. 
Intracellular adhesion molecule 2 is a critical player in lymphocyte recruitment and 
extravasation (Li et al. 1993). ICAM-2 or CD102 is constitutively expressed on 
endothelial cells even in their resting state and is essential for interaction of 
lymphocytes and endothelial cells through integrins in particular for ICAM-2, LFA-1 
(lymphocyte function-associated antigen 1; αL β2) expressed on circulating 
leukocytes (Oppenheimer-Marks et al. 1991) (Reiss et al. 1998), This expression in 
unstimulated endothelial cells implicates ICAM-2 in the process of immune 
surveillance where leukocytes traffic through uninflamed tissues. It has been shown 
by Reiss et al that if ICAM-2-deficient mouse endothelioma cells are used in a 
transmigration assay the migration of T-cells across the endothelial surface was 
greatly inhibited compared to the migration across wild type cells treated with anti-
ICAM-2 functional blocking antibodies (Reiss et al. 1998). 
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1.14.2.2 VCAM-1 
  
Vascular cell adhesion molecule or CD106 is another member of the large Ig gene 
superfamily expressed on activated endothelium and a ligand for VLA-4 (very late 
antigen α4 β1) (Steinhoff et al. 1993;Scoazec et al. 1991;Worthylake et al. 2001). 
VCAM-1 is involved in the initial step of the leukocyte recruitment cascade ‘tethering 
and rolling’ of the leukocyte in conjunction with the E and P- Selectins, although 
under flow conditions VCAM-1 supports the capture of leukocytes at lower shear 
stresses than the selectins and is thought to effectively capture eosinophils. 
Expression of VCAM-1 is required de novo and synthesis peaks 24 hours after 
stimulation (Reinhardt et al. 1998). 
 
1.14.3 Junctional Molecules 
 
Following tight adhesion to the endothelial surface the leukocytes must then enter the 
surrounding tissues to home to the site of inflammation. In order to do this they must 
traverse the endothelial cell barrier and underlying basement membrane and stromal 
cells. A number of different adhesion molecules are expressed at endothelial cell 
junctions aiding the process of transmigration and extravasation. 
 
1.14.3.1 CD31 
 
CD31 or PECAM-1 (platelet/endothelial cell adhesion molecule) can be used as a 
pan-endothelial marker. It is a transmembrane glycoprotein of ~ 130 kDa (Schenkel 
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et al. 2004;Newman et al. 1990). A member of the immunoglobulin superfamily 
(Newton et al. 1999) it has been shown to be important in mediating both homo and 
heterophilic cellular interactions (Delisser et al. 1993;Piali et al. 1995;Zocchi et al. 
1996) and be involved in signalling events accredited to two ITIM (Immunoreceptor 
tyrosine-based) motifs on the cytoplasmic tail (Schenkel et al. 2004). This cell 
adhesion molecule has six Ig-like domains and is abundantly expressed on 
endothelial cell borders and diffusely over the surface of platelets, monocytes, 
neutrophils and subsets of T-Cells. CD31 is widely used, as a marker of ‘continuous’ 
or classic vascular endothelium but the presence of this marker on LSEC remains 
controversial. CD31 has been shown to be expressed on liver sinusoidal endothelial 
cells in primary biliary cirrhosis liver biopsies. The tubule like expression pattern of 
CD31 in conjunction with VCAM-1 is an indicator of neovessel development in an 
attempt to repair liver damage (Medina et al. 2005). It has however been shown in 
rodent studies to be present in normal sinusoidal endothelium (Neubauer et al. 
2000a) (Do et al. 1999). It has been suggested however that in disease CD31 is 
down regulated on LSEC after treatment with pro-inflammatory factors such as 
Carbon tetrachloride (CCl4) and TNF-α as observed in cultured rat endothelium 
(Neubauer et al. 2000b). Conversely CD31 expression has also shown to be absent 
in normal tissue and this expression profile along with CD4 expression can be used 
as a method of isolating rodent LSEC cells (Knolle et al. 1999). CD31 has shown to 
be very important in influencing several aspects of leukocyte migration and is thought 
to create a haptotactic (surface bound) gradient directed toward the intercellular 
junctions guiding leukocytes through their migratory route (Neubauer et al. 2000a).  
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1.14.3.2 JAM-2  
 
JAM-2 or junctional adhesion molecule 2 is a member of the JAM family of which 
there are three members (Luscinskas et al. 2002b). The JAM’s are also members of 
the Ig superfamily, and one of three transmembrane proteins present in intercellular 
tight junctions along with occludin and claudin (Johnson-Leger et al.  2003;Muller 
2003). JAM-2 has been shown to localise to newly formed cell-cell junctions within 
minutes (Johnson-Leger et al.  2000). It has been postulated that JAM-2 may interact 
with JAM-3 to mediate lymphocyte homing (Luscinskas et al. 2002b). Although JAM-
2 may bind to JAM-3 it may also interact with many other molecules including GM-
CSF (Granulocyte Macrophage- Colony Stimulating Factor), several subsets of 
circulating NK (Natural Killer) cells and T-cell lines. The role of JAM-2 in 
transendothelial migration of lymphocytes has also been investigated. JAM-2 is 
highly expressed during embryogenesis (Aurrand-Lions et al. 2002b;Johnson-Leger, 
et al. 2000;Michel Aurrand-Lions et al. 2001) and then in adult populations it 
becomes restricted to the endothelium of HEV’s present in secondary lymphoid 
tissue such as the spleen and Peyer’s patches (Johnson-Leger et al. 2002; Aurrand-
Lions et al. 2001). In murine cases JAM-2 has shown to greatly increase the 
proportion of lymphocytes migrating across endothelioma cells in monolayer culture 
(Johnson-Leger et al. 2002). Also in a human experimental system using HUVEC 
cultured on transwell inserts when abrogated using anti-JAM antibodies or soluble 
JAM, the transmigration of peripheral blood leukocytes across the HUVEC, which 
express JAM-2 was blocked. The same group obtained results that suggest this is 
also true in the murine system (Johnson-Leger et al. 2002). 
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1.14.3.3 CD99 
 
CD99 is a heavily glycosylated transmembrane protein around 32 kDa and is another 
member of the Ig superfamily of adhesion molecules (Luscinskas et al. 
2002a;Luscinskas et al. 2002b). Present on a broad range of haematopoietic cells it 
is thought by Schenkel et al (Schenkel et al. 2002) to be localised to the endothelial 
cell to cell borders and in addition on the surface of peripheral blood monocytes 
(Schenkel et al. 2002). It has been postulated that CD99 plays an important role in 
monocyte transmigration mediating the interaction between CD99 present on the two 
opposing cell types, although it is not known as yet whether CD99 plays the same 
role in the migration of other lymphocyte subsets (Luscinskas et al. 
2002a;Luscinskas et al. 2002b). When blocked, diapedesis of monocytes was 
reduced by 90% distal to the point of action mediated by CD31, when both these 
molecules were blocked transmigration was almost completely abolished (Schenkel,  
et al. 2002).  
 
1.15 Markers of mLSEC 
 
In addition to traditional endothelial cell markers and adhesion molecules involved in 
the recruitment cascade, the expression of sinusoidal associated molecules was 
assessed in this study. LYVE-1 and VAP-1 expression is not limited to LSEC 
however the presence of these molecules in addition to other physical sinusoidal 
characteristics such as fenestrations can be used to identify LSEC. As mentioned 
previously, no one marker can be used to identify mLSEC populations rather a set of 
characteristic properties. 
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1.15.1 LYVE-1 
 
LYVE -1 is one of a number of receptors for hyaluronic acid (HA) an extracellular 
matrix mucopolysaccharide. It has been suggested that the ability of LYVE-1 to bind 
hyaluronic acid (HA) in liver sinusoidal endothelial cells could be a process that is 
tightly regulated in vivo (Jackson et al. 2001;Jackson 2003). In diseased livers, in 
particular cirrhosis and primary liver cancer or HCC (hepatocellular carcinoma), the 
expression of LYVE-1 is unusual as it is absent in tumour blood vessels and 
regenerative hepatic nodules which develop in cirrhotic livers, this absence however 
is not seen in the lymphatics of diseased patients. There is a difference in the 
vascular structures of normal and diseased livers, in diseased livers the sinusoids 
resemble capillaries, identified by decreasing number and diameter of the 
characteristic fenestrae and the appearance of a basement membrane and increased 
serum HA (Fausto et al. 1991). In cirrhosis these characteristic symptoms of 
capillarisation could be due to TGF-β (transforming growth factor beta) having 
adverse effects on the fenestrae and increasing HA synthesis by Ito cells and hepatic 
stellate cells involved in liver fibrosis. HA is a key molecule involved in cell migration 
during inflammatory responses, wound repair and embryogenesis (Reed et al.  1992) 
it is turned over rapidly with a half life of ~24 hrs (Prevo et al. 2001;Reed et al. 1992). 
The majority of these HA-binding proteins contain a HA-binding domain called the 
‘Link’ module, only one of these receptors is a cell surface receptor, CD44 an 80-95 
kDa protein expressed on leukocytes and erythrocytes to which LYVE-1 has 
significant homology (Jackson et al. 2003;Kohda et al. 1996). In CD44 knockout mice 
it is thought that LYVE-1 may compensate for its function in binding HA in response 
to pro-inflammatory cytokines and directing extravasation of leukocytes. LYVE-1 was 
also discovered to be an important molecule in the lymphatics as expression is high 
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on human, mouse and rat endothelial cells (Banerji et al. 1999). It has also been 
found in distinct cohorts of activated tissue macrophages and on LSEC and 
endothelial cells of the spleen, sites where HA is taken up and degraded (Carreira et 
al. 2001;Grant et al. 2002). 
 
1.15.2 VAP-1 
 
Vascular adhesion protein 1 is a homodimeric 170 kDa sialylglycoprotein (Kirton et 
al. 2005) which possesses dual functionality as both a semicarbazide sensitive amine 
oxidase (SSAO) which catalyse oxidative deamination of primary amines and an 
adhesion molecule regulating leukocyte transmigration (Salmi et al, 2001). Identified 
in the late 1980’s VAP-1 was first characterised as an endothelial molecule acting as 
an ‘address code’ for lymphocyte homing to inflamed joints. Expression of VAP-1 
however is not solely isolated to the synovial vessels it was first discovered in. 
Staining with monoclonal antibodies directed against VAP-1 indicated that it is 
expressed in high endothelial venules (HEV’s) in lymphatic organs, LSEC and the 
small vessels of other tissues (Salmi et al, 2001) but unusually absent from all 
leukocytes. Another form of VAP-1 with different oligosaccharide modifications is 
however expressed in other cells such as adipocytes, pericytes and smooth muscle 
cells suggesting that these two forms may have differential functions (Jaakkola et al. 
1999). 
 
 The level of VAP-1 expression seems to be tightly controlled. VAP-1 is stored in 
intra-cellular granules and expression has been shown to be induced in pigs and 
dogs only in inflammatory situations, indicated by examining the distribution of 
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intravenous anti VAP-1 monoclonal antibodies (MAbs) throughout the whole 
experimental animal (Salmi et al. 2001). This expression pattern is similar to P-
selectin, which is selectively expressed upon inflammation. In flow systems designed 
to mimic the shear stresses of in vivo situations, VAP-1 expressed on hLSEC, rabbit 
endothelium and transfected rat endothelium has shown to bind flowing lymphocytes, 
but knockout models indicated that the absence of VAP-1 leads to increased rolling 
velocity and decreased rate of leukocyte transmigration (Kirton et al. 2005). VAP-1 is 
an essential part of the process of lymphocyte transmigration under non-static 
conditions. 
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1.16 Outlines of project 
 
 
The liver is an important immunological organ inducing tolerance and combating 
pathogens. A large amount of leukocyte recruitment occurs in this tissue and the 
unique environment of the liver sinusoids provides intriguing insights into recruitment 
during inflammatory disorders. We are interested in how recruitment in liver 
compares to mechanisms controlling recruitment in other organs, which differ not 
only physiochemically but immunologically. The aim was to investigate the 
phenotypic differences in EC from different locations and examine how these relate 
to the functional ability of the endothelium to regulate adhesion and transmigration in 
immune surveillance and inflammation. Phenotypic variation was assessed using 
whole gene arrays, cell-based Enzyme linked immunosorbant assay (ELISA) and 
immunohistochemical techniques. Functional capabilities of endothelial cell 
populations were tested using flow-based and static adhesion assays developed at 
the University of Birmingham. These experiments allow the investigator to not only 
examine the effect of various treatments and manipulate parameters of the 
physiochemical environment under physiological conditions but also assess all 
stages of the leukocyte recruitment cascade in real time.  
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2.1 Isolation and maintenance of primary endothelial cells 
 
Much of this thesis was concerned with reviewing and developing methods used to 
isolate primary murine endothelial cells. Liver sinusoidal and brain microvascular 
endothelial cells were of particular interest due to the unusual phenotype. The 
majority of this research and method development is outlined in Results Chapter 1. 
Here I will briefly touch on generic methods for isolating and culturing primary 
endothelial cells. When reviewing the literature regarding endothelial cell isolation 
methods, there are several stages in common, outlined in Figure 2.1 below. Each 
isolation method is broadly split into three stages, dissociation of the tissue, and 
separation of component cell populations and selection of endothelial cell type of 
interest. We tried several different isolation protocols using a number of different 
methods of dissociation, separation and selection. In addition cells were cultured 
under a number of different conditions. We used several basal mediums RPMI, 
DMEM, EBM, growth factors EGF, HGF, VEGF, ECGF cultured on gelatin or 
collagen substrates. 
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Figure 2. 1: Schematic of general endothelial cell isolation protocols including 
details of isolation methods used in this thesis. 	  
Each method can be broken down into three distinct steps, dissociation of the tissue, 
separation and selection. All isolations follow a similar pattern. 
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A single celled suspension of the tissue of interest is obtained using a combination of 
proteolytic enzymes and physical dissociation. Cells are then separated on the basis 
of size and relative buoyancy using density centrifugation materials to remove debris 
and contaminating cell populations. Cells at the desired gradient interface are then 
further positively or negatively selected using an antibody bead step and are plated 
out onto tissue culture plastic coated with basement membrane proteins to aid cell 
adherence. 
 
In the case of primary cell populations used in this research primary endothelial cells 
were pelleted and gelatin coated tissue culture vessels. Livers sinusoidal EC were 
cultured in Roswell Park Memorial Institiute (RPMI) with 100U/ml penicillin, 100ng/ml 
streptomycin and 2mM glutamine, whereas brain microvascular EC were cultured in 
complete BMEC medium consisting of Dulbecco’s Modified Eagles Medium (DMEM) 
(Gibco, UK), 20% Foetal Calf Serum (FCS) (Sigma, UK), 10ng/ml EGF, 10ng/ml 
VEGF (Peprotech, UK), 100U/ml penicillin, 100ng/ml streptomycin and 20mM 
HEPES (Sigma, UK) both at 37°C in a humidified 5% CO2 incubator. 
 
2.1.1 Isolation of mLSEC via in situ perfusion of murine liver 
 
Male C57BL/6 mice were obtained from Biomedical Services Unit, Birmingham UK 
and Schedule 1 was performed by cerviacal dislocation prior to procedure. The 
mouse was stretched out and pinned in place on a platform. A wedge of tissue was 
placed underneath the lower thoracic region to elevate the abdomen and expose the 
liver. All buffers (Appendix) were heated to ~40°C in a water bath and used to prime 
all tubing to remove bubbles. The peritoneum was cut and the portal vein (PV) 
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visualised using a dissecting microscope. The PV was incised above the branch of 
the vein and rapidly cannulated. The inferior vena cava (IVC) was cut to allow buffers 
to wash through the liver and flow rate was increased from 3ml/min to 7ml/min. 
Enzyme buffer was then perfused through the liver until the edges of liver lobes 
became transluscent. The cannula was removed and perfusion stopped. The liver 
was carefully removed from the abdomen and transferred to a petri dish in perfusion 
buffer. The gall bladder and glissons capsule was removed and the remaining liver 
tissue was disaggregated with forceps. The resulting cell suspension was stored at 
4°C until transferred to the laboratory. Cells were spun 54G/2min/4°C to pellet 
hepatocytes which were discarded. The remaining supernatant was pelleted at 
1349G/10min/4°C and resuspended in 5mls of preservation buffer. The cell 
suspension was layered onto a Percoll gradient (23/50% 10mls of each) and 
centrifuged at 1349G/30mins/4°C with no brake. The cells at the interface of 23% 
and 50% containing the non-parenchymal fraction were removed with a Pasteur 
pipette and washed in an excess of PBS at 1349G/10min/4°C. The resulting pellet 
was resuspended in ~2mls of RPMI, seeded into a petri dish and cultured at 37°C for 
10 mins to allow Kuppfer cells to adhere. Adherent cells were washed vigorously to 
remove non-adherent LSEC that were then seeded into collagen coated culture 
vessels in basal RPMI and cultured at 37°C/5% CO2. 
 
2.1.2 Isolation of mLSEC using Miltenyi αLSEC microbeads. 
 
Murine livers were obtained from adult female Balb/c mice in BMSU, University of 
Birmingham. In initial experiments the number of livers used in each isolation varied, 
but it was found that multiples of 3 livers per prep was optimal. Livers were washed in 
phosphate buffered saline (PBS) to remove excess blood and diced using scalpels. 
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Collagenase Type 2 (Sigma, UK) was reconstituted to 0.25% in DMEM/10% FCS 
and filter sterilised, 5mls of which was added to homogenised tissue for ~5mins. An 
excess of RPMI/10% FCS was added to quench enzyme activity; the tissue 
suspension was then sieved through a fine mesh (60µm) and washed through with 
sterile PBS to give a final volume of 200mls. The tissue suspension was centrifuged 
at 30G/10min three times to remove hepatocytes pellets. Non-parenchymal cells 
were pelleted at 300G/10mins and resuspended in ~6ml RPMI/10% FCS. Three ml of 
60% Optiprep (diluted with 0.85% Sodium Chloride-NaCl) was added to 1.5ml of cell 
suspension and mixed well to which 4ml of DMEM was layered on top and 
centrifuged at 400G/15 mins. The cells at the interface were collected and washed in 
an excess of PBS to remove Optiprep at 400G/5mins. The pellet was resuspended in 
~100µl of PBS to which 15-20µl of α-LSEC microbeads were added (per 2-3 livers) 
and made up to 1 ml with DMEM before incubating at 15-20 mins on ice. Selection 
columns were placed within a magnetic field and washed with 500µl of PBS. Cells 
were washed 400G/5mins and resuspended in 300µl of PBS and passed through 
columns to which labelled cells attached. Columns were washed with three 500µl 
volumes of PBS, labelled cells were eluted in 1ml of PBS by removing the column 
from the magnetic field. Selected cells were pelleted at 400G/5mins and distributed 
between collagen coated vessels and cultured at 37°C/5% CO2 in DMEM containing 
10% FCS, mEGF, HGF and VEGF (all 10ng/ml). 	  
2.1.3 Isolation of mLSEC in the absence of selection method. 
 
Murine livers were obtained from adult female Balb/c mice from 4th floor Thymus 
Development group, University of Birmingham. Livers were washed in PBS to 
remove excess blood and minced with scalpels. Tissue was incubated in 5ml/liver of 
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filter sterilised Collagenase Type 4 (Sigma, UK) reconstituted to 0.05mg/ml in 
DMEM/10% FCS for 40 mins at 37°C. Tissue suspension was mechanically digested 
in Seward Stomacher® 400 Circulator at 250rpm for 30 secs and passed through a 
fine tissue sieve (60µm) in an excess of PBS to a final volume of 200ml. Cells were 
pelleted at 400G/5min, resuspended in PBS and spun several times 40G/3min to 
remove hepatocyte pellets. The remaining supernatant was centrifuged at 400G/5min 
and resuspended in a combined volume of 5ml PBS/liver. Two ml of pure Optiprep 
per liver was added, mixed well and split between several 15ml Falcon tubes onto 
which 1ml of PBS was layered. Gradient was centrifuged at 400G/20min, cells at the 
interface were collected and washed in PBS at 800G/5min. Resulting cell pellets 
were resuspended in complete endothelial basal medium (1% FCS/10ng/ml VEGF) 
and plated out into collagen coated vessels and cultured at 37°C/5% CO2. 
 
2.1.4 Isolation of mLSEC with Miltenyi αCD146 MACS kit. 
 
Murine livers were obtained from adult female Balb/c mice in BMSU, University of 
Birmingham. Livers were washed in PBS to remove excess blood. Collagenase Type 
4 (Sigma, UK) was reconstituted to 2mg/ml in DMEM/10% FCS and filter sterilised. 
Approximately 5 mls of collagenase was injected into liver tissue with a 21G needle 
prior to dicing the tissue with two scalpels. The remaining collagenase solution 
(5ml/liver) was added, transferred to a sterile beaker and incubated at 37°C for 
40mins, agitating every 5-10 mins. Digested liver tissue was sieved through a coarse 
(200µm) then fine (60µm) mesh in an excess of PBS using a syringe bung. The 
resultant cell suspension was centrifuged at 1349G/7min/4°C, pellets were 
resuspended in PBS (10ml/3 livers) and layered over a Percoll gradient (23 over 50% 
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20mls of each) and spun at 1349/30min/4°C. Cells were removed from the gradient 
interface and washed in an excess of PBS and pelleted 1349G/7min/4°C. The pellet 
was resuspended in an appropriate volume of PBS and αLSEC (CD146) microbeads 
(Miltenyi), 90µl buffer to 10µl beads per 107 cells. Sample was incubated shaking on 
ice for 15-20 mins, washed in an excess of PBS, spun 1349G/7min/4°C and 
resuspended in ~1ml PBS. Magneticall activated cell sorting (MACS) magnets and 
MS columns were prepared and primed with 500µl of PBS/column. A 500µl aliquot of 
cells was passed through each column and then washed with three 500µl volumes of 
PBS. MS columns were then removed from the magnetic field and flushed through 
with 1ml of buffer. Both the ‘waste’ and ‘cellular’ fractions were pelleted and plated 
out onto gelatin coated tissue culture vessels in RPMI with 100U/ml penicillin, 
100ng/ml streptomycin and 2mM glutamine and cultured at 37°C. This method 
produced a reproducible yield of primary cells, which were used in further 
experiments. 
 
2.2 Culture and maintenance of cell lines 
 
Three immortalised murine endothelial cell lines were used in this investigation. 
mUCEC-1 (mouse cardiac endothelial cells) were cultured in complete media 
composed of DMEM (Gibco, UK), 10% FCS (Sigma, UK), 10ng/ml mEGF, 
(Preprotech, UK) 100U/ml penicillin, 100ng/ml streptomycin and 2mM glutamine 
(Sigma, UK). The skin endothelioma cell line (s.END, gift from Roy Bicknell) and 
Brain endothelioma (b.End.5) were cultured in complete media composed of DMEM 
(Gibco, UK) and 10% Foetal Calf Serum (Sigma, UK). In addition b.End cells 
required DMEM containing 1mM sodium pyruvate and antibiotic and glutamine 
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supplementation (as above, Sigma, UK).  Cells were plated in various different tissue 
culture vessels and maintained at 37ºC, in a humidified 5% CO2 incubator until 
confluent. To passage, cells were dissociated using 5 mls of Sigma TrypLe Express 
and re-plated at a ratio of 1:3. When confluent, cells cultured in chamberslides and 
multiwell tissue culture plates were fixed by removing growth media and replacing it 
with 500µl of cold methanol (Fisher Scientific, UK) for 5 mins. Fixed cells were 
washed 3 times in PBS and stored at 4°C until use. 
	  
 
2.3 FACS Analysis using a murine anti LSEC-FITC conjugated monoclonal 
antibody. 
 
Here, the LSEC isolation protocol was carried out as outlined in Section 2.1.2 but 
only 2 slow spins at 30G for 10 mins were carried out. A 200µl aliquot of cells was 
removed at various stages throughout the isolation protocol as outlined below. 
 
(1, 2) Post collagenase digest and fine mesh (x2) 
(3) Post slow spin 1, supernatant 
 (4) Post slow spin 1, pellet 
  (5) Post slow spin 2, supernatant 
  (6) Post slow spin 2, pellet 
   (7) Pelleted NPC’s 
   (8) Post OptiPrep gradient centrifugation 
   (9) MACS column waste 
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All samples were stored in 1.5ml Eppendorfs pre-coated in FCS and stored on ice. 
Samples were pelleted by centrifugation at 2500 rpm for 5 mins and washed in PBS 
+ 1% FCS. Samples were resuspended in 50µl of antibody solutions summarised 
below and incubated in the dark, on ice for 30 mins. Rat IgG was used as the isotype 
control at 5µg/ml and the test antibody murine α LSEC-FITC (Miltenyi, UK) was used 
at 1/30 dilution of manufacturers stock. Dilutions were in PBS + 1% FCS.  
 
Monoclonal Abs Sample Total Volume from 
which aliquot was 
extracted. Rat	  IgG	   1	   20	  
αmLSEC-­‐FITC	   2	   20	  
αmLSEC-­‐FITC	   3	   180	  
αmLSEC-­‐FITC	   4	   10	  
αmLSEC-­‐FITC	   5	   180	  
αmLSEC-­‐FITC	   6	   10	  
αmLSEC-­‐FITC	   7	   8	  
αmLSEC-­‐FITC	   8	   1	  
αmLSEC-­‐FITC	   9	   4	  
 
Table 2. 1: Table of samples extracted, monoclonal antibodies with which they 
were labelled and total volumes from which they were extracted. 
 
Samples were diluted in and additional 1ml of PBS-FCS and pelleted and finally 
resuspended in 500µl of PBS-FCS and analysed on Coulter Epics XL FACS machine 
to visualise distinct cell populations and analyse expression levels of FITC 
fluorophore. 	  
2.4 Immunohistochemical staining of murine tissue sections 
 
2.4.1 Preparation of tissue sections 
 
In order to visualise localisation of molecules of interest in murine tissues we used 
Immunohistochemical and immunofluorescent staining. Murine tissue was obtained 
from Balb/c and C57BL/6 mice that were surplus to requirements. Fresh brain, liver, 
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lung and kidney were snap frozen in liquid N2 and stored at –70ºC prior to sectioning. 
Frozen organs were embedded in OCT mountant (TissueTek Thermo Shandon) and 
5 or 10µM sections were cut using a cryostat (Bright OTF) and mounted on glass 
microscope slides (BDH UK) coated with 0.01% Poly-L-Lysine (Sigma, UK). Once 
mounted, sections were fixed in acetone (Fisher Scientific, UK) for 2 mins, wrapped 
in foil and stored at –20ºC. 
 
2.4.2 Demonstration of molecule expression by Immunohistochemical staining 
(IHC) 
 
Sections from murine organs, chamberslides (Nalge Nunc International, USA) 
containing cell lines at various passages and primary murine endothelial cells were 
all stained using the following method. All the monoclonal antibodies used for 
Immunohistochemical staining are summarised in Table 2.2 
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Monoclonal Abs	   Source	   Final Concentration 
(IHC)  
Final Concentration 
(ELISA) 
Rat IgG Control	   Sigma, UK	   25µg ml-1	   5µg ml-1 
Rabbit IgG Control	   Sigma, UK	   5 µg ml-1	   5µg ml-1 
RαM CD31	   Serotec, UK	   25µg ml-1	   5µg ml-1 
RαM VAP-1	   Gift of David Smith*	   25µg ml-1	   5µg ml-1 
RαM VCAM-1	   Serotec, UK	   25µg ml-1	   5µg ml-1 
RαM CD99	   Gift of Gabi Bixel	   25µg ml-1	   5µg ml-1 
RαM ICAM-2	   BD Biosciences, UK 25 µg ml-1 5µg ml-1 
RabαM LYVE-1	   Abcam, UK 1,5 µg ml-1 1,5 µg ml-1 
RαM CD34	   Serotec, UK 25 µg ml-1 5µg ml-1 
RαM JAM-2	   Serotec, UK 25 µg ml-1 5µg ml-1 
RαM Endoglin BD Biosciences, UK 1.5 µg ml-1 1.5 µg ml-1 
RαM E-Selectin Abcam, UK 25 µg ml-1 5µg ml-1 
Gt α Rat HRP Sigma, UK 1/1000 of stock 1/500 of stock 
GtαRab-HRP Serotec, UK 1/2000 of stock 1/2000 of stock 
Gt α Rat-Alexa Fluor 
633 
Invitrogen, UK 1/1000 of stock N/A 
 
Table 2. 2: Source and working concentration of monoclonal antibodies (MAbs) 
used in immunohistochemical staining of experimental samples.   
All antibodies were diluted in PBS. VAP-1 kind gift of David Smith, University of 
Oxford. 
 
 
Prior to staining, all samples were equilibrated to room temperature before being re-
fixed in acetone for 10 mins. After air-drying, samples were labelled and a wax pen 
was used to draw a line round the tissue section to create a small well to retain 
antibody solutions. Slides were pre-wetted with PBS wash buffer before staining, to 
prevent desiccation of samples. 
Tissue sections were incubated for 20 mins in blocking solution (1% Goat serum in 
PBS) to abrogate non-specific binding of antibodies. Samples were incubated in a 
humidified chamber and placed on a rocker to ensure complete coverage of samples 
in the antibody solutions. Sections were washed (3x in PBS) and incubated with 
150µl of relevant primary mAbs (monoclonal antibodies) directed against the 
molecules of interest for 1 hour. Purified immunoglobulins (IgG’s) were used as 
negative control antibodies at equivalent concentrations and assessment of non-
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specific staining of the 2° MAb was permitted by omission of the primary mAb step in 
some wells. Post primary antibody incubation, slides were washed and quenched in 
0.5% w/w H2O2 in methanol with sodium azide for 5 mins.  After washing three times 
in PBS the Horseradish Peroxidase (HRP)-conjugated secondary antibodies were 
added for a further hour.  
 
Following a final wash in an excess of PBS positive staining was visualised by the 
addition of DAB (DAKO EnVision Detection System) substrate prepared according to 
manufacturers instructions. Sections were incubated for ~5 mins to permit 
development of a HRP-catalysed colour reaction in the substrate resulting in the 
formation of a brown-black precipitate. Staining was normalised against 5 minute 
staining time. Samples were quenched by immersion in distilled H2O and incubated 
with haematoxylin counterstain (Sigma, UK) for ~30 seconds before being rinsed in 
tap water. Sections were dehydrated in increasing concentrations of Industrial 
Methylated Spirits (IMS) (50/70/90/100%) for 2 mins in each followed by a final 2 
mins in Xylene before mounting with glass coverslips and Immunomount (Shandon, 
USA). Sections were examined using an Axioskop 40 microscope and images 
captured using a digital camera and Axiovision software (Karl Zeiss, UK). Samples 
were assessed according to staining intensity compared to negative isotype matched 
control and positive CD31.  
 
Cells cultured in chamberslides were stained in a similar fashion to that described 
above for sections. Here antibodies and substrates were added into each well of the 
8-welled chamberslides and the chambers were removed from the cells after the 
addition of the DAB substrate prior to haematoxylin counterstain. 
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2.4.3 Demonstration of molecule expression by Immunofluorescent staining 
(IF) 
 
Primary mLSEC cultured on glass coverslips were stained using immunofluorescent 
methods to visualise the location of markers of interest using confocal microscopy. 
Prior to staining mLSEC were fixed with 4% paraformaldehyde (PFA) (Sigma, UK) for 
10 mins and washed three times in PBS. Cells were permeabilised by the addition of 
ice-cold methanol for 10 mins at -20°C and then incubated for 20 mins in blocking 
solution (1% Goat Serum in PBS). Cells were washed (3x in PBS) and incubated with 
150µl of primary antibodies in 1% Goat Serum in PBS (Table 2.2) for 1 hour. Isotype 
matched control and no primary were used as negative controls. Post-primary 
incubation the fluorescently conjugated secondary antibody (Goat α Rat- Alexa Fluor 
633) was added for a further hour in the dark.  Cells were washed to remove 
unbound antibodies, after the final wash, 200µl of DAPI (Fluka, UK) solution was 
added as a counterstain to each sample and incubated in the dark for 5 minutes. 
Samples were washed and dried and mounted on glass coverslips in non-fluorescent 
mounting media (Dako) to retard fading. Coverslips were examined on Axiovert 100M 
Confocal Microscope (Leica, Germany), images captured at x63 magnification using 
Axiovision software (Karl Zeiss, UK) and processed using LSM Image Browser. 
 
2.5 Testing the specificity of α-mouse LSEC MAb using immunofluorescent 
methods. 
 
 
In addition to IF of primary cells a modified immunofluoresence method was also 
used to localise the distribution of certain molecules of interest throughout murine 
liver tissue and also to examine the adherence of antibody conjugated MACS beads, 
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which were used in certain stages of this project. This method was adapted from the 
immunohistochemical technique outlined above. All washes as in the IHC were 
carried out in PBS and sections were fixed using the sodium azide method to reduce 
quenching of the fluorophores. Sections were stained with either Rat anti mouse 
(RαM) LSEC-FITC at 1/50 or 1/100 of manufacturers stock, an isotype match control 
(Rat IgG at 5µg/ml) or a no primary control (omission of the primary antibody). When 
examining the adherence of the α LSEC microbeads (MACS) a 200µl aliquot 
containing 10µl of beads (Miltenyi Biotech, UK), 10µl BSA (Sigma, UK) and 180µl of 
PBS was added to the tissue section in place of the primary antibody. A Rabbit α 
Rat-FITC secondary was used at 1/50 dilution of manufacturers stock for Rat IgG, 
beads and No Pri samples. In the case of sections stained with Rat anti mouse 
(RαM) LSEC-FITC antibody there was no need to use a primary as the antibody was 
already conjugated to the fluoroscein isothiocyanate (FITC) fluorophore. All 
incubations were carried out in a foil-wrapped tray to protect samples from light.  
 
After the final wash in PBS, 200µl of DAPI (4’-6’-Diamidino-2phenylindole) (Fluka, 
UK) solution was added as a counterstain to each sample and incubated in the foil 
tray for 5 minutes. Samples were washed and dried and mounted on glass coverslips 
in non-fluorescent mounting media (Dako) to retard fading. Sections were then 
examined for staining using an Axiovert fluorescence microscope (Karl Zeiss, UK). 
Images were captured using a digital camera and Axiovision software (Karl Zeiss, 
UK) 
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2.6 ELISA protocol for endothelial cells in 96-well plates 
 
Enzyme linked immuno-sorbent assays (ELISA) were used to quantify protein 
expression levels on cells cultured in 96-well tissue culture plates, and to assess the 
effects of cytokines on expression. The monoclonal antibodies used in this assay are 
outlined above in Table 2.3. 
 
 
Cytokine Stock Conc. (U/ml) Dilution Final Conc. 
TNF-α	   1x105	   1/1000 100U 
IL-1β	   5x106	   1/100,000 50U 
IL-1β	   5x106	   1/50,000 100U 
LPS	   1mg/ml	   1/1000 1µg/ml 
IFN-γ	   1x105	   1/1000 100U 
TNF-α + IFN-γ	   1x105	   1/1000 100U 
 
 
Table 2. 3: Cytokine treatments for ELISA.  
Cytokines (Peprotech, UK) were diluted in complete TCM and 100µl was added to 
appropriate wells for 4 or 24 hours before fixing the cells in methanol. 
 
 
A confluent T75 flask of cell lines were passaged using TrypLE Express a third of 
which was resuspended in 10 mls of complete media (varied depending on cell line). 
100µl aliquots were plated out into a 96 well tissue culture plate and incubated 
overnight in a 37°C/5% CO2 constant temperature incubator to allow cells to adhere 
and spread. Semi-confluent, cells were stimulated with a combination of pro-
inflammatory mediators (Table 2.3) in tissue culture medium (TCM) for 4 or 24 hours 
at 37°C. Stimulation was carried out at this stage to prevent rapidly dividing cells 
becoming overconfluent. After ensuring that the cells were confluent by light 
microscopy the media was removed and the cells were fixed in methanol (Fisher 
Scientific, UK). Plates were stored at 4°C for up to 2 weeks until ELISA development. 
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All wells were washed twice with 1% BSA (Sigma, UK) in PBS and incubated with 50-
100µl of blocking buffer (PBS containing 1% goat serum) for ~1 hour. Wells were 
washed three times with PBS before addition of primary antibodies of interest (initial 
experiments were performed to optimise the concentrations at which primary and 
secondary monoclonal antibodies were used to obtain the most reliable results, 
outlined in Table 2.2) at various concentrations and incubated for 45 minutes. Isotype 
matched controls were used as negative controls with the addition of CD31 as a 
positive control at 2.5µg/ml. All tests were performed in triplicate. Wells were washed 
thrice with PBS and 50µl of the secondary antibody conjugated to horse radish 
peroxidase (HRP) was added and incubated at RT (room temperature) for a further 
45 minutes.  
 
The ELISA plate was developed using a substrate buffer that contained 1 OPD tablet 
dissolved in 3mls of distilled water and 1.25µl of 30% H2O2 solution (all Sigma, UK). 
After washing thoroughly with PBS, 50µl of freshly made substrate buffer was added 
to each well and incubated for ~5 mins. The ELISA plate was closely observed for 
appearance of brown chromagen yielded by the catalytic action of HRP and OPD. 
The reaction was quenched after 5 mins with 50µl of 0.5M sulphuric acid (H2SO4) 
and the plate was read at an absorbance of OD 490nm on a Synergy HT plate 
reader. Corrected values were obtained by taking the mean value of triplicate wells 
minus IgG control values.  
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2.7 Collection of liver and/or spleen from murine samples  
 
Samples for lymphocyte isolation, generation of tissue sections and endothelial 
isolation were collected from freshly culled mice. Frequently tissue was extracted 
from mice that were excess to the experimental requirements or our laboratory or of 
other groups and would have otherwise been discarded. The source of tissue 
changed depending on what strain of mouse was available at the time tissue was 
needed. Thus we used carcasses of Balb/c weaners, adults and C57BL/6 adult mice 
obtained from Birmingham University Medical School Biomedical Services Unit 
(BMSU), the Thymus Development Laboratory, Institute of Biomedical Research and 
Dean Kavanagh, Institute of Biomedical Research, (all in Birmingham, UK).  
 
To collect liver tissue samples, the mouse was stretched out on a polystyrene 
platform and fixed in place with several needles. The abdomen was liberally sprayed 
with alcohol to wet fur and prevent contamination of cells with fur or dander. The 
abdominal skin and peritoneum were cut exposing the internal organs. The 
multilobular liver was located and the ligaments holding liver in place were cut. The 
liver was removed and placed in plain RPMI-1640 /DMEM (Gibco, UK). This process 
was repeated several times depending on the number of animals used per isolation. 
The spleen was removed in a similar fashion for use as a source of lymphocytes. The 
organ was isolated and any excess adipose tissue was removed before storing the 
spleens in RPMI-1640/DMEM. 
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2.8 Isolation and fluorescent labelling of murine splenocytes 
 
The spleen was dissociated by gently pushing through a cell strainer in an excess of 
PBS. The resulting cell suspension was pelleted by centrifugation at 2000rpm/5 min 
and resuspended in ~2mls of RBC Lysis buffer (Sigma, UK). Cells were lysed for 5-
10 mins before an excess of sterile PBS was added and cells were pelleted again. 
Cells were resuspended in RPMI+10%FCS, plated out in a T75 tissue culture flask 
and incubated overnight at 37°C for use in adhesion experiments.  
 
After overnight incubation, the flask was agitated to aid detachment of the 
splenocytes from the tissue culture plastic and the cells were centrifuged at 2000rpm 
for 5min. Splenocytes were counted using Trypan blue exclusion and resuspended to 
a final density of 1x10-6/ml. Cell tracker green (CTG), a fluorescent dye was added 
to the cell suspension at a final concentration of 2.5µM and incubated at 37°C for 40 
mins in RPMI 10% FCS. Cells were washed in an excess of medium and left to rest 
for 30 mins before use in functional assays. 
 
2.8.1 Leukocyte subset isolation using MoFlo 
 
In order to isolate CD4+/CD8+ cells from murine spleen, a mixed lymphocyte 
population was obtained, as outlined above. Cells were resuspended in 1ml PBS and 
a 50µl aliquot was removed for isotype matched control and FITC/PE single colour 
controls. The remaining sample was labelled with a combination of CD4+/CD8+ 
fluorescently conjugated antibodies (See Table 2.5). All samples were labelled for 20 
mins at 4°, washed in PBS and filtered before running on MoFlo Cell sorter to isolate 
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single positive populations of >99% purity. Single positive lymphocytes were washed 
in PBS before labelling with cell tracker green. 
Antibody	   Manufacturer	   Dilution	  Rat	  IgG2a	  IMC-­‐FITC	   eBioscience	   1/500	  Rat	  IgG2b	  IMC-­‐PE	   eBioscience	   1/1000	  RαM	  CD8a-­‐FITC	   eBioscience	   1/500	  RαM	  CD4-­‐PE	   eBioscience	   1/1000	  
 
Table 2. 4: Antibodies used for MoFlo sorting of T-Cell subsets CD4+ and CD8+ 
 
 
2.9 Isolation of murine neutrophils from bone marrow 
 
Carcasses of adult male C57BL/6 or Balb/c mice were obtained and prepared as 
described previously. Bones were isolated from the legs and used as a source of 
bone marrow neutrophils.  The skin was removed from both legs to expose the bone 
and muscle. Each leg was pulled at an angle to dislocate the hip from the pelvis so 
that the femoral head appeared. An incision was made past the head of the bone to 
allow the leg’s removal. The remaining skin and muscle was removed to expose the 
leg bones. Bending the leg separated the upper and lower leg bones and an incision 
was made just past the patella. The foot was also removed at the ankle joint and any 
remaining skin and muscle was removed by scraping along the length of the bones 
with the scalpel. In the case of the lower tibia and fibula, the smaller fibula was 
separated from the tibia and discarded. All bones were kept on ice until required. 
 
Incisions were made at the top and bottom of each bone to expose the red marrow. 
In the case of the fibula an incision was made where the marrow became red in 
colour. Approximately 2ml of calcium and magnesium free PBS (PBSA -Ca2+/Mg2+, 
Sigma, UK/Oxoid, UK) was flushed through the bore of each bone using a 21 gauge 
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needle, and collected into a 15ml Falcon tube, until the bones appeared white in 
colour. Eluted bone marrow cells were gently resuspended using a 25-gauge needle. 
This cell suspension was left for 5 min to allow the debris to settle out. The 
supernatant was collected and centrifuged at 200g for 5min. The supernatant was 
discarded and the pellet resuspended in 1ml 1% PBSA (PBS+BSA -Ca2+/Mg2+) to 
prevent clotting. Contaminating red blood cells (RBC) were lysed by the addition of 
6ml of ice-cold distilled water to the sample. This was mixed for 30 seconds before 
adding 2ml of 4x concentrated PBS (-Ca2+/Mg2+) to the sample and centrifuging at 
200g for 5min. The subsequent supernatant was removed and the pellet 
resuspended in 1ml PBSA (PBSA -Ca2+/Mg2+). A Percoll (Sigma, UK) density 
gradient was prepared by first mixing 9 parts Percoll with 1 part 10x PBS (Oxoid, 
UK). This 100% solution was diluted to several desired concentrations with PBS (52, 
64 and 72%). In general, 2.5ml of each percentage was layered on top of one 
another in a 15ml tube, followed by 1ml of cell suspension and centrifuged at 1500g 
for 30min at 20°C. Each layer of Percoll, including the appropriate interfaces, was 
removed and transferred into 10ml round bottomed tubes. Each fraction was made 
up to 10ml with PBS (-Ca2+/Mg2+) and washed by centrifugation at 200g for 5min. 
The supernatant was removed and each fraction was resuspended in 1ml of PBSA 
(PBSA +Ca2+/Mg2+). 
 
Bone marrow isolates, both before and after RBC lysis, and all Percoll fractions were 
counted using a Coulter Multisizer II (Coulter Electronics Ltd., Essex, UK) or a 
Neubauer haemocytometer to determine the number and size of the cells present in 
each sample. The Multisizer gave a frequency distribution of cell diameter, as an 
illustrated in Figs 2.2 and 2.3. This allowed cells in a given peak to be counted and 
aided assessment of RBC and debris. After counting, the middle Percoll fraction, 
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which contained the highest number of neutrophils and the least cellular debris, was 
diluted in PBSA (+Ca2+/Mg2+) to a final concentration of 106 cells/ml. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. 2: Coulter Counter spectra of typical bone marrow isolates before and 
after red blood cell lysis step.  	  
Each peak accounts for a distinct population of cells. The indistinct slope on the left 
accounts for cellular debris present in the sample. From this data you can estimate 
the total cell number, the size and the number of cells in each peak. 
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Figure 2. 3: Coulter Counter spectra of typical bone marrow cell samples 
collected from the Percoll gradient at various interfaces.  	  
Each peak accounts for a distinct population of cells. The indistinct slope on the left 
accounts for cellular debris present in the sample. From this data you can estimate 
the total cell number, the size and the number of cells in each peak. 
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2.9.1 Morphological determination of neutrophil purity in bone marrow 
fractions  
 
To assess what cell types were present in each bone marrow fraction, samples were 
centrifuged onto microscope slides using a Shandon Cytospin II (Scientific 
Instruments, South Trentham, UK). The slides were air dried for 15 mins and stained 
using DiffQuik (Dade Behring), fixed and viewed using light microscopy (LM). A 
differential count was carried out to determine the proportion of neutrophils present in 
each sample based on nuclear morphology. Murine neutrophils possess a 
characteristic doughnut shaped nucleus (apparent in Fig 2.4) as apposed to the 
segmented nuclei of human neutrophils 
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Figure 2. 4: Light microscope image (LM) of a typical cytospin sample from the 
middle fraction of the differential Percoll gradient used in the isolation of bone 
marrow derived neutrophils.  	  
A 100ul aliquot of each gradient post counting was spun onto glass microscope 
slides using a Shandon Cytospin. Samples were spun at 500rpm for 5 min. Slides 
were then dried, stained with Diff Quik and mounted. Neutrophils can be identified by 
ring shaped nuclei. In this sample about 70% of cells are neutrophils. Images were 
captured using an Axiovert microscope at x10 magnification on Image ProPlus 
software. 
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2.10 Culture of murine endothelial cells for flow based adhesion assays 
2.10.1 Microslide System 	  
Microslides are glass capillaries with rectangular cross-section and internal length 
(L), width (W) and depth (D) = 50 x 3 x 0.3 mm (Camlab, Cambridge, UK). 
Microslides were pre-coated with APES (4-aminopropyl-triethoxysliane) as described 
(Cooke, Usami, Perry, & Nash 1993), to aid cell attachment to the surface. Briefly, 
microslides were soaked overnight in concentrated nitric acid and then rinsed first 
with water followed by acetone. They were immersed in APES (4% v/v in anhydrous 
acetone, Sigma, UK), for 30 seconds, rinsed with acetone and several changes of 
water, and finally autoclaved. 
 
In preliminary experiments, microslides were also coated with 1% or 5% gelatin 
(Type B from Bovine Skin, Sigma, UK) solution in distilled water. Sterile gelatin 
solution (50µl) was injected into the microslides and incubated at 37°C for 30 min, 
after which slides were washed three times with 1ml of PBS before the addition of 
cells. However, it was discovered that collagen coating was more favourable. Sterile 
rat tail collagen (RTC) solution (50µl, in house preparation), diluted 1:1 with sterile 
PBS was injected into the microslides and incubated at 37°C for 1hr and 30 min, after 
which slides were washed three times with 1ml of PBS before the addition of cells.  
 
In experiments using purified murine E-Selectin (gift of Dietmar Vestweber) instead of 
endothelial cells, the E-Selectin was diluted to the desired concentration in PBS and 
50µl was injected into microslides and incubated at 37°C for 2 hours. The slide was 
then blocked with 1% PBSA for 1 hour before use. 
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For endothelial coating, one confluent 75cm2 (T75) flask of the appropriate cell line 
was trypsinised and cells centrifuged at 2000rpm for 5min. The pellet was 
resuspended in 1ml of complete medium, 300µl of which was used to seed 
microslides. 50µl of cell suspension was injected into each of 6 microslides. The 
microslides were placed in a Petri dish on a sterile microscope slide and incubated at 
37°C for 3h to allow the cells to settle and attach. Slides were then washed with 50µl 
of fresh medium to check a sufficient number of cells had attached to the surface to 
reach confluency within the desired time period. The microslides were placed in 
specially constructed culture dishes, which had been autoclaved. Microslides were 
attached to glass tubing ports, which had been fused into the wall of the dishes, 
using a short piece of silicone rubber tubing (2mm bore, 1mm wall thickness) and 
sterile forceps. Silicone rubber tubing was connected to each external arm. The dish 
was filled with culture medium and placed in a humidified CO2 incubator. The tubing 
was passed though a port in the incubator wall (manufactured to order; either model 
GA2000, LEEC, Nottingham, UK or Nuaire DH; Triple Red, Thames, UK) and 
attached to a multichannel, 8-roller pump (Watson-Marlow 500 series pump with 
308MC pumpheads; Watson-Marlow Bredel Pumps, Falmouth, UK), which pumped 
to waste. The pump was set to generate a flow rate (Q)=0.2ml/min for 30sec every 2 
hours. Thus, medium contained in the microslide (~50µl) was changed regularly in 
order to permit prolonged growth and avoid hypoxia and media exhaustion. All of the 
above is outlined in Fig 2.5 below. Wall shear stress in the microslide was 0.05Pa 
during perfusion. Original seeding was at a density that yielded confluent monolayers 
in 24-48 hours. 
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Figure 2.5 Diagram of special culture dish for microslides constructed by the 
Glassware Workshop, School of Engineering, University of Birmingham, UK 
and culture system set-up for ‘static’ experiments. 	  
The dish consists of a glass Petri dish with 6 glass adaptors fused into the wall, 
which seeded microslides are connected. The 6 adaptors are connected at the other 
end to lengths of tubing, which connect the microslides to a pump (Watson Marlow 
5025). The system is designed to generate flow of medium across cultured cells 
every 2h to maintain viability. (Sheikh et al. 2004) 
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After 24 hours of culture under intermittent flow, the microslides were removed from 
the dish and stimulated with the pro-inflammatory stimulant at the desired 
concentrations. Cytokines were diluted in complete medium in the flow assay dish 
and reconnected for a further 24hrs of culture or 50µl of cytokine-containing medium 
was pipetted into each microslide every hour for 4 hours and microslides were 
returned to the incubator depending on the experimental requirements. 
 
2.10.2 Culture of EC in IBIDI VI Chambers 
 
Problems were encountered when attempting to examine the functional responses of 
primary LSEC under flow conditions using the microslide system due to the low cell 
yield. LSEC were seeded into gelatin-coated microslides but did not attach efficiently 
and those that did were of poor quality and appeared stressed. Fortunately a new 
system for culturing endothelial cells for flow assays became commercially available 
during my investigation. IBIDI VI chambers are made of gas permeable plastic 
negating the need for flow pumps and exchange of acidic medium during cell culture. 
The manufacturer supplies details of internal dimensions of the chambers and flow 
rates necessary to generate the required wall shear stress (Figure 2.6). Endothelial 
cells (lines and primaries) were rapidly seeded into each channel (30µl/chamber) to 
avoid air bubbles. The reservoirs were covered with the supplied lid and incubated at 
37°C/5%CO2 to allow cells to attach on the accompanying rack, allowing sufficient 
gas exchange and air flow. Afterwards each reservoir was filled with ~60µl of cell free 
medium. For functional flow experiments the endothelium was stimulated with pro-
inflammatory mediators. Control tissue culture medium was carefully removed from 
the reservoirs and replaced by capillary action with stimulating medium for 4 or 
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24hrs. At this point any non-adherent cells (primary cultures) can be removed by 
vigorous pipetting of PBS or culture medium through the channels.  
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Figure 2. 5: IBIDI VI flow chambers. 	  
IBIDI VI chambers are made of gas permeable plastic allowing cells to be cultured in 
small chambers in ~30-50µl of medium. Cells can be subject to flow-based adhesion 
assays or fixed and stained to visualise molecules of interest. 
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2.10.3 Assessment of leukocyte adhesion to endothelial cells under flow using 
the microslide system. 
 
Microslides containing confluent endothelial cells were glued to a glass microscope 
slide, mounted on a microscope stage, and viewed by phase-contrast 
videomicroscopy (Fig 9). One end of the microslide was attached via silicone rubber 
tubing to a Harvard syringe pump (Harvard Apparatus, South Natic, MA), allowing 
control of the flow rate through the microslide. The other end of the microslide was 
attached by silicon rubber tubing to an electronic valve (Lee Products, Gerards 
Cross, UK), permitting smooth switching between the leukocyte suspension and cell 
free buffer. Following insertion of the microslide into the flow system, EC’s were 
washed with flow media (basal medium + BSA) to remove residual cytokines for 2 
min. A 4-min bolus of leukocytes was perfused through the microslide, followed by a 
2 min wash out with flow medium. The flow rate was chosen to yield wall shear 
stresses in the range of 0.05-0.2Pa as desired. Fluorescent videomicroscopic 
recordings were taken at various stages throughout the experiments (Fig. 2.7). 
During the last minute of the bolus and after 2 min of washout 5-10sec of video 
recordings were made of a series of fields, to visualise leukocytes interacting with the 
endothelium. The recordings were analysed off line using a computerised image 
analysis system (ImagePro; DataCell, Finchampstead, UK) or by manual counting. 
The numbers of adherent leukocytes were counted in the series of fields and 
corrected /mm2 /106 leukocytes perfused using the calibrated field size and known 
perfusion rate. Adherent cells were easily distinguished from non-adherent cells, 
which were visible only as faint streaks. The number of rolling cells was also 
determined by digitising several 5-sec fields during washout. The leading edge of the 
adherent leukocyte was marked and tracked over time. Rolling velocities were 
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calculated by taking the mean of the distance moved over the 5sec to give a value in 
µm/sec. 
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Figure 2. 6: Outline of apparatus used to carry out functional experiments 
using murine leukocytes.  	  
The microslide or IBIDI VI chamber is secured onto the microscope stage and 
attached to the syringe pump outflow, which regulates the shear stress, and to the 
sample/wash reservoir. All tubing is primed before connection to allow a smooth 
transition between wash buffer and the murine leukocytes using an electronic valve. 
The microscope and the majority of the experimental apparatus are enclosed in a 
37°C chamber. Video images are captured and analysed offline. 
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2.10.4 Assessment of leukocyte adhesion to endothelial cells under flow using 
the IBIDI VI System. 
 
IBIDI VI chambers containing confluent endothelial cells were mounted on a 
microscope stage, and viewed by phase-contrast videomicroscopy, in a similar 
fashion to microslides. Male adaptors were attached to the standard flow assay 
tubing to fit neatly onto the corresponding female adaptors on IBIDI VI flow chambers 
allowing smooth perfusion of cell free buffer and sample over the endothelium. The 
assessment of cell adhesion under flow was then carried out as outlined in Section 
2.10.3. 
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Figure 2. 7: Comparative images of endothelial cell lines and primary cultures 
in normal tissue culture compared to two methods used for functional flow 
assays; microslides and IBIDI VI chambers.  
All images captured at x10 magnification on Light Microscope. 
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2.11 Static Adhesion Assays 
 
In addition to flow based adhesion assays, static assays were carried out on all cell 
lines and primary cell populations. Endothelium was cultured in 24-well plates to 
semi-confluency before adding pro-inflammatory mediator containing medium (LPS 
1µg/ml or TNF-α+IFN-γ 100U/ml) for 24 hours. Primary LSEC were allowed to settle 
for 2-3hrs before stimulation. Post incubation, medium was removed and replaced 
with 1ml of cell tracker green labelled lymphocytes at 0.5x106/ml in RPMI for 2 hours 
before fixation with methanol. The number of adherent lymphocytes in 10 fields per 
sample was counted using a fluorescent microscope and normalised to give number 
adherent/mm2. 
 
2.12 RNA extraction using Qiagen RNeasy columns 
 
Samples of RNA were extracted from samples of all cell lines and primary cells 
stimulated with a panel of cytokines for 24 hours using a quiagen RNeasy Mini kit 
according to manufacturers instructions. Post-stimulation cells were trypsinised (in 
the case of cell lines) or removed from tissue culture plastic surface with a cell 
scraper (primary isolates). The resulting cell pellets were disrupted with 350µl of RLT 
buffer containing β-mercaptoethanol (1µl βME/100µl RLT) and the DNA was sheared 
with a 21G needle. An equal volume of 70% ethanol was added to the DNA 
suspension before transferring to a Qiagen column, which was then spun at 
10,000rpm for 15sec. RNA present on the membrane was then washed with 700µl of 
RLT buffer in each column and spun at 10,000rpm for 15sec, followed by 500µl of 
RPE and spun again. An additional 500µl of RPE was added and then spun for 
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2min/10,000rpm to dry the membrane. The RNA was then eluted by the addition of 2 
x 40µl of RNAse free water to the column and spinning at 10,000rpm/15sec. The 
amount and purity of RNA was read using a Bio-Tek Synergy HT plate reader. 
Samples were diluted in RNAse free PCR water (5µl RNA: 95µl water) and read at 
260/280nm, values were compared to a blank well containing only water and purity 
and concentration calculated accordingly. The integrity of the RNA was confirmed 
with analysis by the Agilent 2100 Bioanalyser (Palo Alto, CA, USA) using the RNA 
600 LabChipTM kit. 
 
2.13 Analysis of differential gene expression in resting and stimulated 
endothelial cells using DNA microarrays. 
 
All products were purchased from Agilent Technologies Ltd (Wokingham, Berkshire, 
UK) unless otherwise noted. 
 
2.13.1 Labelling 
 
400ng RNA from each sample and 3µl (1:2500 dilution) Agilent One-Colour RNA 
Spike-In RNA were labelled with the Agilent Low RNA Input Linear Amplification Kit 
PLUS, One-Colour according to manufacturers instructions as follows: 1.2µl T7 
Promoter Primer was added to 400ng RNA and 3µl spike in control (in a 11.5µl 
volume and denatured at 65°C. First strand buffer (to 1x), DTT (to 10mM), dNTP (to 
0.5mM), MMLV (1µl of stock provided in the kit in a 20µl reaction) and RNaseOut 
(0.5µl of stock provided in the kit in a 20µl reaction) was added. The cDNA was 
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synthesised during the following incubation step (2h at 40°C). After 10 min 
denaturation at 65°C and the addition of Cy-labelled CTP (to 0.3mM), Transcription 
Buffer (to 1x), DTT (to 10mM), NTP (8µl of stock provided in the kit in an 80µl 
reaction), PEG (to 4%), RNaseOut (0.5µl of stock provided in the kit in an 80µl 
reaction), Inorganic Phosphatase (0.6µl of stock provided in the kit in an 80µl 
reaction) and T7 RNA Polymerase (0.8µl of stock provided in the kit in an 80µl 
reaction) the synthesis of the fluorescent labelled cRNA was performed during the 
second incubation step (2h at 40°C). The labelled cRNA was purified with the 
RNeasy Mini Kit (Qiagen Ltd, Crawley, UK) according to the manufacturers’ protocol. 
 
2.13.2 Hybridisation and Scanning 
 
The Agilent Hybridisation Kit was used in conjunction with Agilent Mouse Oligo 
Arrays. 2µg of the labelled sample RNA were used for hybridisation according to the 
Agilent One-Colour Microarray-Based Gene Expression Analysis Protocol. The 
hybridisation was performed for 17h at 65°C at 10rpm. Slides were then washed for 1 
min at 22°C in Wash Solution 1 and 1 min at 22°C in Wash Solution 2, pre-warmed to 
37°C. Slides were incubated for 30s in Agilent Stabilisation and Drying Solution. The 
slides were scanned with the Agilent G2565BA Microarray Scanner System. 
 
2.13.3 Bioinformatics Analysis 	  
Extracted data were analysed using GeneSpring GX 7.3.1 (Silicon Genetics, CA, 
USA). Agilent standard scenario normalisations for FE-1 colour arrays were applied 
to all data sets. A subset of genes for data interrogation was generated that excluded 
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controls, spots of poor quality and gene probes that were present in less than 50% of 
samples. From these selected probes, relative expression was determined between 
each treatment and control for each cell line. Heatmaps could be generated from 
genes 50% present or marginal from which more specific gene lists could be 
generated for each treatment group and cell line. Genes differentially regulated by 
greater than 2-fold were selected. One-way parametric, ANOVA tests were 
performed followed by Benjamini and Hochberg multiple test correction with a false 
discovery rate of 0.05. Microsoft Excel templates were prepared containing genes 
that were differentially regulated. IngenuityTM Pathway Analysis 3.0 (IngenuityTM 
Systems, CA, USA) was utilised to assemble functional networks and pathways. 
 
2.13.4 Quantitative Real-Time PCR 
 
RNA was prepared as before and in vitro transcription was performed on 1µg total 
RNA using the first strand cDNA synthesis kit (Roche). Real-time PCR was 
performed using a Bio-Rad iCYCLER. QuantiTect® probes (Qiagen) were used for 
real time RT-PCR together with iQTM SYBR® Green supermix (BioRad). The Bio-Rad 
iCYCLER with SYBR Green detection was used for real time RT-PCR. PCR 
thermocycler conditions were 95°C for 2 min, followed by 45 cycles of 95°C for 20s 
and 60°C for 30s. Samples were run in triplicate with test probes using B-Actin as a 
housekeeping gene to control for differences in amount of starting material. Fold-
changes (compared to baseline control) were calculated by normalising the test-
crossing threshold (Ct) with the amplified control Ct.  
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3. ISOLATION AND CULTURE OF PRIMARY MURINE MICROVASCULAR 
ENDOTHELIAL CELLS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 92 
3.1 Introduction 
 
Endothelial cells are a highly heterogeneous cell type, which line the vasculature and 
the lymphatic system. They have major roles in leukocyte recruitment as well as in 
haemostasis, regulation of vascular tone, angiogenesis and the control of movement 
of solutes between the vascular system and tissues (Johnson-Leger et al. 
2000;Matharu et al. 2006;Springer 1995).  The location of endothelial cells means 
they are ideally situated to interact with passing leukocytes in the circulation. By 
modifying the expression of adhesion receptors and chemokines on their surface, EC 
can control the recruitment of leukocytes in response to locally produced 
inflammatory substances, including TNF-α and IL-1β (Bahra et al. 1998;Mantovani et 
al. 1992). There are thought to be differences in leukocyte recruitment due to 
variation of EC phenotype in different levels of the vascular tree and in different 
organs of the body (Berlin et al. 1993;Picker 1992). These phenotypic differences 
may also alter EC morphology, permeability, secretory potential and gene expression 
(Aird 2003;Chi et al. 2003). Whilst tightly regulated under normal circumstances, 
inappropriate leukocyte recruitment underlies chronic inflammatory diseases 
including atherosclerosis, or acute diseases such as ischemia/reperfusion injury and 
early transplant rejection. This pivotal role in a wide variety of fundamental biological 
and physiological processes makes endothelial cells an obvious therapeutic target for 
much research and of particular interest to our research group. Whilst our laboratory 
has much experience isolating human cell populations, before this project began we 
lacked the technological expertise to isolate murine endothelium. Murine endothelial 
cells are widely used for in vitro experiments as a model of human systems. In 
addition to tissue being more readily available than human samples, genetically 
modified mouse models can be generated to examine disease processes, which is 
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not possible in humans. In particular our lab was interested in isolating mLSEC as a 
comparison to human counterparts being routinely isolated.  
 
3.1.1 Liver sinusoidal endothelial cells (LSEC) 
 
LSEC are a variety of specialised endothelial cells that populate the ‘capillary’ 
vascular bed of the liver, with the most noted phenotypic differences observed 
between the vascular endothelium in the portal vessels and the sinusoidal endothelial 
cells (Lalor & Adams 2002;Lalor et al. 2002b). The lining of the sinusoids consists of 
a monolayer of these specialised endothelial cells as well as a Kupffer cells (liver-
resident tissue macrophages) which phagocytose bacteria, cell debris and various 
other deleterious particles from the bloodstream as well as playing a role in immune 
surveillance. In addition hepatic stellate cells (HSC), pericytes in the perisinusoidal 
space, which are involved in fibrosis in response to liver damage, exist in close 
contact with the LSEC. The thin sinusoidal lining allows rapid exchange of nutrients, 
oxygen and other substances between hepatocytes and the bloodstream through the 
space of Disse separating the two distinct cell types as it flows though the liver 
(Scoazec et al. 1994). The location of LSEC and their low shear environment 
facilitates their specific functions, as LSEC are one of the first cell populations to 
come into contact with blood components flowing slowly through the liver. 
 
Thus LSEC form a barrier controlling the exchange of substances into the 
parenchyma of the liver, in addition they are highly specialised endothelial cells which 
regulate inflammation and subsequent leukocyte recruitment into the tissue, the 
hosts’ immune response during infection and receptor mediated clearance of harmful 
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pathogens. LSEC have a unique morphology characterised by the absence of tight 
junctions between cells or basal lamina, and most characteristically the presence of a 
number of open fenestrations forming sieve plates (Smedsrod et al. 1994;DeLeve et 
al. 2004). These sieve plates are a highly evolved structure acting as a ‘dynamic 
filter’ aiding the transportation of macromolecules including pathogens and viruses 
into the liver parenchyma.  
 
3.1.2 Culturing liver sinusoidal endothelial cells. 
 
In the field of sinusoidal endothelial cell research there has been much controversy 
over the optimal isolation and culture conditions for LSEC. There are two schools of 
thought regarding culture of LSEC. One claims that LSEC attributes are only 
apparent in short-term culture (Martinez et al. 2008) whereas the other claims LSEC 
can proliferate and be passaged in long-term culture (Gerlach et al. 2001;Karrar et al. 
2007). Sinusoidal endothelium have a propensity to dedifferentiate in prolonged 
culture and lose many of their functional and morphological characteristics (Hansen 
et al. 2005;Krause et al. 2000). Culture in vitro by definition involves removing 
primary cultures from their physiological niche in vivo. Tissue culture provides a 
vastly altered physiochemical environment resulting in phenotypic and functional 
changes. LSEC cultures have been shown deteriorate after 1-2 days in culture 
leading to decreased fenestration and scavenger activity (Hansen et al, 2005). In 
some studies serum (5-20%) has been shown to be toxic to dividing LSEC leading to 
differentiation from endothelial to stromal like cells (Krause et al. 2000). Under 
normal physiological conditions, cells of the sinusoid are exposed to much lower 
oxygen tension (5% normoxic) than that of air and standard tissue culture incubators 
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(20% hyperoxic) (Martinez et al. 2008). Culture under more physiological conditions 
has been shown to improve LSEC survival, endocytic capacity, and production of 
anti-inflammatory cytokine IL-10 (Martinez et al. 2008).  
 
Similarly there are different opinions regarding the most efficient method of isolating 
LSEC from murine livers; in situ perfusion of the whole mouse liver, developed by 
Smedsrod et al. or physical dissociation of liver tissue followed by positive selection 
using antibody conjugated magnetic beads (Tokairin et al. 2002). Several methods 
using immunomagnetic isolation of LSEC have been published. There has been 
much speculation over the purity of the endothelium isolated. Initially the endothelial 
molecule S-Endo 1 antigen (CD146) first discovered on melanoma cells was used 
but this antibody was not freely available for general use (Tokairin et al. 2002). Knolle 
et al. (Knolle et al. 2001) and Katz et al. (Katz et al. 2004) both used negative 
selection to remove CD45+ KC and CD11b+ DC whereas Onoe et al. (Onoe et al. 
2005) questioned the affectivity of these methods and used CD105 positive selection 
methods. CD31 has been used to isolate LSEC but it has been observed that CD31 
is a better marker for vascular endothelium. This may explain why LSEC isolated 
using CD31 possessed fewer fenestrations than those isolated by counterflow 
elutriation. Schrage et al. (Schrage et al. 2008) have since developed a method for 
isolating endothelial cells from several murine tissues using SE-1. CD146 is 
expressed at endothelial cell junctions in a number of different murine tissues, 
thought to support endothelial cell integrity, the extracellular portion is recognised by 
the monoclonal antibody ME-9F1. In addition the human molecule is also expressed 
on T-cells and follicular dendritic cells (Schrage et al. 2008). 
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3.1.3 Brain microvascular endothelial cells 
 
Whilst our lab is predominantly interested in hepatic endothelium and the 
optimisation of methods for isolating murine LSEC is of major interest, we wanted to 
compare the phenotype of these cells with those isolated from another primary tissue 
source. Many groups have reported isolation of cerebral cells including astrocytes 
and BMEC to study the role of the BBB in vitro. Methods generally involve collecting 
the small brain capillaries and microvasculature out of which endothelial cells are 
subsequently isolated (Tontsch et al. 1989;Wu et al. 2003), and many groups use 
bovine brain tissue. Most methods involve the removal of the meninges, 
homogenisation of the tissue, and enzymatic digestion, followed by either gradient 
centrifugation or antibody selection/depletion (Audus et al. 1996;Raub 1992;Rubin et 
al. 1991). BMEC appear to retain many morphological and biochemical properties 
present in vivo, but once isolated, could begin to dedifferentiate in culture due to the 
absence of external stimuli or direct contact with additional cell types present in the 
brain environment.  
 
We considered the brain to be an interesting source of endothelium for this study 
because the tissue is easily accessible, isolation methods have been previously 
reported and the physiochemical environment of the brain microvasculature is as 
unique and complex as that of the liver sinusoid. In contrast to the sinusoids brain 
endothelial cells are exposed to high shear stress (Liu et al. 2003) and are in close 
contact with surrounding astrocytes. Due to the unique microenvironment in which 
the brain resides and the need to prevent access of pathogens into the brain the 
recruitment of leukocytes to cerebral tissues, and the molecules involved are tightly 
regulated. Access is restricted in order to combat inflammation in the CNS and 
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circulating leukocytes have to overcome the BBB to gain entry (Williams et al. 1995). 
A number of different adhesion molecules, ICAM-1, VCAM-1 and PECAM-1 are 
involved in the recruitment and transport of leukocytes into the brain parenchyma 
(Couty et al. 2007;Greenwood et al. 2002).  
 
3.1.4 Current methodologies to isolate primary endothelial cells 
 
A number of widely accepted methodologies for isolating primary human endothelial 
cells exist in the literature, in particular for HUVEC and hLSEC. HUVEC have been 
used successfully for many years, becoming the cells of choice for vascular 
researchers due to ready availability of tissue and ease of isolation (Jaffe et al. 
1973). The isolation procedure involves cannulation of the umbilical vein and 
digestion with the proteolytic enzyme collagenase to release the endothelial cells 
(Cooke et al. 1993). Whilst popular, reproducible and easy to perform for human 
tissue this methodology is not translatable to rodent systems where cells have been 
isolated from aortic rings, fat pads, lungs and so on. Furthermore, HUVEC are a 
macrovascular endothelial population from a large vein, and often research is 
focused upon the microvasculature, such as cells of the hepatic sinusoid, as this is 
where disease processes tend to be localised. Isolation methods for cells from 
microvascular compartments prove more challenging as cannulation is not possible. 
The majority of methods use physical dissociation of whole tissue followed by 
enzymatic digestion. Phenotypic analysis may then be restricted to examining 
adherent cells and identifying those with cobblestone morphology. This is often 
inadequate as other adherent cells including fibroblasts may be present which tend to 
outgrow other cell populations in culture. Therefore, in order to minimise non-
 98 
endothelial contamination a variety of purification methods can be used. Cell 
preparations can be separated by size with meshes or filters of varying pore sizes 
and/or buoyant density via density gradient purification (Percoll, Optiprep). The 
desired endothelial population can then be positively/negatively selected using 
antibodies against endothelial markers such as acetylated low-density lipoprotein 
(AcLDL),CD31 and CD146 using FACS or immunomagnetic beads.  
 
The isolation of human LSEC (hLSEC) is more complicated, the tissue is dissociated 
and digested using collagenase, non-parenchymal cells (NPC) are separated on the 
basis of buoyant density on a Percoll gradient. Biliary epithelial cells (BEC) a major 
constituent of the NPC fraction are removed by positive magnetic bead selection 
using HEA-125 followed by positive endothelial cell selection with CD31. HSEC are 
cultured in human basal endothelial cell medium in the presence of human serum 
and several growth factors (HGF and VEGF) to maintain the in vivo phenotype in 
vitro (Lalor et al. 2002b;Lalor et al. 1999). Human cells require the presence of 
human serum in culture, whereas the use of autologous serum in murine LSEC 
(mLSEC) cultures is controversial, as serum has been shown to be toxic (Krause et 
al. 2000). It is important to provide an artificial matrix to for the cells to adhere to, 
including gelatin, collagen, fibronectin and vitronectin.  
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Author	   Species	   Isolation	  
Method	  
Cells	   Medium	   Matrix	   Expressio
n	  	  
Profile	  Karrar	  et	  al.	  2006	   Human	  Normal	  Liver	  	  
hLSEC	  method	   hLSEC	   MCDB1	  	  10%	  Human	  Serum	   Gelatin	   CD54,	  AcLDL,	  	  CD105,	  	  L-­‐Sign	  Daneker	  et	  al.	  	  1998	  	   Human	  Resected	  Liver	  	  
Dispase	  Percoll	   hLSEC	   EC	  Specific	  Medium	  20%	  Human	  Serum	  
Not	  Detailed	   CD31,	  CD34,	  CD54,	  	  vWF	  Martinez	  et	  al.	  2008	  	   Rat	   Perfusion	   rLSEC	   DM10	  Tissue	  SS	  5%/20%	  O2	  	   Rat	  Tail	  Collagen	  1	   IL-­‐10,	  IL-­‐6	  ICAM-­‐1	  DeLeve	  et	  al.	  2006	  	   Rat	   Perfusion	  αCD31	  selection	   rLSEC	   Not	  Detailed	   Fixed	  2%	  Glut	  	   Lack	  of	  sieve	  plates	  by	  SEM	  Katz	  et	  al.	  	  2004	  	   Mouse	   Perfusion,	  Collagenase,	  Percoll,	  metrizamide	  
mLSEC	   N/A	   N/A	  FACS	  and	  	  Ag	  Uptake	   CD31,	  CD32,	  vWF,	  CD11c	  Wu	  et	  al.	  2003	   Mouse	  	  C57BL/6	   Collagenase	  Dispase,	  Percoll,	  	  
αCD31	  MACS.	  
mBMEC	   MCDB	  131,	  10%	  FCS	  30µg/ml	  ECGS	  
Rat	  Tail	  	  Collagen	  1	   vWF,	  CD31.	  VCAM-­‐1,ICAM-­‐1	  only	  on	  stimulated.	  Marelli-­‐Berg	  
et	  al.	  2000	  	   Mouse	  CBA	  C57BL/6	  Balb/c	  
Collagenase	  
αCD31/CD105/IB4	  MACS	  
Lung	  Heart	   DMEM	  HEPES	  GPS	  150µl	  ECGS	  	  20%	  FCS	  
2%	  Gelatin	  	  Type	  B	   CD31,	  CD105,	  CD106,	  CD54,	  CD102,	  IB4	  Cha	  et	  al.	  2005	  	   Mouse	  Balb/c	   Skin	  flaps,	  Collagenase,	  Percoll	   Dermal	  EC	   MDCB	  131	  10%	  FCS	  30µg/ml	  ECGS	  
3%	  Collagen	  Type	  4	  	   CD31,	  Tie-­‐2,	  VEGFR2,	  Ac-­‐LDL	  Knolle	  et	  al.	  1999	  	  	   Mouse	  Balb/c	   Collagenase	  perfusion	  0.05%,	  30%Nycodenz,	  
αCD146	  MACS.	  
mLSEC	   DMEM	  10%	  FCS	  1%	  Glutamine	   Collagen	  	  Type	  1	   Immunological	  functions	  
Table 3. 1: Summary of sample of methods for isolating primary endothelial cell 
populations. Evidence for the variety of methods available for isolation from various 
organs and markers used to identify endothelial cell populations. 
 
 
When reviewing the literature regarding endothelial cell isolation methods, there are 
several stages in common, outlined in Figure 3.1 and Table 3.1. Each isolation 
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method is broadly split into three stages; dissociation of the tissue, separation of 
component cell populations and selection of the endothelial cell type of interest. 
 
A single celled suspension of the tissue of interest is obtained using a combination of 
proteolytic enzymes and physical dissociation. Cells are then separated on the basis 
of size and relative buoyancy using density centrifugation to remove debris and 
unwanted cell populations. Cells at the desired gradient interface are then further 
positively or negatively selected using an antibody bead step and are plated out onto 
tissue culture plastic coated with basement membrane proteins to aid cell adherence. 
Similar methods were used based on this framework to optimise the isolation of 
primary murine endothelial cells. In the sections that follow I will describe the 
development of each method in our laboratory, discuss any problems encountered, 
explain how problems were resolved and describe the final outcomes of 
investigations.  
 
 
 
 
 
 
 
 
 
 
 
 
 101 
3.2 Results 
3.2.1 Isolation of mLSEC via in situ perfusion of murine liver 	  
The gold standard method for LSEC isolation was reported by Smedsrod et al. in 
1985 (Smedsrod et al. 1985). High numbers of LSEC from rat livers were obtained by 
perfusing the liver via the portal vein. Perfusion involves swift killing of the animal and 
cannulation of the portal vein through which enzyme containing buffers are perfused 
utilising the resident vasculature to digest the tissue from within. I visited the 
Smedsrod laboratory in order to learn this procedure, which is outlined in more detail 
in Fig. 3.1 This procedure was successfully performed 6 times in Tromso. Primary 
mLSEC obtained by this procedure (~5-8 x105/liver) were seeded (104/well) onto 
collagen coated glass coverslips in 24-well plates in basal RPMI. mLSEC were fixed 
in methanol for 5 mins one-day post-isolation and transported back to the UK in 
sterile PBS. Figure 3.2 shows the results of preliminary immunochemical analysis of 
these cells confirming that the mLSEC had appropriate endothelial morphology, were 
of high purity and were positive for Endoglin and LYVE-1.  
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Figure 3. 1: Detail of perfusion method for isolating mLSEC. 	  
Simplified methodology of in situ perfusion of murine livers in laboratory of 
B.Smedsrod, Norway. (A) Outline of protocol, (B) Image of perfusion apparatus. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 103 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. 2: Immunohistochemical staining of mLSEC. 	  
Initial phenotypic analysis of mLSEC obtained as a result of perfusion isolation 
method carried out in Norway. mLSEC were cultured on glass coverslips, fixed in 
methanol and stored in PBS. Samples were stained for the presence of a number of 
adhesion molecules and endothelial markers using DAB method. Images captured at 
x10 magnification on Axioskop using Axiovision software. 
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The next step was to recreate the perfusion technique in Birmingham. The perfusion 
apparatus available resembled that of the Smedsrod group consisting of a water 
bath, a pump to regulate flow rate, fine gauge tubing and a Venflon to allow portal 
vein cannulation. The perfusion procedure was performed under a dissection 
microscope with sufficient light to visualise the portal vein (Fig. 3.2). 
Perfusion was carried out as outlined in Figure 3.2 with C57BL/6 mice, however 
several isolations yielded predominantly cell debris with few obvious cell populations, 
as shown by representative images in Figure 3.3. Several modifications were made 
to the procedure including different water sources, cell culture grade buffer reagents, 
collagenase, assistance in perfusing, anaesthatising animals prior to perfusion, using 
older mice and so on. However these modifications were unsuccessful in our hands.   
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Figure 3. 3: Representative images of results of initial perfusion experiments.  
 
Images captured x10 magnification of Axiovision Light Microscope. 
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3.2.1.1 Isolation of mLSEC using immunomagnetic bead selection with Miltenyi 
αLSEC microbeads. 
 
Several different immunomagnetic methods devised from commercially available kits 
and in house reagents were used in order to isolate primary murine endothelial cell 
populations from both liver and brain.  In the initial stages of this project a specific kit 
manufactured by Miltenyi was used in combination with Collagenase 2 digestion and 
an Optiprep gradient (Figure 3.4-3.6). Although cells with the appearance of LSEC 
were isolated in the initial tests of this kit, the procedure was not reliable in latter 
experiments.  We suspected that the α-mLSEC MAb conjugated to the MACS beads 
might have become detached upon storage. To test for this possibility a sample of α-
mLSEC beads were incubated on murine liver sections and then stained with an 
appropriate FITC conjugated secondary antibody. In addition we acquired a sample 
of α -mLSEC FITC conjugated MAb from the supplier, which we also tested on liver 
sections. Figure 6 shows that whilst we saw little or no staining on the samples 
treated with beads (Fig 3.6-A/B) we observed distinct vascular staining (large vessels 
and small arteries in the portal areas, arrows on Fig. 3.6 C/D) with the FITC-
conjugated antibody. Interestingly however there was very little sinusoidal staining 
evident. 
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Figure 3. 4: Schematic isolation of mLSEC using Miltenyi LSEC microbeads. 	  
Outline of initial method used for isolating mLSEC. Resulting cell populations 
obtained post-MACS separation were plated out into various culture vessels 
including collagen coated chamberslides, T25’s and T75’s in DMEM containing 10% 
FCS, mEGF, HGF and VEGF cultured in a 37°C 5% CO2 incubator to encourage cell 
attachment and proliferation. 
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Figure 3. 5: Light micrograph of cellular matter obtained from LSEC 
immunomagnetic bead selection.  
 
Schematic diagram of αLSEC MACS isolation method and resultant cell populations. 
Images are captured at x10 magnification on Axiovision Light Microscope. 
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Figure 3. 6: Image of cryosectioned murine liver stained by immunofluoresence 
methods.  	  
Samples were stained using Rat IgG at 5µg/ml (A) and α murine LSEC MACS beads 
(B) to test the adherence of beads. The α mouse LSEC-FITC was also tested diluted 
1/50 (C) and 1/100 (D) of manufacturers stock.  Positive stain indicated by arrows. 
Image captured at x10 and x20 original magnification respectively on Axiovert 
microscope using Axiovision software. 
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3.2.1.2 Use of cytometry in conjunction with LSEC-FITC to optimise isolation 
procedure 
 
Next the αLSEC-FITC MAb was used to determine whether endothelial cells were 
present at the beginning of the isolation procedure and/or lost during latter stages of 
the isolation protocol. A 200µl aliquot of cells was removed at various stages 
(indicated by red numbers) throughout the isolation protocol as outlined in Figure 3.7 
and labelled with LSEC-FITC. Figures 3.7-3.9 show representative cytometry 
scattergrams and histograms from cells immediately after digestion prior to any cell 
selection. Figure 3.8 indicates that there are a large number of cells present at this 
stage in the isolation protocol. The hepatocytes form a distinct large population with a 
few outliers (cell doublets) and some very small cell debris is evident. Figure 9 shows 
that we saw little non-specific labelling with an isotype matched control antibody (3.9-
A). In contrast a distinct peak of FITC fluorescence is apparent and these cells have 
a location on the scattergram appropriate for endothelium (green cells on scatterplot, 
3.9-B) 
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Figure 3. 7: Schematic diagram summarising the location of LSEC throughout 
the isolation procedure.  
Each stage at which a sample was removed for FACS analysis is labelled with a 
number in red. 
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Figure 3. 8: Flowcytograms depicting cells contained within post collagenase 
digest sample.  	  
The dot plot on the left separates cells by forward scatter and side scatter according 
to size and granularity respectively we can postulate where the mLSEC lie on the 
basis of these parameters and fluorescence levels. (A) mLSEC, (B) Hepatocytes. 
The histogram on the right depicts FITC fluorescence; the red peak is the IgG control 
and the green peak shift represents α mouse-LSEC-FITC at 1/30 dilution of 
manufacturers stock, which labels the cells of interest. The percentage quoted 
represents the number of positively stained cells.  
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Figure 3. 9: Flowcytograms depicting cells contained within post collagenase 
digest sample stained with (A) Rat IgG and (B) α mouse LSEC-FITC at 1/30 
dilution of manufacturers stock.  	  
The dot plots on the left separates cells by forward scatter and side scatter according 
to size and granularity respectively limited to 8000 events for clarity. Events in black 
are red blood cells and debris. Events in green are FITC positive mLSEC in area 
outlined in Fig 3.10. (A). The histograms on the right depict FITC fluorescence and 
percentage FITC positive cells.  
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Table 3.2 shows that as the isolation protocol progresses the number of positively 
labelled cells changes. After removal of hepatocytes the proportion of LSEC-FITC 
positive cells increased as expected. However the number of cells decreased 
dramatically with every subsequent stage in the protocol. 
 Sample	   Isolation	  Stage	   Percentage	  of	  positive	  cells	  (%).	  1	   Post	  Collagenase	  digest	  and	  fine	  mesh.	   5.43	  2	   Post	  slow	  spin	  1	  supn	   62.69	  3	   Post	  slow	  spin	  1	  pellet	   11.08	  4	   Post	  slow	  spin	  2	  supn	   15.82	  5	   Post	  slow	  spin	  pellet	   3.31	  6	   Pelleted	  NPC’s	   3.45	  7	   Post	  Optiprep	  gradient	  centrifugation	   2.82	  8	   MACS	  Column	  Waste	   0.28	  
 
Table 3. 2: Representative Data of FACS experiment determining at which stage 
of isolation endothelial cells were being lost. 
 
 
3.2.1.3 Isolation of mLSEC using Easy Sep MACS beads 
 
Next I attempted a method more analogous to that we use for isolating human LSEC.  
This technique (outlined in Fig. 3.10-A) again involved labelling the mLSECs with the 
α mLSEC-FITC conjugated MAb after collagenase digestion of tissue. Magnetic 
beads conjugated to an α-FITC secondary MAb were then used to pull out the 
labelled cells. However this technique did not select any cells (Fig 3.10-B). 
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Figure 3. 10: Schematic showing the principle behind the Easy-Sep method.  	  
Light micrograph of cellular debris post Easy-Sep selection cultured in collagen 
coated T25 flasks with 5ml DMEM + 10% FCS, mEGF, HGF and VEGF. Image 
captured at x10 magnification on Axiovision microsope 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 116 
3.2.1.4 Isolation of mLSEC with Miltenyi αCD146 MACS kit. 
 
In the course of my investigation, Schrage et al. reported using αCD146 
immunomagnetic beads in combination with perfusion to isolate high numbers of 
pure mLSEC. A CD146 immunomagnetic bead kit was available from Miltenyi as an 
alternative to αLSEC beads. Therefore I tested this reagent using an adapted 
protocol similar to that used for the αLSEC reagent (Fig. 3.11). This method was 
successful and yielded large numbers of mLSEC.  For example, in the initial isolation, 
50cm2 of confluent cells (2 x107) with appropriate LSEC morphology were isolated 
(Fig. 3.12). Phenotypic analysis of cells isolated using this methodology confirmed 
that the cell populations were positive for CD31, LYVE-1 and Endoglin (Fig. 3.13). 
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Figure 3. 11: Diagram of mLSEC isolation using MACS αCD146 kit. 	  
Outline of current version of liver sinusoidal endothelial cell isolation method for 
approximately 6 livers. The number of livers used in each isolation varied but 
quantities of reagents were changed in accordance with the amount of tissue. 
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Figure 3. 12: Light micrograph images of LSEC cell populations resulting liver 
endothelial cell isolation protocol.  
 
Images captured at x10 and x20 magnification on Axiovision Light Microscope. 
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Figure 3. 13: Light micrograph and confocal images of primary mLSEC. 	  
mLSEC were seeded into chamberslides or onto glass coverslips and fixed in 
methanol. Samples were stained for a range of molecules using DAB 
immunohistochemical and immunofluroescence methods. Images captured at x20 
magnification for LM pictures of chamberslides and x63 for fluorescent confocal 
images. 
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3.2.1.5 Optimal protocol for LSEC isolation 
 
In summary, several different methods for isolating mLSEC from whole murine livers 
were attempted (Table 3.3). All of these methodologies have been used by other 
groups and are reported to be successful. However in our hands, with the equipment 
available to us, we found some protocols resulted in poor cell yields or did not 
reproducibly produce high quality cell isolates. We found the best method utilised a 
combination of Collagenase 4 to digest the tissue, a Percoll gradient to remove 
parenchymal cells and selection with αCD146 immunomagnetic beads to generate 
homogeneous mLSEC populations. 
 
Dissociation	   Enzyme	   Gradient	   Selection	   Cell	  Yield	  
In	  situ	  perfusion	   Liberase	   Percoll	  23/50%	   KC	  Adherence	   0	  Mince/Meshes	   Collagenase	  2	  (0.25%)	   Optiprep	  60%	   α-­‐mLSEC	   0	  Stomacher/Meshes	   Collagenase	  4	  (0.05mg/ml)	   Optiprep	  100%	   N/A	   6	  Livers	  1	  semi	  confluent	  T25	  0.5	  x106	  Mince/Meshes	   Collagenase	  4	  (2mg/ml)	   Percoll	  23/50%	   α-­‐CD146	   6	  Livers	  2	  confluent	  T25’s	  2x106	  
 
Table 3. 3: Typical results of the various mLSEC isolation methods used.  
Details of method development and modifications leading to final method used to 
isolate mLSEC from whole murine livers. 
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3.2.2 Isolation and culture of primary murine brain microvascular endothelial 
cells (BMEC). 
 
The literature details several methods for isolating BMEC from bovine brain (Raub et 
al. 1992;Rubin et al. 1991) involving removal of the meninges, homogenisation of the 
tissue, enzymatic digestion, and either gradient centrifugation or antibody selection or 
depletion. I used these methods as described by digesting murine brains with 
Collagenase 4 and selection of endothelial cells with an αCD31-Biotin antibody and 
streptavidin conjugated dynabeads (Fig. 3.14). The isolation procedure did generate 
viable cells in considerable number but the purity of the end results was poor. Figure 
3.15 shows that a number of different cell populations were observed in the resulting 
cell isolates. Endothelial like cells were present initially but diminished as the number 
of epithelial and fibroblastic cells increased. Small populations of neuronal cells were 
also observed but these did not appear to proliferate in contrast to epithelial and 
fibroblastic cells. Despite several attempts to improve the purity of the preparations I 
was unable to generate a homogenous brain endothelial culture. 
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Figure 3. 14: Schematic of mBMEC isolation method 	  
Outline of current version of brain microvascular endothelial cell isolation method. 
The number of brains used in each isolation varied but quantities of reagents were 
adjusted in accordance with the amount of tissue used. 
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Figure 3. 15:Light micrograph images of varying cell populations resulting from 
brain microvascular endothelial cell isolation protocol. 	  
Images captured at x10 magnification 
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3.3 Discussion 
 
The aim was to isolate primary murine endothelial cell populations from different 
organs for further in vitro experiments to highlight any phenotypic and functional 
differences. Several different methods for isolating endothelial cell populations are 
available in the literature (See Table 3.1). Generic methods include, tissue 
dissociation, cell separation and further selection or depletion to obtain the desired 
population.  Murine liver sinusoidal endothelial cells (mLSEC) were of particular 
interest due to the unusual phenotype and immunological functions. In addition brain 
microvascular endothelial cells (mBMEC) were examined as an additional EC 
population due to the privileged site they inhabit. Murine in vitro systems allow the 
investigator to manipulate parameters more difficult to examine in the whole animal 
(shear stresses, cytokine stimulation). In addition murine models of inflammatory 
diseases are available and results can be considered in parallel to human systems.  
 
A number of methods were carried out including both immunomagnetic and perfusion 
techniques to isolate mLSEC and mBMEC. Isolation of mLSEC proved difficult until 
the advent of a new commercially available kit (Miltenyi, UK) directed against CD146 
a molecule present on endothelial cells in a number of murine organs (Schrage et al. 
2008). The mBMEC isolation protocol yielded a number of different cell populations 
including contaminating adherent cells that proved problematic. Each isolation 
method attempted was further developed from that published to obtain high yields of 
pure endothelial cells. 
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3.3.1 Use of perfusion to isolate rodent sinusoidal endothelium 
 
Perfusion of the liver has been used to isolate several different populations from 
animal livers in particular mice, rats (DeLeve et al. 2006;Smedsrod et al. 1984) and 
pigs. In addition to isolating mLSEC Smedsrod et al. pioneers of the technique, 
isolated hepatocytes and cells of the reticuloendothelial system (rLSEC and KC) from 
rat livers (Smedsrod et al. 1985). Elvevold et al. (Hansen et al, 2005) perfused 
porcine livers to isolate pLSEC.  Perfusing the organ allows a more delicate and 
comprehensive tissue dissociation by digesting the tissue in situ. A variety of 
proteolytic enzymes can be used including Collagenase and Liberase, a more stable 
mix of proteases used to avoid enzymatic batch variability found with Collagenase.  
 
Although in situ perfusion via the portal vein is a reliable digestion method in many 
laboratories it is a highly skilled procedure, which requires specialist equipment. 
When I performed the procedure under expert guidance in Norway it was successful 
and reproducible. However, many problems were encountered when I attempted to 
recreate the methodology in Birmingham.  Of particular importance is the fact that the 
perfusion apparatus used here was modified due to cost considerations and 
availability of more the complicated elements of apparatus.  The absence of a heat 
exchanger to maintain the temperature of the perfusion solutions and buffers 
probably resulted in inadequate temperature control and it is likely that upon 
perfusion the reagents were a little cool (24-28°C). The reagents were pre-warmed in 
a water bath but I resisted maintaining this too hot for fear of adversely affecting 
enzyme activity. In addition, the procedure needs to be completed as rapidly as 
possible after death of the animal. In published methods animals are rapidly killed 
with high concentrations of CO2, but this method is not licensed in the UK. Here the 
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Home Office permits sacrifice of animals by decreasing O2 and increasing CO2 over 
a number of minutes. Thus our best rapid alternative was cervical dislocation, which 
was carried out some distance from the perfusion apparatus. Thus by the time 
animals were ready for cannulation I noted that some blood clotting had occurred 
which impeded the perfusion of buffer into the livers. This could have been avoided 
by the injection of heparin into the animals prior to Schedule 1 but this could not be 
completed without a license, which I do not hold. These issues in combination with 
some problems arising from different sources of reagents and plasticware meant that 
I was unable to reproducibly isolate high numbers of pure cells using this 
methodology and thus moved on to methods based upon immunomagnetic selection. 
 
3.3.1.1 Use of magnetic selection to isolate rodent sinusoidal endothelium  
 
Several methods using immunomagnetic isolation of LSEC have been published, but 
controversy exists over the purity of the endothelium isolated. Initially the endothelial 
molecule S-Endo 1 antigen (CD146/mCAM) first discovered on melanoma cells was 
used but this antibody was not freely available for general use (Tokairin et al. 2002). 
Knolle et al. (Knolle et al. 2001) and Katz et al. (Katz et al. 2004) both used negative 
selection to remove CD45+ KC and CD11b+ DC from endothelium isolated by 
counterflow elutriation. However Onoe et al. (Onoe et al. 2005) questioned the 
efficacy of these methods suggesting CD105–based selection methods were 
superior. Our laboratory uses CD31 to isolate human LSEC due to its widespread 
expression on all endothelium particularly in diseased livers. However LSEC isolated 
using CD31 have been suggested to possess fewer fenestrations than those isolated 
by counterflow elutriation (DeLeve et al. 2006).  
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Our problems using the initial αmLSEC kit may have several sources, and was not 
helped by the fact that the identity of the antigen recognised by the antibody in the 
αmLSEC MACS kit used in 3.7 was not made available by the manufacturer. 
Additionally we suspected that the antibody could have become detached from the 
beads rendering them ineffective. Our immunofluorescent staining (Fig. 3.6) indicated 
that the immunomagnetic beads were binding non-specifically to liver tissue. In 
addition I believe that LSEC were lost during certain elements of the isolation 
procedure. Thus an alternative method of immunomagnetic separation was trialled 
utilising an αLSEC-FITC antibody. However, neither method yielded any cells. I also 
attempted to remove the specific cell selection step using soley digestion with 
Collagenase 4 (data not shown) specifically designed for the release of liver cells 
produced cells resembling mLSEC. However, due to the absence of specific 
selection, a number of other non-parenchymal cells present in the same density 
gradient band were obtained in addition to mLSEC. The non-adherent cells were 
washed off Day 1 post-isolation, but adherent cells such as Kupffer and Stellate cells 
were present in some cultures, which would affect subsequent phenotypic analysis.   
 
Schrage et al. (Schrage et al. 2008) have since developed an antibody (ME-9F1) 
against CD146 can be used to isolate endothelial cells from several murine tissues. 
CD146 is expressed at endothelial cell junctions in a number of murine tissues and it 
is thought to support endothelial cell integrity. The extracellular portion of CD146 is 
recognised by the monoclonal antibody ME-9F1. In addition the human molecule is 
also expressed on T-cells and follicular DC, however the murine counterpart was 
only found at low levels on a subset of NK1.1+ cells. My experience using this 
antibody suggested that the αCD146 beads yielded the highest number of pure 
mLSEC compared to the other available methods 
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attempted. Immunohistochemical phenotypic analysis of the isolated cells indicated 
that they expressed CD31, ICAM-2, CD34, VAP-1, LYVE-1, and Endoglin as found in 
published literature (Table 3.1). Further phenotypic analysis of these cells follows in 
later chapters. 
 
It is crucial to be able to phenotype and identify primary isolated cell populations. 
Endothelial cell characteristics include, expression of CD31, CD34, vWF, uptake of 
ac-LDL, binding of lectins, appearance of ‘cobblestone’ morphology and the 
propensity to form tubes in matrigel (Aird 2007a). Although present on populations of 
EC these features are not universal and vary temporally, spatially in vitro, in vivo and 
between cultures, accounting for marked EC heterogeneity. As previously mentioned 
LSEC are highly endocytic expressing a number of scavenger receptors including 
stabilin-2 and LYVE-1 that can be used to identify LSEC (Hansen et al. 2005). At 
present no single marker or characteristic is sufficient to confirm liver sinusoidal 
endothelial cell cultures. 
 
In order to correctly identify endothelial cell populations and to use them in model 
experimental systems in vitro the challenge is to maintain the in vivo phenotype in 
vitro. As mentioned previously the best methods for culture of LSEC are 
controversial. hLSEC are cultured in the presence of serum and a number of growth 
factors, can be subcultured and maintain their original phenotype up to passage 6. 
Conversely it has been reported that mLSEC do not proliferate in culture, that serum 
might be toxic to them and that maintainance of original phenotype can be prolonged 
by culturing cells at lower oxygen tension (5%) (Elvevold et al. 2008). The mLSEC 
obtained with the αCD146 isolation method were cultured in basal RPMI (+PSG) in 
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the absence of serum in gelatin coated culture vessels. Cells were used in 
experiments the day after isolation and deteriorated from Day 2 post-isolation 
onwards. mLSEC did not proliferate even in the presence of hGF and VEGF 
(10ng/ml) and could not be subcultured. mLSEC died when subjected to passage 
with Trypsin and Versene (EDTA).  
 
mLSEC are used by a number of different research groups to examine antigen 
presentation (Knolle et al. 1997), endocytic capacity (Matsumoto et al. 2000) and 
their role in inflammation. LSEC are thought to play a role in innate immunity in the 
liver presenting foreign antigens via FC-γR and pattern recognition receptors (PRR) 
(Elvevold et al. 2008). Blood flowing through the liver contains many benign soluble 
food antigens to which the immune system is tolerant. LSEC are thought to be 
important in this process however, there is much debate over their specific role in 
hepatic tolerance. Early studies by Knolle et al. (Knolle et al. 2000) showed that 
LSEC in addition to normal scavenger receptors expressed MHC I/II, CD80/86 and 
CD40 involved in antigen presentation and induced the differentiation of naïve T-
Cells to a Th0 rather than Th1 driven by other APC’s. However, Katz et al. (Katz et al.  
2004) found that LSEC had a high capacity for taking up antigens and in the absence 
of costimulation were insufficient to activate naïve T-cells but did not express 
markers of APC’s. Onoe et al. (Onoe et al. 2005) then discovered LSEC isolated by 
CD105 positive selection methods expressed MHC II and CD86. When examining 
data published by these groups it must be considered that methods used to isolate 
and culture LSEC varied between each group and factors such as selection method, 
serum concentration, contaminating cell populations and cultivation techniques have 
affects on phenotype and functional responses (Elvevold et al. 2008). As of yet no 
decisive conclusion can me made on the role of LSEC in liver immunology. The 
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mLSEC obtained in these studies were not examined for expression of 
immunological markers involved in antigen presentation. This research is more 
focussed on the role that mLSEC play in inflammation and subsequent leukocyte 
recruitment. However this supports the idea that mLSEC are an elusive and complex 
cell type. 
 
3.3.2 Isolation of Brain microvascular EC  
 
In addition to developing an effective method of isolating mLSEC, an alternative 
source of homogenous primary microvascular endothelial cells was investigated. 
Unlike the low shear environment of the liver sinusoids, brain microvascular 
endothelial cells are exposed to high levels of shear and are an integral part of the 
BBB (Lui et al. 2003). 
 
Much research on brain microvascular cells have used bovine sources to model the 
blood brain barrier, cells are isolated and can be co-cultured with astrocytes or in 
astrocyte conditioned media (Dehouck 1990;Rubin et al. 1991). Little work has been 
done using murine sources. Early research used young animals, which were of 
limited value (DeBault et al. 1979;Tontsch et al.1989). Wu et al. (Wu et al. 2003) 
have since developed a simple method for isolating mBMEC separating cells using 
Dextran and Percoll and positively selecting EC with αCD31 immunomagnetic beads. 
Their cells were cultured in MCDB media with 10% FCS and 30µg/ml endothelial cell 
growth supplement (ECGS). The resulting mBMEC cultures possessed cobblestone 
morphology, formed tubes and tight junctions in matrigel, expressed vWF and 
demonstrated uptake of acLDL. TNF-α stimulated mBMEC expressed ICAM-1 and 
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VCAM-1. The importance of ICAM-1/VCAM-2 and other adhesion molecules have 
been demonstrated on cytokine stimulated primary mouse, rat and human BMEC 
and in inflammatory conditions in vivo such as the Experimental Autoimmune 
Encephalitis (EAE) model. In particular ICAM-1 (CD54) and PECAM-1 (CD31) are 
thought to be involved in downstream signalling events post adhesion, via G-protein 
coupled receptors and thus to perpetuate further recruitment. For example by 
inducing cytoskeletal changes and creating ‘transmigratory cups’ to permit access of 
subsequent cells (Greenwood et al. 2002) (Adamson et al. 2002;Couty et al. 2007). 
In such studies, many research groups use the commercially available brain 
endothelial cell line b.End.5 isolated from hemangiomas (vascular tumours) 
generated by a retroviral construct encoding polyoma middle-sized T-Ag (Rohnelt et 
al. 1997). 
 
The method I used to isolate primary brain endothelium (outlined in Fig. 3.14) relied 
on similar methods to that used by Wu et al. α-CD31 biotin was used in conjuction 
with streptavidin conjugated dynabeads to positively select endothelial cells from 
homogenised tissue. Despite blocking non-specific binding with avidin a number of 
different cell populations were obtained (Fig. 3.15). In initial days post-isolation a 
number of endothelial like cells were apparent in culture however as cultures 
progressed the fibroblast cells outgrew EC a common feature when isolating primary 
cells. I am confident that the protocol could have been further optimised to minimise 
contaminating cell populations or to further purify the endothelium, but due to time 
constraints I instead focussed on isolating mLSEC and opted to use the cell line 
b.End.5 for comparison. 
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3.3.3 Primary cells vs. Immortalised Cell Lines. 
 
In vitro systems using primary cells are of most value as they enable the researcher 
to obtain the most representative impression of the in vivo situation. Although the 
most desirable system to use they pose many experimental difficulties. They are 
notoriously difficult to isolate and protocols vary widely throughout the literature. 
Once isolated and removed from the in vivo physiochemical environment, EC begin 
to dedifferentiate into stromal like cells due to the absence of external stimuli 
(Elvevold et al. 2008). Primary hLSEC and mLSEC lose phenotypic markers over 
time such as L-Sign, and the characteristic fenestrations disappear. Thus cells are 
generally used up to passage 6 or 1-2 days post culture respectively. There is much 
controversy over culture conditions with differing opinions on maintained culture, 
serum levels, growth supplements (hGF, VEGF, ECGS, Tissue SS), oxygen tension 
and so on (Elvevold et al. 2008).   
 
Due to the difficulty of isolating homogeneous primary EC populations immortalised 
cell lines have been developed to allow further research and understanding of 
endothelial cell function. Cell lines originate from a primary cell population and are 
often conditionally immortalised with viral mechanisms to prevent senescence. 
Immortalised cells can be continually subcultured to high passages maintaining a 
constant stable phenotype. These characteristics make such cells ideal for studying 
the effects of inflammation on the phenotype and function of endothelial cells from 
different organs. Thus we decided to use several cell lines as comparators in our pilot 
experiments in order to determine the key experiments to take forward when stable 
primary murine endothelial cell populations were obtained.  
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A number of immortalised endothelial cell lines were used in this study including 
mUCEC-1 (Lidington et al. 2002), s.END (Bussolino et al. 1991) and b.End.5 
(Rohnelt et al. 1997) originating from heart, skin and brain respectively. Two viral 
methods of immortalisation were used to generate these lines. H-2KB-tsA58 
transgenic mice express a thermolabile strain (tsA58) of the simian virus (SV40) 
large T-Antigen linked to an inducible major histocompatibility complex H-2K 
promoter. T-Ag expression is only apparent when cells are cultured at the lower 
temperature of 33°C and promoter activity can be up regulated by the addition of 
IFN-γ. A cardiac endothelial cell population (mUCEC-1) immortalised in this manner 
has been shown to rapidly expand in culture, respond to growth factors and cytokines 
(TNF-α, IL-1β and LPS) and express appropriate adhesion molecules involved in 
leukocyte recruitment including CD31, Endoglin, ICAM-1/2, and VCAM-1 (Lidington 
et al. 2002). Endothelial cells from the ‘immortomouse’ have been isolated from lung, 
colon, kidney, heart, brain, pancreas, uterus, ovaries, bladder and prostate (Langley 
et al. 2003). A number of endothelial cell characteristics were examined including; 
formation of tubes in matrigel, uptake of acLDL, cell morphology and doubling time. 
Unfortunately no data regarding mLSEC from these animals have been described. 
However, data has been published using an immortalised liver endothelial cell line 
from the H-2KB-tsA58 transgenic mouse for use in radial-flow bioreactors to generate 
artificial liver (Matsuura et al. 2003). 
 
In addition cells have been isolated from hemangiomas (vascular tumours) generated 
by a retroviral construct encoding polyoma middle-sized T-Ag from skin (s.END), 
heart, brain (b.End.5), kidneys and whole embryos (Bussolino et al. 1992). Brain 
endothelioma cells have been used to model the blood brain barrier, examine the 
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adhesion and transmigration of T-Cells (Klotz et al. 2007;Rohnelt et al. 1997) across 
microvascular endothelium and the role of VCAM-1, ICAM-1 and ICAM-2 (Etienne et 
al. 1998;Etienne-Manneville et al. 2000). Skin endothelioma cell lines have been 
used to investigate signalling pathways (PKC) (Bussolino et al. 1992) and cytokine 
production (Il-6, KC, IL-1α, MCP-1, GM-CSF) (Bussolino et al. 1991). Thus we 
believe that the cell lines we have chosen should represent good models for studying 
inflammation in different organs. However although cell lines are an invaluable 
experimental tool, it must be considered that the biology of these cells 
could be altered by the presence of the viral constructs. 
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4. PHENOTYPIC CHARACTERISATION OF ORGAN SPECIFIC ENDOTHELIAL 
CELLS. 
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4.1 Introduction 
 
The endothelium could be considered as an organ, which is distributed throughout 
the body, since endothelial cells form the lining of all blood vessels from arteries to 
capillaries in the microcirculation. A highly heterogeneous organ both structurally and 
functionally EC play a role in many physiological processes including vascular 
permeability, haemostasis, vasomotor tone, blood cell trafficking, proliferation and 
both innate and adaptive immunity. Not all EC perform all these functions, for 
example cells of the microcirculation are involved in leukocyte trafficking whereas 
arterial EC participate in regulating vascular tone. No universal endothelial cell 
phenotype has been discovered and many endothelial characteristics vary 
throughout the vasculature. Due to the privileged position of EC, they are involved in 
or affected by almost every type of disease making them an obvious therapeutic 
target. 
 
Endothelial cells are highly plastic, moderating their phenotype in response to the 
local extracellular environment. EC constantly sample the surrounding 
physiochemical environment from the luminal, abluminal and junctional surfaces. 
These environmental factors can be biochemical (cytokines, growth factors, 
hormones, oxygenation etc) or biomechanical including haemodynamic forces such 
as shear stress and pulsatile flow as a result of the cardiac cycle. These cues 
activate signalling pathways leading to posttranscriptional modifications and 
alterations in patterns of gene expression resulting in phenotypic changes. 
Environmental factors vary temporally and spatially resulting in a constant flux of 
phenotype (Garlanda, 1997). For instance arterial EC will be more affected by 
haemodynamic forces compared to microvascular EC that are more affected by 
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biochemical signals due to close proximity to the underlying tissues. Shear stress 
varies throughout the vascular tree, from low shear in the microcirculation to high 
shear pulsatile flow in arteries (Nash, 2004). Flow varies in straight vessels where 
laminar flow is present, in comparison to arterial bifurcations where EC areas are 
exposed to disturbed flow (Eddys), which renders them more vulnerable to 
atherosclerotic plaque formation (Cybulsky, 1991). Patterns of blood flow can be 
affected by disease, age and exercise. Biochemical fluctuations can be altered post-
prandially, and in response to infection, diurnal rhythms and age (Aird 2006). 
 
In addition to changes as a result of alterations in the local environment, EC 
phenotype can be affected by epigenetic modifications. Epigenetic properties are 
passed from parental to daughter cells through S-phase without the need for the 
original signal that induced them. These modifications include DNA methylation, 
acetylation, histone modification and chromatin remodelling, which are highly 
dynamic and could be affected by age, disease and therapeutic manipulation (Aird 
2006;Aird 2008).  
 
Due to the high importance and relevance of these factors it is of no surprise that 
there is much dedifferentiation and transdifferentiation in in vitro EC systems. EC 
phenotype appears to be a balance of factors with certain genes being affected by 
either environmental or epigenetic alterations. Chi et al examined gene expression 
patterns of cultured endothelial cells from various areas of the vasculature and found 
notable differences between microvascular and macrovascular and arterial and 
venous sites (Chi et al. 2003). 
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4.1.1 Structure and Function of EC 
 
Endothelial structurally heterogeneity was first demonstrated in the 50’s and 60’s 
using an electron microscope (EM) (Aird 2007b). EC structure varies throughout the 
vasculature, although conventionally flat in vessels they are cuboidal in shape in high 
endothelial venules (Girard et al. 1995) and thickness can vary from 0.1µm in 
capillaries to 1µm in the aorta. There are 2 main types of junctions between EC, tight 
junctions (zona occludens) and adherens junctions (zona adherens) (Dejana 2004). 
Tight junctions form barriers between individual cells and help to maintain cell 
polarity. These physical barriers vary within the vascular tree with large numbers in 
the macrovasculature compared to smaller, leakier junctions in the microvasculature 
according to the functions that they perform (Aird 2007b). Arterial EC are exposed to 
high shear and pulsatile flow, whereas the microvasculature is involved in leukocyte 
recruitment and movement of solutes in inflammation. The exception is the BBB 
where a large number of tight junctions maintain the immunologically privileged state 
of the brain (Aird 2007a).  
 
4.1.2 Markers of endothelial cells 
 
Endothelial cells (EC) are notoriously difficult to define, as no specific marker of EC’s 
exist. In addition any ‘endothelial-like’ markers such as CD31 or VE-Cadherin, or 
structural characteristics for example Weibel-Palade bodies or fenestrations, vary 
between subsets of EC’s and can also be present on additional non-endothelial cell 
types (Aird 2007b). When isolated for culture, EC are removed from their normal 
physiological environment and all elements and factors contained within that leading 
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to phenotypic drift (Aird 2008). This makes identification and phenotypic analysis of 
isolated cell types more challenging. In order to prevent this, researchers recapitulate 
the in vitro microenvironment by adding serum, conditioned media, basement 
membrane proteins and try to model exposure to haemodynamic forces (Elvevold et 
al. 2008). 
 
4.1.3 Endothelium in disease 
 
As mentioned previously, EC are involved in the pathology of many different 
diseases. The location of endothelial cells means they are ideally situated to interact 
with passing leukocytes in the circulation. It was found in the 80’s that if EC are 
incubated with pro-inflammatory mediators (cytokines and bacterial products) they 
become activated resulting in pro-adhesive, antigen presenting and procoagulant 
properties (Bevilacqua et al. 1987;Pober et al. 1987).  
 
An area of particular research interest regarding endothelial cells is atherosclerosis. 
This disease is topical due to the increasing prevalence of morbid obesity in the 
population and the growing number of deaths from heart attacks in which 
atherosclerotic plaques are a major contributing factor. Atherosclerotic lesions form 
at sites of disturbed blood flow such as arterial bifurcations, where altered flow 
patterns are thought to impact on EC expression profiles leading to a phenotype with 
an increased propensity to respond to systemic changes (high cholesterol/glucose) in 
a pro-inflammatory fashion. Saphenous veins have been shown to possess arterial 
like properties when grafted into the coronary circulation including a tendency to 
become atherosclerotic (Aird 2006). 
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Under normal situations, the recruitment of neutrophils is an essential mechanism for 
combating invading pathogens. If however, this process is modified or malfunctions 
in someway, as is the case in some autoimmune diseases, it can lead to undesirable 
consequences. If recruitment is ineffective it can increase the host’s susceptibility to 
infection leading to recurrent or persistent infections, which are never resolved 
effectively. If clearance of tissue resident apoptosing neutrophils is deregulated it can 
lead to chronic inflammation and organ damage (Morgan et al. 2005). 
 
4.1.4 Use of cell lines to study in vitro endothelial cell systems 
 
In vitro systems using primary cells are of most value as they enable the researcher 
to obtain the most representative impression of the in vivo situation in a particular 
organ. Although the most desirable system to use they pose many experimental 
difficulties. They are notoriously difficult to isolate and protocols vary widely 
throughout the literature. Once isolated and removed from the in vivo physiochemical 
environment, EC begin to dedifferentiate into stromal like cells due to the absence of 
external stimuli (Elvevold et al. 2008).  
 
Due to the difficulty of isolating homogeneous primary EC populations immortalised 
cell lines have been developed to allow further research and understanding of 
endothelial cell function. Cell lines originate from a primary cell population and are 
conditionally immortalised with viral mechanisms to prevent senescence. 
Immortalised cells can be continually subcultured to high passages maintaining a 
constant stable phenotype. These characteristics provided a favourable cell type on 
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which to study the effects of inflammation on the phenotype and function of 
endothelial cells from different organs. A number of immortalised endothelial cell 
lines were used in studies including mUCEC-1 (Lidington et al. 2002), s.END 
(Bussolino et al. 1991) and b.End.5 (Rohnelt et al. 1997) originating from heart, skin 
and brain respectively.  
 
Research in our lab has focussed on the inflammatory response and the process of 
leukocyte recruitment. Although cell lines are an invaluable experimental tool, it must 
be considered when interpreting results that the biology of these cells could be 
altered by the presence of the viral construct. 
 
4.1.5 Recruitment in Kidney and Lung Tissue 
 
The process of leukocyte recruitment in skin, brain, heart and liver was previously 
discussed in Sections 1.5.1-4. However, the expression pattern of EC markers and 
adhesion molecules was examined in sections of murine kidney and lung, however 
we did not examine expression in primary EC cultures or immortalised cell lines from 
these tissues, recruitment in these tissues is therefore discussed briefly.  
 
ICAM-1 has been reported to be important for recruitment in both lung and kidney. 
Human glomerular cells were found to express ICAM-1 constititively and lack VCAM-
1 and E-Selectin expression (Savage et al. 1997). The glomerulus is one of the few 
sites where recruitment takes place in capillaries, as observed in a murine model of 
glomerulonephritis (Kitching et al. 2009). In addition blockade of CCR1 has been 
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shown to block the progression of chronic kidney disease in mice (Anders et al. 
2006).  
 
In the lung ICAM-1 was shown to be involved in leukocyte recruitment but not fibrosis 
in a mouse model of bleomycin-induced lung injury (Matsuse et al. 1999). 
Chemokines play a role in recruitment in response to granulomatous diseases, KC 
and MIP-1α were shown to be involved in neutrophil recruitment of Paracoccidioides 
brasiliensis- infected mice in the acute phase reaction (Souto et al. 2003).  
 
4.2 Results 
4.2 1 Optimisation of methodology for comparison of endothelial cell marker 
expression. 	  
In order to analyse the expression of particular markers by primary liver endothelial 
cells and to compare this to expression in situ in tissue we began using a 
combination of Immunohistochemical (IHC) and cell-based ELISA techniques. In all 
cases expression was compared to endothelium in other organs and to cell lines 
isolated from different tissues. Figures contain representative images from at least 3 
repeats of each experiment. In every experiment the appropriate isotype matched 
controls and negative No Pri controls were done (Fig.4.1). 
 
Initially sections of tissues were stained with haematoxylin and eosin to highlight 
gross anatomy and structure. In the liver, large portal vessels and smaller sinusoids 
are seen. In the kidney areas of both the cortex and medulla were captured showing 
glomeruli, capillaries (cortex), arteries and vessels (medulla). In the lung many 
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alveolar structures are present in addition to small bronchioles and branches of the 
pulmonary artery. The normal architecture of the brain is present showing the 
parenchyma. Sections were also stained for CD31 a pan-endothelial cell marker 
used as a positive control. CD31 expression was high in all tissues, with distinct 
staining patterns seen in lung and liver. In both kidney and liver there was more 
intense staining in the parenchyma and on the microvasculature. 
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Figure 4. 1: Control stained murine tissues. 
  
Representative light micrographs of isotype matched control and no primary stained 
cryosectioned murine tissues quenched with 0.5% H2O2 in methanol and sodium 
azide, stained by IHC methods and counterstained with haemotoxylin. Primary 
antibody used at 25µg/ml, secondary at 1/1000. Image captured at x10 original 
magnification on Axiovert microscope using Axiovision software. 
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Similar histological methods were used to stain isolated cells grown in 
chamberslides. Figure 4.2 shows the typical appearance of cells in culture captured 
using phase contrast microscopy. mUCEC, sEND and b.END.5 cells all resembled 
EC with classical cobblestone morphology also seen in primary mLSEC. All grew 
rapidly and were split 1:3 every other day and were viable over extended periods with 
little or no apparent phenotypic drift (as judged by morphological stability). Of note, 
mUCEC-1 cells had a tendency to form small clusters on top of the monolayer when 
close to confluency and s.END cells initially adopted mixed endothelial/fibroblast 
morphology with some spindle shaped cells present.  
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Figure 4. 2: Images of immortalised EC lines and mLSEC.  	  
Phase contrast light micrograph images of cell lines and primary mLSEC in culture. 
Images captured at x10 magnification on Axioskop. 
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Figure 4. 3: Control stained immortalised EC lines and mLSEC. 
 
Representative light micrographs of isotype matched control and no primary stained 
methanol fixed EC stained by IHC methods and counterstained with haemotoxylin. 
Primary antibody used at 25µg/ml, secondary at 1/1000. Image captured at x10 
original magnification on Axiovert microscope using Axiovision software. 
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We decided to use more quantitative ELISA technology to quantify protein 
expression on the cultured cells and to analyse changes in expression induced by 
cytokine treatment. In each experiment isotype-matched control reagents were used 
to determine background absorbance values resulting from non-specific binding. In 
subsequent figures data is represented as absorbance values minus background 
signal. The working concentrations of both primary and secondary antibodies were 
adapted from stock concentrations (data not shown) and optimised as outlined in 
Table 2.3. However to confirm the reproducibility of the system and to illustrate 
whether cytokine treatment altered non-specific binding of the antibody, pooled 
control data is shown in figures 4.1-4.5.  
 
Due to complications and delays due to development of methodology for isolating 
mLSEC, ELISA experiments were not performed on these cells. Phenotypic analysis 
was instead performed by whole genome arrays (data not available for thesis). 
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Figure 4. 4: Rat IgG control samples for cell-based ELISA.  	  
Data summarising ELISA for Rat IgG carried out on (A) mUCEC-1, (B) s.END and 
(C) b.End.5 cells stimulated with a variety of cytokine treatments for 4/24 hrs. Data 
expressed as absorbance normalised to control cytokine group. Error bars represent 
the +/- SEM n=3. One- way ANOVA, Bonferroni post-tests were carried out on all 
data.  
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Figure 4. 5: Rab IgG control samples for cell-based ELISA.  	  
Data summarising ELISA for Rab IgG carried out on (A) mUCEC-1, (B) s.END and 
(C) b.End.5 cells stimulated with a variety of cytokine treatments for 4/24 hrs. Data 
expressed as absorbance normalised to control cytokine group. Error bars represent 
the +/- SEM n=3. One- way ANOVA, Bonferroni post-tests and were carried out on all 
data. 
 
 
 	  	  	  	  	  	  	  	  	  	  	  	  	  
 151 
4.2.2 Expression of classical endothelial cell markers is maintained in culture. 
 
Next we used the optimised methodologies described above to analyse the 
expression of key endothelial proteins on our cells in tissue and in culture. 
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Figure 4. 6: Expression profile of CD31 by IHC 	  
Summary of CD31 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 7: Expression profile of CD31 in response to stimuli demonstrated by 
ELISA.  	  
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3.One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. 
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CD31 expression was high in all tissues (Fig 4.6), with distinct staining patterns seen 
in lung and liver. In the liver CD31 was present in portal structures and the sinusoids. 
In both kidney and liver there was more intense staining in the interstitium and 
microvasculature. All EC lines constitutively expressed CD31 to different degrees, 
with little variation after prolonged exposure to cytokines in mUCEC-1 cells. The 
presence of cytokines did not upregulate levels of CD31 above control in mUCEC-1 
cells (Fig 4.7-3A). However, cell lines containing the murine polyoma construct (Fig 
4.7-3B/C) expressed considerably higher levels of CD31; there was also a dose-
dependent response to Il-1β and TNF-α. 
 
Endoglin was present in the larger cerebral vessels in brain and smaller capillaries 
and in distinct patterns in the kidney vasculature but absent from the lung and liver 
(Fig. 4.8). Interestingly, modest levels were detected on primary isolated mLSEC, 
which were not apparent in whole tissue. Cell lines containing the polyoma virus 
construct (b.END.5 and sEND) expressed higher levels than SV40 immortalised cells 
(mUCEC-1). In particular expression in sEND cells was high and increased 
significantly upon prolonged exposure to pro-inflammatory stimuli with IFN-γ having a 
pronounced effect (Fig. 4.9). 
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Figure 4. 8: Expression profile of Endoglin by IHC 	  
Summary of Endoglin expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 9: Expression profile of Endoglin in response to stimuli demonstrated 
by ELISA.  	  
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. ***<0.001 
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JAM-2 was observed at low levels in the brain and more widely distributed in lung 
and liver (although somewhat non-specifically-Fig. 4.10) and diffusely in the kidney. 
JAM-2 was expressed in all unstimulated EC lines with the highest levels of 
expression apparent in sEND and mUCEC-1 cells which both significantly changed 
over time (Fig. 4.11). JAM-2 expression was high by immunohistochemistry but lower 
in ELISA. However, larger amounts are present in the control at 24 hours. In sEND 
and b.END.5 cells increased stimulation lead to a decrease in expression unlike 
mUCEC-1 where expression was slightly increased in particular in response to LPS 
and TNF-α+IFN-γ. 
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Figure 4. 10: Expression profile of JAM-2 by IHC 	  
Summary of JAM-2 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 11: Expression profile of JAM-2 in response to stimuli demonstrated 
by ELISA.  
 
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. *<0.05 and ***<0.001 
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CD34 expression appeared high in lung and kidney sections (Fig. 4.12). However 
staining was somewhat non-specifically in kidney. In liver, distinct CD34 staining was 
present in vascular and sinusoidal areas and present in isolated mLSEC. Expression 
was constitutive in all cell lines with the highest levels present in b.END.5 despite the 
absence in whole brain tissue (Fig. 4.13). On the whole levels increased over time 
with stimulation and these changes were significant in mUCEC-1 and s.END cells. 
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Figure 4. 12: Expression profile of CD34 by IHC 	  
Summary of CD34 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 13: Expression profile of CD34 in response to stimuli demonstrated 
by ELISA.  	  
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. *<0.05 
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4.2.3 Induction of adhesion molecules in response to cytokine treatment. 
 
Constitutive E-Selectin expression was insignificant in the majority of samples, 
although modest staining was present in kidney tissue around the glomeruli (Fig. 
4.14). In cultured cell lines high dose TNF-α and LPS produced significantly higher 
expression of E-Selectin in b.END.5 cells and IL-1β 100U/ml in s.END cells. E-
Selectin levels significantly decreased in s.END cells over time (Fig. 4.15). 
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Figure 4. 14: Expression profile of E-Selectin by IHC 	  
Summary of E-Selectin expression in whole murine tissues, EC lines and mLSEC. 
and modulation of expression in response to cytokines.  5µm sections of murine 
tissue and methanol fixed EC lines and mLSEC cultured in chamberslides were 
stained using OHC methods. Images captured on Axioskop using Axiovision software 
at x10 magnification. 	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Figure 4. 15: Expression profile of E-Selectin in response to stimuli 
demonstrated by ELISA.  
 
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. *<0.05, **<0.01 and ***<0.001 
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ICAM-2 expression was high in sections of liver, kidney and lung. Interestingly 
intense staining was present in the liver parenchyma and microvasculature but 
expression was absent on isolated cells (Fig. 4.16). In the kidney ICAM-2 was 
present in the interstitium and larger vascular structures. However staining was 
absent in the brain. ICAM-2 was constitutively expressed in immortalised EC lines 
with higher levels apparent in s.END and b.END.5 cells. A significant increase in 
expression was produced in s.END cells upon prolonged cytokine stimulation (Fig. 
4.17). 
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Figure 4. 16: Expression profile of ICAM-2 by IHC 	  
Summary of ICAM-2 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 	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Figure 4. 17: Expression profile of ICAM-2 in response to stimuli demonstrated 
by ELISA.  
 
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. **<0.01 
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VCAM-1 expression was absent or very low in all tissues tested (Fig. 4.18) and on 
EC lines from brain and skin by ELISA (Fig. 4.19). mUCEC-1 cells in particular 
expressed VCAM-1 even in the absence of stimuli. In addition the opposing dose 
dependent response of mUCEC-1 to increasing concentrations of IL-1β seen in a 
number of different markers was also apparent (i.e. increasing dose induced 
increases in expression at 4hrs compared to decreased expression at 24hrs) 
however this was not statistically significant. VCAM-1 was present in b.End.5 cells at 
low levels by ELISA, which can be seen in IHC and low levels were present diffusely 
in whole brain tissue. VCAM-1 expression significantly increased over time and 
particular increases in expression were observed following treatment with high dose 
TNF-α (500U/ml) and TNF-α and IFN-γ combined. 
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Figure 4. 18: Expression profile of VCAM-1 by IHC 	  
Summary of VCAM-1 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 19: Expression profile of VCAM-1 in response to stimuli demonstrated 
by ELISA.  
 
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. *<0.05, **<0.01 and ***<0.001 
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4.2.4 Expression of VAP-1 and LYVE-1 is minimally altered by cytokine 
treatment. 
 
As mentioned previously no characteristic single marker of mLSEC exists. mLSEC 
are identified by morphological and functional properties in addition to expression of 
a number of different markers. Although expression of VAP-1 and LYVE-1 are not 
exclusively limited to liver sinusoidal endothelium dual positivity in cells cultured from 
liver is indicative of mLSEC.  
 
VAP-1 was generally absent from the murine tissues tested but there were odd 
darker structures present in liver, which may have been artefacts of staining (Fig. 
4.20). In addition diffuse staining was apparent in kidney. VAP-1 was detected by 
ELISA at very low levels under certain stimulation conditions in s.END and b.End.5 
cells, confirmed by IHC (Fig. 4.21). Globally VAP-1 expression significantly 
decreased over time.  Primary mLSEC appeared to express low levels. 
 
 
 
 
 
 
 
 
 
 
 173 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. 20: Expression profile of VAP-1 by IHC 	  
Summary of VAP-1 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 21: Expression profile of VAP-1 in response to stimuli demonstrated 
by ELISA.  	  
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. **<0.01 
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LYVE-1 expression was absent from brain and kidney tissue however positive stain 
was present in lung and liver (Fig. 4.22) In the liver the staining pattern was as 
expected in the sinusoids and around some hepatic veins, in addition freshly isolated 
mLSEC were also positive. In the lung LYVE-1 may be staining lymphatic structures.  
LYVE-1 was present at low levels in all cell lines (Fig. 4.23). However s.END cells in 
particular expressed higher levels of LYVE-1 at 4 hours and this significantly 
decreased over time. IHC images show isolated LYVE-1 positive cells present in the 
population. This could have resulted from contamination of initial cultures with 
lymphatic EC as the skin contains large amounts of lymphatic structures. 
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Figure 4. 22: Expression profile of LYVE-1 by IHC 
 
Summary of LYVE-1 expression in whole murine tissues, EC lines and mLSEC. and 
modulation of expression in response to cytokines.  5µm sections of murine tissue 
and methanol fixed EC lines and mLSEC cultured in chamberslides were stained 
using OHC methods. Images captured on Axioskop using Axiovision software at x10 
magnification. 
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Figure 4. 23: Expression profile of CD31 in response to stimuli demonstrated 
by ELISA.  	  
Analysis of molecule expression using cell-based ELISA on (A) mUCEC-1, (B) s.END 
and (C) b.End.5 immortalised cell lines treated with a variety of pro-inflammatory 
substances for 4/24hrs. Error bars represent the +/- SEM n=3. One-way ANOVA, 
Bonferroni post-tests were used to assess effect of treatment. Two-way ANOVA was 
used to assess the effect of time. *<0.05 
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4.3 Discussion 
 
The initial aim of these experiments were to optimise phenotypic assays using whole 
tissue and immortalised cell lines to in order to determine the best conditions for 
analysis of primary endothelial cell populations. However, in addition they provided 
interesting insights into tissue specific variation in expression of endothelial cell 
markers, adhesion molecules and responses to pro-inflammatory stimuli. 
 
4.3.1 Contribution of immortalised cell lines to research 
 
Primary cells are notoriously difficult to isolate effectively to generate high numbers of 
pure cell populations, as covered in Chapter 3. An important experimental tool is 
available to allow researchers to carry out preliminary experiments and optimise 
conditions for more insightful experiments using primary cells. Immortalised 
endothelial cell lines have been developed to allow further research and 
understanding of EC function. In general viral mechanisms are used to prevent 
senescence. Care must be taken when utilising cell lines as the immortalisation 
process can result in phenotypic changes or altered responses to stimuli. The EC 
lines used were hardy and tolerant to stress. However, in some instances the EC 
lines were unresponsive to levels of cytokine stimulation, which would have been 
expected to yield a more pronounced response than elicited. 
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4.3.2 Expression of endothelial markers and adhesion molecules by IHC and 
response of EC to pro-inflammatory insult. 
 
We examined several murine sources for the expression of a number of endothelial 
cell markers and adhesion molecules. Samples of murine liver, brain, lung and 
kidney were obtained from Balb/c mice and small numbers of primary mLSEC for 
immunohistochemical analysis. In addition expression of all molecules was assessed 
on a number of immortalised EC lines from heart (mUCEC-1), skin (s.END) and brain 
(b.End.5). To further support these qualitative techniques, quantitative cell-based 
ELISAs were used to assess the response of EC lines to pro-inflammatory insult over 
varying time periods. Expression of most of the markers was consistent with current 
published research; however, the majority of available data is from human rather 
than murine tissues (Feuerhake et al.1998;Savage et al.1997;Steinhoff et al. 1993). 
In general no positive staining was observed in control samples (No Pri, IMC), with 
the exception of Rat IgG in liver where some non-specific background stain was 
apparent. All data is summarised in Table 4.1.  
 
The expression profile of CD31 has previously been examined in murine tissues  
(Daneker et al. 1998;Sheibani et al. 1999) and is present at high levels in lung, heart 
and kidney and at lower levels in brain and liver. We also found that expression was 
high in lung, kidney and liver and lower levels in brain. In concurrence our ELISA 
data showed that CD31 was expressed on all cell lines and on mLSEC. Expression 
was more pronounced in EC immortalised with the polyoma construct. However, 
there was little variation in expression to prolonged exposure to cytokines. This 
expression is likely to be functionally important as rodent models have indicated that 
 180 
leukocyte diapedesis can be abrogated with the use of anti CD31 blocking antibodies 
(Schenkel et al. 2004). The process is however not completely lost in a C57BL/6 
CD31 knockout mouse but it is thought that this specific strain in the event of 
inflammation, possesses the ability to compensate for lack of CD31. Though the 
specific process is unknown, it is most likely due to the action of other unidentified 
adhesion molecules (Schenkel et al. 2004).  
 
CD31 is widely used as a pan-endothelial cell marker and was indeed abundantly 
expressed on vascular endothelium and to a lesser extent on the hepatic sinusoids. 
Expression of this marker on sinusoidal endothelium remains controversial (reviewed 
in (Do et al. 1999;Neubauer et al. 2000a)), it has been shown to be expressed in 
murine mLSEC (Do et al. 1999) but the presence of this molecule in hLSEC is 
unclear. Some reports suggest that it is present in cirrhotic liver but minimally in 
normal liver (Daneker et al. 1998) others report the opposite (Medina et al. 2005). 
Data from our group have shown CD31 to be present in both vascular and sinusoidal 
endothelium (Lalor et al. 2006). CD31 expression has been examined by PCR a 
qualitative method (Unger et al. 2002) however it is not recommended to use either 
method in isolation. CD31 it has been used as a determining feature of hepatic 
endothelial cells in rat (Ruhnke et al. 2003). The data presented here clearly shows 
that it is expressed on both sinusoidal and vascular endothelium in mouse.  
 
Endoglin is expressed on the majority of EC with levels increasing in activated 
vascular endothelial cells at sites of angiogenesis, inflammation and wound healing 
(Cheifetz et al. 1992;ten Dijke et al. 2008). As a component of the TGF-β receptor 
Endoglin has been found on EC, activated macrophages, fibroblasts and smooth 
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muscle cells (Conley et al. 2000). The involvement in vascular development, 
remodelling and angiogenesis (Duff et al.  2003) in addition to elevated levels of 
expression in cancerous tumours make it attractive as a potential therapeutic target 
(Carmeliet et al. 2000). Distinct expression of Endoglin was present on vascular 
structures of murine brain and kidney. In brain Endoglin is expressed on all EC and in 
the adventitia (Matsubara et al. 2000) and has been found in human renal cell 
carcinomas (Sandlund et al. 2006). Endoglin was expressed on distinct single 
mUCEC-1 cells and also present at high levels in s.END and b.End.5 cells sites of 
angiogenesis and highly vascularised areas. ELISA data showed a particular 
increase in s.END cell expression in response to IFN-γ. Distinct staining in mUCEC-1 
could be due to contaminating vascular EC but this is unusual as this cell line is 
immortalised cardiac endothelium and expression should be high. Endoglin is 
involved in the development of the heart and was found to be expressed in epicardial 
and myocardial vessels (Valeria et al. 2008). 
 
The expression pattern of JAM-2 had not previously been examined in the liver, and 
our data show that it is expressed in the lung and non-specifically in the liver and was 
also present at low levels in kidney. JAM-2 expression was present in all cell lines 
and on mLSEC as confirmed by ELISA but the effects of cytokine exposure on 
expression varied with cell type. JAM-2 has been reported to be expressed on 
endothelial and lymphatic cells in high endothelial venules (HEV) in mice (Aurrand-
Lions et al. 2001). In murine studies JAM-2 has shown to greatly increase the 
proportion of lymphocytes migrating across endothelioma cells in monolayer culture 
(Johnson-Leger et al. 2002). It has also been shown in a human experimental system 
using HUVEC cultured on transwell inserts that blocking of JAM reduced the 
transmigration of peripheral blood leukocytes. The same group obtained results that 
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suggest this is also true in the murine system (Aurrand-Lions et al. 2002a;Aurrand-
Lions et al. 2002b).  The concept that JAM-2 is an important molecule involved in 
directing the transmigration of leukocytes is also interesting as the levels increased in 
conjunction with ICAM-2, another critical molecule involved in leukocyte recruitment 
(Springer 1995). Here we describe for the first time the non-specific expression 
pattern of JAM-2. JAM-2 was present on both vascular and sinusoidal areas. The 
particularly high expression of JAM-2 in s.END cells in combination with LYVE-1 
expression again supports the idea of contamination of these cells by lymphatic EC. 
 
CD34 is a marker of vascular endothelium.  It is absent in most sinusoidal cells of 
normal human liver (Couvelard et al. 1993;Daneker et al. 1998;Xu et al. 2003) but 
present in disease states following the process of capillarisation (Cui et al. 
1996;Frachon et al. 2001) and during liver development (Nava et al. 2005). CD34 
expression was high in all non-hepatic tissues and cell types examined here as 
previously published (Baumhueter et al. 1994), and was present in all EC cell lines 
and primary mLSEC with particularly high levels in b.END.5 cells  
 
Both E and P-Selectin have been shown to be critical for leukocyte recruitment in 
intravital studies (Lawrence et al. 1991;Zimmerman et al.1991;Zimmerman et al. 
1992), however more recent studies have shown that  CD44, CD34 and VAP-1 can 
compensate in their absence (Ley et al. 2007).  E-Selectin (CD62E) is expressed 
rapidly and synthesised de novo in activated endothelium in response to 
inflammatory mediators. During an inflammatory response P-Selectin is immediately 
trafficked to the cell surface from Weibel-Palade bodies, followed closely by E-
Selectin leading to enhanced leukocyte recruitment and decreasing rolling velocity, 
increasing the chances of firm adhesion to the endothelium. Selectins bind to heavily 
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glycosylated carbohydrate or mucin ligands including sialyl lewis and P-Selectin 
glycoprotein ligand (PSGL-1). E-Selectin binds both of these ligands in addition to 
CD43, CD44 and E-Selectin ligand-1 (Ley et al. 2007).  E-Selectin was absent from 
all tissues and expressed at low levels in all cell types by ELISA despite stimulation 
and the inducible nature of E-Selectin. Small responses were seen in with high TNF-
α (500U/ml) and LPS, which supports the idea that immortalised cell lines, are more 
resistant to insult reducing the responsiveness to cytokines. The lack of expression in 
the liver tissue highlights the absence of a role for selectins in recruitment to the liver. 
Due to the small size of sinusoidal vessels, and low shear forces present within them, 
selectins are not required for tethering and rolling along the vascular wall and this 
role can be compensated for by additional molecules.  However, E-Selectin knockout 
mice were shown to have a reduced responsiveness to Gal/ET liver injury by 
inhibiting the activation and transmigration of neutrophils (Lawson et al. 2000). 
 
ICAM-2 is constitutively expressed on endothelium and is a crucial player in 
leukocyte recruitment and adhesion (Lehmann et al. 2003). This expression in 
unstimulated endothelial cells could implicate ICAM-2 in the process of immune 
surveillance where leukocytes traffic through uninflamed tissues. It has been shown 
by Reiss et al that if ICAM-2 deficient mouse endothelioma cells are used in a 
transmigration assay the migration of T-cells across the endothelial surface was 
greatly inhibited compared to the migration across wild type cells treated with anti-
ICAM-2 functional blocking antibodies (Reiss et al. 1999). ICAM-2 was expressed 
highly in distinct patterns in kidney and liver and at lower levels in lung and brain. 
Although expression was only apparent in b.End.5 cells by IHC, ELISA’s indicated 
lower expression in mUCEC-1 and s.END cells despite previously reported 
expression (Ghigo et al. 1995). Dose responses to TNF-α and IL-1β were apparent. 
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The immortalised b.End.5 cells have been reported to express ICAM-1 which is 
indicated to play a role in actual tissue, hence the absence of staining in whole tissue 
(Bussolino et al. 1991). 
 
VCAM-1 is involved in the initial step of the leukocyte recruitment cascade ‘tethering 
and rolling’ the leukocyte in conjunction with the E and P- selectins. Under flow 
conditions VCAM-1 supports the capture of leukocytes at lower shear stresses than 
the selectins but it is thought to capture eosinophils very effectively. Expression of 
VCAM-1 is required de novo and synthesis peaks 24 hours after stimulation 
(Reinhardt et al. 1998), as was apparent in our ELISA data. Expression was low in all 
tissue sections and cultured cells (with the exception of mUCEC-1) by IHC as 
expected in the absence of any pro-inflammatory stimuli. The levels of VCAM-1 were 
particularly high in mUCEC-1 cells by ELISA, up to 3-fold higher than all other 
molecules examined. This finding is concurrent with published research and the high 
expression, even in the absence of a cytokine stimulus had ramifications in functional 
experiments (Lidington et al. 2002). In contrast s.END and b.End.5 expression was 
almost absent by ELISA although levels increased in b.End.5 cells after prolonged 
exposure. 
 
VAP-1, is constitutively expressed on human lymphatic and hepatic endothelium, 
rabbit endothelium and transfected rat endothelium (Lalor et al. 2006) and has shown 
to bind flowing lymphocytes, but knockout models indicated that the absence of VAP-
1 leads to increased rolling velocity and decreased rate of leukocyte transmigration 
(Kirton et al. 2005). In support of this our data showed that VAP-1 was present at low 
levels in liver and kidney (Kurkijarvi et al. 2001). The presence of VAP-1 in mLSEC 
populations is also in concurrence with previous reports (Lalor et al. 2006). The 
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positive stain is present on sEND cells by ELISA. The skin contains large amounts of 
lymphatic tissue and VAP-1 has previously been found in the skin and serum of 
psoriatic patients suggesting a role in inflammation (Madeja et al. 2007). It is 
interesting that both LYVE-1 and VAP-1 which can be considered as positive 
identifiers of sinusoidal endothelium are expressed on both the lymphatic and 
sinusoidal endothelium as both maintain a similar immunological environment where 
a lot of antigen presentation is taking place.   
 
LYVE-1 was has also been demonstrated to be an important molecule in the 
lymphatics where expression is high on human, mouse and rat endothelial cells 
(Banerji et al. 1999). It has also been found in distinct cohorts of activated tissue 
macrophages and on LSEC and endothelial cells of the spleen, sites where HA is 
taken up and degraded (Carreira et al. 2001). We found LYVE-1 was absent from 
brain but distinct staining patterns were present in the lung and liver. Expression also 
decreased over time unlike mUCEC-1 and b.End.5 cells where expression was low 
and stable. The previously unreported expression of LYVE-1 on mUCEC-1 and 
b.End.5 cells is unusual, this lymphatic marker is thought to be expressed in the liver 
and lymphatics but not the heart or brain. This may be an artefact of immortalisation.  
 
Taken together, this data produces valuable qualitative and quantitative images of 
expression patterns. Overall the expression profiles provide some useful phenotypic 
data, which helped correctly identify primary endothelial cells yielded by isolation 
protocols or from a mixed population of cells or tissue. s.END cells lacked expression 
of E-Selectin important for recruitment to skin but generally cell lines immortalised 
with the polyoma virus construct were on the whole more ‘endothelial-like’ with higher 
expression of CD31, CD34 and Endoglin. The most notable differences were seen 
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with mUCEC-1 cells, previous reports showed that these cells expressed CD31 but 
we found limited amounts compared to the high expression of VCAM-1 even in the 
absence of external stimuli. These differences most likely as a result of 
immortalisation must be taken into account when considering the functional 
properties of immortalised cell populations.  
 
mLSEC express markers found on liver tissue and within the sinusoids, in particular 
LYVE-1, CD31, Endoglin and to some extent VAP-1. Morphologically mLSEC 
resembled the human counterparts with a cobblestone appearance giving us 
confidence in the primary cell populations obtained. 
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5. FUNCTIONAL ANALYSIS OF LEUKOCYTE RECRUITMENT TO ORGAN 
SPECIFIC ENDOTHELIAL CELLS IN RESPONSE TO CYTOKINE STIMULATION. 
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5.1 Introduction 
 
The preceding chapters have confirmed that cells isolated from different murine 
organs maintain a distinct phenotype in culture. EC from heart, brain, skin and liver 
were positive for classical EC markers such as CD34 and Endoglin and expression of 
adhesion molecules involved in recruitment was induced by pro-inflammatory stimuli. 
Therefore this chapter considers the ability of the different cell isolates to support the 
adhesion and migration of whole purified lymphocytes and CD4+ and CD8+ subsets. 
In general the process of inflammatory cell recruitment is the same in most tissue 
beds, however there are some differences, which I will highlight here.  
 
5.1.1 Leukocyte Recruitment via endothelial cells 
 
The recruitment of leukocytes into tissues is a highly regulated process, under 
physiological conditions. A general paradigm of leukocyte recruitment exists (Fig. 
5.1), involving a defined sequence of events divided into several steps (Adams et al.	   
1994;Buckley et al.	   2000; Springer 1994). Flowing leukocytes must make contact 
with the vessel wall. On contact with the endothelium, rapidly-reversible interactions 
are formed with Selectin receptors (Lawrence et al.	  1991) in general, leading to 
tethering and rolling of the leukocyte along the vascular wall (Alon et al.	   2002;Bahra, 
et al.	   1998). Chemokines present on the surface of vascular endothelial cells initiate 
activation of the leukocyte leading to tight adhesion to the vascular surface via 
integrins and their receptors (Springer 1995). In the final stages, the leukocyte 
migrates through the endothelium to the surrounding tissue in response to a 
chemotactic gradient generated by endothelial or resident inflammatory cells.  In this 
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chapter I wanted to investigate how the molecular regulation of this process differs on 
endothelium from different tissues.  	  
5.1.1.1 STEP ONE: Capture on the endothelium. 
 
The selectins consist of a family of cell adhesion molecules, which share a common 
structure, consisting of an N-terminal lectin-binding domain, an epidermal growth 
factor domain, a transmembrane region and a variant number of consensuses 
repeats. There are three main types of Selectins, L, P and E, named in accordance 
with the cell type on which they were first discovered, lymphocytes, platelets and 
endothelium respectively. L-selectin is constitutively expressed on most leukocytes 
and the levels of expression alter when the cell becomes activated. For example 
upon neutrophil activation, L-Selectin is rapidly shed from the neutrophil surface 
(Eriksson et al. 2001). This molecule binds to specific carbohydrate moieties on the 
vascular endothelium (Bevilacqua et al. 1993) and is particularly important in 
recruiting lymphocytes to the lymphatics. P-selectin is involved in platelet aggregation 
and essential for the clotting response. This molecule is stored in intracellular 
granules (α-granules in platelets and Weibel-Palade bodies in EC), as it needs to be 
rapidly mobilised to the cell surface. P-selectin is also found on activated endothelial 
cells and is up regulated by TNF and histamine. E-selectin is unique to endothelial 
cells and expression increases in response to proinflammatory cytokines such as IL-
1, TNF-α and LPS (Ley et al.  2007;Parkin et al.  2001). Various selectin ligands 
have been discovered and all three bind to the oligosaccharide Sialyl Lewis (sLEx) 
with low affinity. Among the best characterised is P-selectin glycoprotein ligand 1 or 
PSGL-1(Adams et al. 1994;Springer 1994). Interactions between selectin adhesion 
molecules and ligands are transient. The interaction permits the leukocyte to scan 
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the vascular surface for activatory messages. If the adherent cell is not activated by 
specific factors initiating firm adhesion the cell is released in this reversible reaction 
(Springer 1994;.Sims et al. 2002). This close proximity between adherent leukocyte 
and luminal endothelial surface is favourable for the presentation of surface bound 
chemokines to initiate subsequent steps in the cascade (Tanaka et al. 1993). 
Selectin mediated adhesion has been found to be particularly important in post 
capillary venules of tissues with large vessel diameters and high shear environments 
such as the skin (Hickey et al. 1999). However, in tissues such as the liver where the 
sinusoids are so narrow and shear so low such interactions are unnecessary (Wong 
et al. 1997). Initially cells were thought to become trapped, but further studies have 
found VCAM-1 and ICAM-1 to be important. In addition adhesion can occur via 
integrin dependent or independent mechanisms such as the non-classical pathway 
involving CLEVER-1, the mannose receptor, CD44 and VAP-1 (Lee et al. 
2008;Shetty et al. 2008).  
 
5.1.1.2 STEP TWO: Leukocyte Activation or ‘triggering’ 
 
After initial capture and/or rolling the leukocyte must become activated by specific 
resident factors to initiate strong adherence to the vascular endothelium. This 
activation is mediated by chemokines, a group of chemoattractive cytokines which 
bind specifically to different subsets of leukocytes bearing appropriate chemokine 
receptors (Miller et al. 1992). These chemokines are produced by various 
inflammatory cells and activated endothelium and bind to specific G-protein coupled 
chemoattractant receptors expressed on the surface of leukocytes. Chemokine and 
receptor contact initiates intracellular signalling pathways, through G-protein coupled 
receptors resulting in the mobilisation of high-affinity integrin receptors to the cell 
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surface (Adams et al. 1994;Buckley et al. 2000). The specificity of chemokine action 
can be increased by site-specific or activation-specific expression of proteoglycans 
on the endothelium, which bind and present chemokines to particular leukocyte sub-
populations (Adams et al. 1994).  
 
Chemokines can be grouped according to the location of two highly conserved 
cysteine (C) residues within a number of different amino acids (X) in their structure. 
Thus there are CXC (α-chemokines) and CC (β-chemokines). CXC chemokines can 
be further subdivided on the presence of a glutamic acid leucine-arginine (ELR) motif 
prior to CXC. ELR containing CXC chemokines act on neutrophils (IL-8) whereas 
those lacking the motif act upon T-Cells (ITAC/MIG). CC chemokines act mostly on 
lymphocytes, eosinophils and monocytes for example MIP and SDF. There are some 
exceptions; to date only fractalkine (CXXXC) and lymphotactin (C) are known to exist 
(Murdoch et al. 2000;Negus et al. 1996). Chemokines are presented on the surface 
of endothelial cells by binding heparin sulphate proteoglycans (i.e. IL-8 and Gro-α) or 
the Duffy antigen receptor for chemokines (DARC), also found on erythrocytes 
(Hadley et al. 1997). Proteoglycan binding is thought to increase the efficiency of 
chemokine presentation and binding to leukocytes (Parkin et al. 2001).  
 
Aside from chemokine-dependent signalling, adhesion can also be stimulated by a 
number of phospholipid-derived mediators such as leukotrienes and prostaglandins 
metabolites of arachidonic acid (AA) and platelet activating factor (PAF). PAF and AA 
are released by endothelial cells and cellular phospholipases respectively in 
response to inflammatory mediators. The cycloxygenase pathway generates 
prostoglandins from AA, stimulating vasodilation whereas the lipoxygenase pathway 
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produces a number of leukotrienes, which are potent chemotactic agents. PAF was 
originally named for its ability to aggregate and cause the degranulation of platelets 
but is also know to interact with neutrophils leading to activation via PAF receptor (Au 
et al. 2001). Juxtacrine signalling in conjunction with P-Selectin tethering the 
leukocyte to the EC wall leads to activation of β2 integrins (CD11/18) causing tighter 
adhesion to the endothelium (Prescott et al. 1990). In addition products of 
Cytochrome P450 (CYP450) enzymes activated distinct Ca2+ channels regulating B-
Cell plasma membrane potential and adhesion to integrins ICAM-1 and VCAM-1 
involved in trafficking (Liu et al. 2006). 
 
5.1.1.3 STEP THREE: Firm adhesion 
 
Strong and tight adhesion to the luminal endothelial surface is the next step in the 
extravasation process and is mediated by integrins binding to immunoglobulin-
superfamily endothelial ligands. The expression of heterodimeric integrin 
glycoproteins varies with cell type. Composed of two non-covalently linked alpha (α) 
and beta (β) sub-units of which the former is the shorter, integrins can be classified 
according to their β-subunit. The α and β domains can interact in many different 
combinations, resulting in a wide variety of integrins, only six of which are involved in 
leukocyte endothelial interaction. The β-1 and β-2 families are most important, α4β1, 
also known as very-late activation antigen-4 (VLA-4) is expressed by activated T-
Cells and αLβ2 or the lymphocyte function associated antigen-1 (LFA-1) is expressed 
by both naïve and effector T-Cells (Adams et al. 1994). In addition β2 integrins (Mac-
1) are involved in adhesion of polymorphonuclear neutrophils (PMN) to endothelium 
aggregation of which induces production of IL-8 (Walzog et al. 1999). The counter 
receptors for leukocyte integrins Intercellular adhesion molecule-1 (ICAM-1) and 
 193 
ICAM-2 bind to the β2 integrins whereas vascular adhesion molecule-1 (VCAM-1) 
binds to the β1 integrins (Adams et al. 1994). ICAM-2 is constitutively expressed on 
vascular endothelium, and supports lymphocyte recruitment to uninflamed tissue 
(Springer 1994). Conversely ICAM-1 and VCAM-1 are induced in response to pro-
inflammatory cytokines recruiting leukocytes to the site of infection and inflammation 
(Bevilacqua et al.1993;Springer 1990a;Springer 1990b).  
 
5.1.1.4 STEP FOUR: Transmigration  
 
Next the leukocyte must extravasate or transmigrate across the endothelial wall and 
enter the surrounding tissues in a process called diapedesis or transendothelial 
migration (TEM). For a significant period of time it was thought that leukocytes only 
traversed through the endothelium into the surrounding tissues through the junctions 
between juxtaposed endothelial cells (i.e. a paracellular route) (Feng et al. 1998). 
However, a growing amount of research has demonstrated that leukocytes may also 
pass through pores in endothelial cell bodies (the transcellular route) but this remains 
controversial (Burns et al. 2003). This migratory process is controlled by various pro-
migratory factors including cytokines and chemoattractants. Several molecules are 
thought to be involved in paracellular transmigration in particular PECAM-1 (CD31), 
CD99 and Junctional Adhesion Molecules (JAM’s) (Muller et al.  2003). CD99 and 
CD31 are both expressed on most types of leukocytes and bind to the same 
molecule on adjacent EC in homophilic interactions having a synergistic effect on 
TEM. JAM-A was originally identified in murine tight junctions (TJ) in endothelial and 
epithelial cells and found to be important in the migration of Neutrophils and 
monocytes (Martin-Padura et al. 1998). Endothelial JAM-A acts as a ligand for LFA-1 
and if blocked reduces lymphocyte TEM. JAM-2 has also been shown to enhance 
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leukocyte TEM and facilitate platelet binding to PMN via CD11b/CD18 (Mac-1) (Liu et 
al. 2004). 
 
Transcellular migration was first described in the 60’s, where it was revealed that a 
significant number of leukocytes traversed the endothelium without disrupting EC 
junctions suggesting that they migrated through endothelial cytoplasm. This area of 
research has been under explored since, due to the inability to effectively visualise 
such events. Now with the advent of the electron microscope, confocal microscopy 
and computerised image analysis techniques scientists are able to distinguish 
neutrophils migrating through a transcellular pore distinct from endothelial junctions 
(Feng et al. 1998;Marchesi et al. 1964). EC’s are heavily involved in regulating 
vascular permeability and contain several subcellular membrane structures including 
fenestrae, caveolae and vesiculo-vascular organelles (VVO’s) to accommodate for 
this. The current hypothesis suggests that several of these structures may fuse to 
form a pore through which the leukocyte can migrate (Carman et al. 2007). For 
example it has been observed that leukocytes transmigrate at caveolin-1 rich sites 
and knockdown by siRNA decreases TEM (Wittchen et al. 2009). Interestingly in one 
study transcellular migration of lymphocytes accounted for ~30% of total TEM across 
microvascular endothelium but <10% across macrovascular HUVEC (Carman et al.  
2007). This implies that EC heterogeneity will result in differential regulation of TEM. 
 
Migrating leukocytes must negotiate several obstacles to enter the surrounding 
tissues, in addition to tight and adherens junctions in the endothelium cells must 
penetrate any underlying basement membrane, interstitium and tissue epithelium (Liu 
et al. 2004). These elements differ from one tissue environment to another 
depending on the characteristics of that vascular bed. Endothelial adherens junctions 
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(AJ) contain VE-Cadherin a transmembrane protein, which interacts with the actin 
cytoskeleton, stabilising the cell (Lampugnani et al. 1997). Adhesion of neutrophils 
and monocytes was found to trigger transient displacement of VE-Cadherin due to 
uncoupling from actin to allow passage of leukocytes via activation of signalling 
events. In recent years it has been suggested that the EC themselves play an active 
role in TEM, with the discovery of the transmigratory cup structure (Liu et al. 2004). 
This cellular dock, which partially captures the leukocyte, is rich in actin in addition to 
α-actinin, vinculin, VASP, the ERM proteins ezrin and moesin, ICAM-1 and VCAM-1. 
Barreiro et al postulated that leukocyte attachment induced clustering of ICAM-1 and 
VCAM-1 at the endothelial surface, leading to activation of bound ERM proteins, 
causing local cytoskeletal remodelling forming protrusions, which encased the 
transmigrating leukocyte (Barreiro et al. 2002). It was thought that cup formation was 
required for efficient capture of leukocytes under shear flow, but this was disproved. 
It is now suggested that these structures are not for adhesion strengthening but 
rather required for TEM. Much more research is required to fully characterise this 
structure but it is an important consideration in TEM. 
 
5.1.2 Modulation of EC responses by their environment 
 
The generic stages in the extravasation process described above are applicable in 
most settings. However there is growing evidence that the functional responses of 
endothelial cells can be modulated by their local physiochemical environment (Nash 
et al. 2004). One aspect considered albeit briefly in the current project is the effect of 
haemodynamic forces on the ability of EC to recruit leukocytes. These forces affect 
intra-cellular signalling, secretion, and protein and gene expression (Chien et al.  
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1998;Jalali et al. 1998). In addition, underlying stromal cells and matrix substrates 
can modify EC phenotype and their ability to recruit leukocytes (Aird 2003;Nash et al. 
2004). Interestingly the specific phenotype of endothelial cells isolated from different 
tissues may be retained in vitro for extended periods (Nash et al. 2004). For instance, 
isolated murine cardiac and lung EC, both supported adhesion of flowing T-cells in 
vitro, but were shown to use different mechanisms. Cardiac EC after stimulation with 
TNF-α were found to used VCAM-1:VLA-4 and RANTES:CCR5 induced 
mechanisms, whereas in lung EC, ICAM-1, MIP-2 and MIP-1β were thought to be 
important (Lim et al. 2003).  
 
5.1.2.1 Modulation of EC responses by shear stress 
 
Vascular endothelium is exposed to a number of different haemodynamic forces. 
These include the frictional shear stress imposed by the bloodstream and hydrostatic 
pressure acting perpendicular to the vessel wall, which exerts compression and 
circumferential strain (Matharu et al. 2006). The most widely studied of these forces 
is shear stress (Lelkes et al. 1999). Shear stress varies in different organs and 
throughout the vasculature, with arterial stress in the range of 1 to 4 Pa in 
comparison to 0.1 to 2 Pa in the microcirculation where leukocyte recruitment takes 
place. Variation in shear stress is dependent on local pressure gradients, flow rate 
and the diameter of the vessels (Matharu et al. 2006). 
 
Endothelium responds to changes in haemodynamic forces by rapidly releasing a 
number of vasoactive substances including NO. Over time shear stress can also 
modify levels of expression of genes, a number of which are involved in leukocyte 
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recruitment (Matharu et al. 2006). The altered expressions of some of these genes 
are too short lived to have a prolonged effect on leukocyte recruitment. Many studies 
have examined the change in gene expression over time after exposure to shear. 
Comparisons are made to static controls, or between responses to laminar vs. 
oscillatory flow (Brooks et al. 2002). Gene array analysis has indicated that the 
expression of a number of genes alters within a short time of exposure to shear 
stress, but that the expression levels return to normal or less than the baseline after 
24 hours (McCormick et al. 2001).  For example, the expression of genes encoding 
both ICAM-1 and monocyte chemoattractant protein-1 (MCP-1) increased upon 
exposure to shear but levels returned to normal after 24 hours (Sheikh et al. 2005) 
(Sampath 1995).  Sheikh et al (Sheikh et al. 2003;Sheikh, Rahman et al.  2005) also  
demonstrated that when HUVEC were cultured under shear for 24 hours the 
increased levels of the CXC-chemokines, IL-8 and growth related oncogene (Gro-α) 
normally induced by TNF-α stimulation were inhibited (Sheikh et al. 2005).  
 
Furthermore, Nash and colleagues demonstrated that endothelial cells conditioned 
under low shear stress of 0.3Pa exhibited decreased levels of leukocyte migration in 
response to TNF-α stimulation (Sheikh et al. 2003).  At a higher shear stress of 
2.0Pa, conditioning lead to reduction of adhesion itself (Matharu et al. 2006). This 
differential response was due to the effects of shear on the ability of EC to upregulate 
adhesion molecules and chemokines. The effect of shear on the signalling pathways 
upstream from pro-inflammatory genes has also been examined.  The mitogen 
activated protein kinases (MAPK) signalling pathways including c-Jun, JNK (N-
terminal kinase), p38 and extracellular regulated kinases (ERK 1/2) are known to 
activate gene transcription factors of the NF-kB/Rel family and activating protein 1 
(AP-1) in response to TNF-α (Jalali et al. 1998) and Il-1β (Jalali et al.  1998;Li et al. 
 198 
1996;Surapisitchat et al. 2001). Upon application of shear stress ERK, JNK and p38 
activity was shown to increase in a variety of endothelial cells (Jalali et al. 
1998;Surapisitchat et al. 2001). However brief exposure to shear was found to inhibit 
the activation of JNK in response TNF-α and IL-1-β (Surapisitchat et al. 2001) while 
after exposure for extended periods, all three MAPK were inhibited (Yamawaki et al. 
2005). Studies have found that long term exposure to shear inhibited TNF-α induced 
activation of NFkB and the associated up-regulation of adhesion molecules and 
chemokines in HUVEC (Sheikh et al. 2005).  
 
The above supports the theory that initial exposure to shear or changes in shear 
cause transient responses, while prolonged exposure establishes a new phenotype 
with, for instance, altered response to pro-inflammatory cytokines. This is important 
because the ability of EC’s to alter their phenotype under varying shear stresses 
could be important in situations where blood flow is disturbed such as 
ischemia/reperfusion and altered flow as a result of surgery (Nash et al. 2004). 
 
5.2 Results 
 
5.2.1 Optimisation of the flow assay using murine neutrophils 
 
In order to optimise use of our flow assay with murine leukocyte populations we 
began by performing pilot experiments with neutrophils to confirm their adhesion to 
recombinant adhesion protein. Murine bone marrow neutrophils were perfused over 
increasing concentrations of purified murine E-Selectin (0.125-2µg/ml) at 0.05Pa and 
 199 
adhesion was quantified and categorised into static and rolling cells. As expected the 
total number of adherent neutrophils increased with E-Selectin concentration, whilst 
rolling velocities decreased in a dose-dependent manner (Fig. 5.1). 
 
In addition the effect of increasing shear stress on neutrophil adhesion to E-selection 
(1-2µg/ml) was tested (Fig. 5.2). As shear stress increased we observed a dramatic 
decrease in the number of neutrophils captured. In general the percentage of rolling 
neutrophils also decreased with increasing shear stress (Fig. 5.2) although 
interestingly overall rolling velocities appeared unaffected by shear stress. Thus 
confident that our assay worked appropriately with murine leukocytes we moved on 
to studies using endothelial monolayers. 
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Figure 5. 1 Effect of E-Selectin concentration on the number of adherent 
neutrophils (A), velocity of rolling neutrophils (B). 
 
Murine bone marrow neutrophils were isolated and perfused over glass microslides 
coated with purified murine E-Selectin. Video microscopic data was collected from 3 
functional flow experiments and analysed offline using Image ProPlus. Error bars 
represent mean +/- SEM, N=3. Data was subject to one-way ANOVA and Dunnets 
post-test. *<0.05.  
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Figure 5. 2: The effect of increasing shear stress and E-Selectin concentration 
on the number of adherent neutrophils (A), percentage rolling of adhered (B) 
and rolling velocities (C). 	  
 Murine bone marrow neutrophils were isolated and perfused over glass microslides 
coated with purified murine E-Selectin at increasing concentrations at varying fluid 
shear stresses. Video microscopic data was collected from 3 functional flow 
experiments and analysed offline using Image ProPlus. Error bars represent mean 
+/- SEM, N=1.  
 
 
 
 
 
 
 
 
 
 
 
 202 
Here, bone marrow neutrophils were isolated from adult mice and perfused over a 
mUCEC-1 monolayer stimulated with different doses of TNF-α. We quantified the 
number of adherent neutrophils, the percentage of these neutrophils that rolled and 
their rolling velocities. We saw higher levels of neutrophil adhesion to the endothelial 
monolayer than were previously observed on immobilised E-selectin. Fig. 5.3 shows 
that increasing TNF-α concentration up to 500U/ml resulted in a dose-dependent 
increase in the total number of neutrophils adhering to mUCEC-1, whilst a decrease 
in adhesion was apparent at the highest dose (1000U/ml, Fig 5.3-A). This same 
pattern occurred when the percentage of rolling neutrophils was calculated (Fig 5.3-
B), whilst neutrophil-rolling velocities decreased with increasing concentration of 
TNFα (Fig 5.3-C). 
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Figure 5. 3: Effect of TNF-α concentration on the number of adherent 
neutrophils (A), the percentage of adherent cells that were rolling (B) and the 
velocity of rolling neutrophils (C).  	  
Murine bone marrow neutrophils were isolated and perfused over glass microslides 
containing confluent mUCEC-1 monolayers, which had been stimulated with TNF-α 
at several doses for 4hrs. Video microscopic data was collected from 3 functional 
flow experiments and analysed offline using Image ProPlus. Error bars represent 
mean +/- SEM, N=3 with exception of 5.4-C n=1. Statistics were carried out using 
one-way ANOVA and Dunnets post-test. * p<0.05. 
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5.2.2 Optimisation of the lymphocyte flow assay using murine endothelial 
monolayers 
 
Again we began our studies by performing some pilot investigations to optimise the 
system. Firstly mixed lymphocyte populations from murine spleens were perfused 
over confluent TNF-α stimulated mUCEC-1 monolayers at increasing shear stresses 
(0.05-0.2Pa). As shear stress increased, a significant reduction in total adhesion of 
lymphocytes was observed (Fig. 5.4-A) Whilst performing these experiments we 
observed that the nature of the mUCEC-1 monolayer morphology observed under 
phase-contrast microscopy (Fig. 2.6) with occasional phase-bright, rounded cells, 
made it difficult to differentiate adherent lymphocytes. The same was true of 
experiments using sEND cells. 
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Figure 5. 4: Effect of increasing shear stress and cell tracker green on the 
ability of lymphocytes to adhere to a TNF-α stimulated EC monolayers in 
microslides.  	  
Murine splenocytes were isolated and perfused over glass microslides containing 
confluent mUCEC-1 monolayers that had been stimulated with TNF-α (100U/ml) for 
4hrs at increasing shear stresses (A). In addition cell tracker green lymphocytes were 
perfused over mUCEC-1 (B) and s.END (C) cells. Video microscopic data was 
collected from 4 (Shear) or 1 (CTG) functional flow experiment and analysed offline 
using Image ProPlus. Error bars represent +/- SEM. One-way ANOVA was 
performed. *<0.05, **<0.01. 
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Thus in order to accurately quantify lymphocyte-endothelial cell interactions, we 
labelled the splenocytes with a fluorescent dye, cell tracker green (CTG). We then 
used fluorescent microscopy to count the adherent cells in the flow assay. First we 
examined whether fluorescent labelling of lymphocytes altered their ability to adhere 
to endothelial monolayers. Fig. 5.4-B/C shows results of experiments where we 
compared adhesion of labelled and unlabelled lymphocytes to confluent mUCEC-1 
and s.END monolayers in the presence or absence of TNF-α pretreatment (100U/ml 
for 4 hours). It was considerably easier to quantify the adhesion of labelled cells, and 
we saw no effect of the labelling strategy on adhesion to control or stimulated 
endothelium. Interestingly we observed far greater adhesion to the mUCEC-1 
monolayers and minimal effects of a short prestimulation with TNFα on either 
endothelial cell. We observed a negligible difference in the adhesive properties of 
labelled and unlabelled lymphocytes. The number of adherent cells increased 
modestly upon cytokine stimulation above control treatment as expected. We were 
therefore able to conclude that CTG labelling had no significant deleterious effect and 
could be used in subsequent experiments. 
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Figure 5. 5: Effect of tissue culture vessel on the ability of CTG labelled 
lymphocytes to adhere to endothelial monolayers mUCEC-1 (A), s.END (B) and 
b.End.5 (C) stimulated with TNF-α+IFN-γ. 	  
 Murine splenocytes were isolated and perfused over rat tail collagen coated glass 
microslides or IBIDI treat VI chambers containing confluent EC monolayers 
stimulated with TNF-α+IFN-γ (100U/ml) for 4hrs. Video microscopic data was 
collected from functional flow experiments and analysed offline using Image ProPlus 
N=2-4.  
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Whilst these functional studies were underway an alternative to our traditional glass 
capillary microslide culture system (Rainger et al.	  1998) became available. IBIDI VI 
chambers enable culture of EC in small gas permeable tissue culture treated 
capillaries with favourable optical resolution. We decided to test this system, as the 
glass microslide system is complex and time consuming to set up. Certainly we 
observed that endothelium cultured in the IBIDI chambers assumed an appropriate, 
healthy morphology and grew more efficiently and reproducibly than similar cells 
cultured in microslides. We then compared the performance of both systems in the 
flow assay context. Mixed lymphocytes were perfused over endothelial cell 
monolayers (mUCEC-1 (A), send (B) and b.END.5(C)) cultured to confluence in 
either rat-tail collagen-coated glass microslides or ‘IBIDI-treat’ chambers, which had 
been stimulated for 4 hours with TNF-α and IFN-γ (100U/ml) (Fig.5.5). In general 
lymphocyte adhesion to EC cultured in IBIDI chambers was lower than that observed 
using microslides. However for both systems we noted an appropriate response to 
cytokine stimulation (i.e. increased total adhesion) and the magnitude of adhesion on 
one-endothelium vs another was maintained (i.e. mUCEC-1>b.END.5>sEND).  
 
 
 
 
 
 
 
 
 
 
 209 
 
 
 
 
 
 
 
 
 
Figure 5. 6: Effect of TNF-α and pertussis toxin (PTX) treated lymphocytes on 
the number of lymphocytes adhering to mUCEC-1 monolayer (A) and the 
number of shape-changed lymphocytes (B).  	  
Murine splenocytes were isolated and treated with PTX at 20ng/ml for 15 mins and 
perfused over glass microslides containing confluent mUCEC-1 monolayers that had 
been stimulated with TNF-α (100U/ml) for 24hrs. Video microscopic data was 
collected from 3 functional flow experiments and analysed offline using Image 
ProPlus. Error bars represent mean +/- SEM, N=3. Statistics were carried out using 
two-way ANOVA and Bonferroni post-test, ** p<0.01.   
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As a final confirmation of the reliability of our murine flow assay systems we 
examined the contribution of chemokines to the recruitment and adherence process 
by incubating lymphocytes with pertussis toxin to block Gi-protein linked signalling. 
Lymphocyte total adhesion, and shape changed cells (static) across both 
unstimulated and stimulated (TNF-αU/ml, 24hrs) mUCEC-1 monolayers were 
compared in the presence and absence of pertussis toxin treatment. Levels of 
adhesion were increased by TNFα-stimulation of the endothelium due to prolonged 
exposure (24hrs) and this increased both the number of static and activated cells 
(Fig. 5.6-A/B).  Interestingly, PT treatment reduced total adhesion to both stimulated 
and unstimulated endothelium, although the effect was more pronounced on 
stimulated endothelium. Similarly numbers of both shape-changed and statically 
adherent cells were reduced by PT treatment. Both PTX and TNF-α had effects on 
adhesion but were not dependent on each other. 
 
5.2.3 Comparison of the ability of endothelium from different organs to support 
leukocyte adhesion under different conditions. 
 
5.2.3.1 A: The effects of cytokine treatment on lymphocyte adhesion to murine 
endothelium under flow. 
 
We began by assessing how each of our different immortalised endothelial cell lines 
responded to cytokine treatment in terms of ability to recruit lymphocytes. Here the 
endothelial cell monolayers were treated with a number of pro-inflammatory stimuli 
for 4 (Fig.5.7) or 24 (Fig. 5.8) hours prior to performing flow-based adhesion assays.  
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Figure 5. 7: Effect of pro-inflammatory stimuli on the number of adherent 
lymphocytes for 4 hours.  	  
CTG labelled murine splenocytes were isolated and perfused over glass microslides 
or IBIDI VI chambers containing confluent mUCEC-1 (A), s.END (B) and b.END.5 (C) 
monolayers that had been stimulated for 4 hours. Video microscopic data was 
collected from 3 functional flow experiments and analysed offline. Error bars 
represent mean +/- SEM n=3. Statistics were carried out using a one-way ANOVA 
and Dunnets post-test. *<0.05, **<0.01, ***<0.001. 
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Figure 5. 8: Effect of pro-inflammatory stimuli on the number of adherent 
lymphocytes for 24 hours.  	  
CTG labelled murine splenocytes were isolated and perfused over glass microslides 
or IBIDI VI chambers containing confluent mUCEC-1 (A), s.END (B) and b.END.5 (C) 
monolayers that had been stimulated for 24 hours. Video microscopic data was 
collected from 3 functional flow experiments and analysed offline. Error bars 
represent mean +/- SEM n=3. Statistics were carried out using a one-way ANOVA 
and Dunnets post-test. *<0.05. 
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Short-term exposure (4hrs) to pro-inflammatory stimuli induced variable responses in 
all cell types. mUCEC-1 and b.End.5 exhibited variable responses dependent upon 
which cytokine stimulation protocol was used. Adhesion of lymphocytes to mUCEC-1 
significantly increased above control in stimulated samples. This cell line also 
exhibited the highest level of basal adhesion in the absence of stimulation. In addition 
adhesion to b.END.5 was significantly elevated after stimulation and TNF-α and IFN-
γ induced a significant reduction in adhesion. Basal levels of adhesion to b.End.5 
were about tenfold less than seen on mUCEC-1. sEND cells supported similar levels 
of basal adhesion as seen on b.END.5 but showed more consistent elevations in 
adhesion in response to stimulation with  IL-1β and TNF-α and IFN-γ combined 
leading to significant increases in adhesion above control (Fig. 5.7).  
 
Prolonged exposure produced a reduction in total adhesion in all cell lines with 
similar responses to quoted treatments at 4 hours. In addition basal levels of 
adhesion were low with the exception of mUCEC-1 cells where treatments 
significantly increased levels of adhesion above control. b.END.5 cells however 
exhibited similar behaviour with a reduction in adhesion across the board but unlike 
at 4 hours all treatments induced levels of adhesion above baseline controls (Fig. 
5.8). 
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5.2.3.2 B: The ability of murine endothelial cell lines to recruit leukocyte 
subsets from flow 
 
In addition to analysing recruitment of mixed populations of lymphocytes, subsets of 
lymphocytes were isolated using MoFlo cell sorting to obtain pure CD4+ and CD8+ 
cells. Initially pilot studies were done to assess the efficiency of cell sorting. We 
sorted individual subsets of cells from whole spleens to up to 99% purity as indicated 
in Fig. 5.9. 
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Figure 5. 9: Isolation of CD4+/CD8+ single positive cells from whole murine 
spleen using the MoFlo Cell Sorter.  	  
Murine splenocytes were labelled with αCD8-FITC and αCD4-PE and separated on 
the expression of these flurochromes into single positive populations from the whole 
sort (A) using Beckman Coulter MoFlo XDP to over 90% purity. Appropriate 
compensation was carried out using single colour controls and samples were 
checked for purity post-sort (B/C). 
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All three endothelial cell lines were stimulated with the pro-inflammatory treatments 
used in previous flow based experiments for 4hrs as these parameters had shown 
the most promising results. As before, highest levels of adhesion were observed on 
mUCEC.  
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Figure 5. 10: Effect of pro-inflammatory stimuli on the adherence of lymphocyte 
subsets.  	  
CTG labelled murine splenocytes were isolated and perfused over IBIDI VI chambers 
containing confluent EC monolayers that had been stimulated with TNF-α 100U/ml 
(A), IFN-γ 100U/ml (B), LPS 1µg/ml (C) and TNF-α+IFN-γ 100U/ml (D) for 4 hours. 
Video microscopic data was collected from 3 functional flow experiments and 
analysed offline. Error bars represent mean +/- SEM n=3. Statistics were carried out 
using a two-way ANOVA and Bonferroni post-test to control. CD4+ and CD8+ cells 
were treated separately for statistics. Statistics shown indicate the impact of cell line 
but this does not depend on treatment *<0.05, **<0.01 and ***<0.001. 
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EC stimulated with the panel of treatments recruited CD4+ and CD8+ cells to 
differing extents. The effect of cell line was significant in all treatments with the 
exception of CD8+ LPS treatment. With mUCEC-1 vs s.END having a significant 
effect on CD4+ recruitment in response to LPS (p<0.05) and mUCEC-1 vs s.END 
effecting CD4+/CD8+ (p<0.001). Treatment impacted significantly on adhesion of 
both cell types when treated with IFN-γ and CD4+ with LPS (p<0.05). CD4+ 
recruitment was unaffected by TNF-α however recruitment of CD8+ cells was lower. 
Pronounced responses were observed in response to LPS (Fig. 5.10-C) in mUCEC-1 
and b.End.5 cells, particularly in the recruitment of CD4+ cells with ~50% increase in 
adhesion. Stimulation increased adhesion above control in all treatments and groups 
tested. 
 
Levels of recruitment in mUCEC-1 cells were much higher than other cell types as 
seen in response to TNF-α. This response was not seen with IFN-γ alone but was 
seen when two cytokines were combined suggesting TNF-α was accounting for the 
response seen here (Fig. 5.10-D). Small cytokine dependent responses were seen in 
s.END (LPS) and b.End.5 (IFN-γ) cells with most effect seen in the recruitment of 
CD4+ cells to s.END cells. 
 
5.2.3.3 C: The effects of cytokine treatment on lymphocyte adhesion to primary 
murine hepatic endothelium under flow 
 
Immortalised EC lines were used to optimise protocols for use with primary EC 
populations. A primary murine liver sinusoidal endothelial cell population was 
obtained using αCD146 magnetic bead isolation from whole Balb/c livers to sufficient 
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purity (~98%). mLSEC were seeded into ‘IBIDI-treat’ chambers and assessed in 
functional assays. 
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Figure 5. 11: Effect of pro-inflammatory stimuli on the number of lymphocytes 
adhering to mLSEC.  	  
CTG labelled murine splenocytes were isolated and perfused over IBIDI VI chambers 
containing mLSEC that had been stimulated for 4 (A) or 24 (B) hours. Video 
microscopic data was collected from 2 functional flow experiments and analysed 
offline. Error bars represent mean +/- SEM n=4. Statistics were carried out using a 
one-way ANOVA and Dunnets post-test.  
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Interestingly, recruitment of lymphocytes to mLSEC was low and comparable to the 
endothelioma cell lines (Fig. 5.11). Levels of adhesion were far less than we have 
observed on human sinusoidal endothelium (Shetty et al. 2008). After 4 hours, the 
majority of treatments induced levels of adhesion above control with LPS and TNF-
α+IFN-γ having the most effect in accordance with our observations using cell lines. 
IL-1β had no effect on adhesion after 4 hours stimulation (Fig. 5.11-A). Prolonged 
exposure to stimuli had no additional stimulatory effect on adhesion and if anything 
slightly reduced recruitment compared to untreated mLSEC.(Fig. 5.11-B) although 
none of these treatments were significant. This also supports the trend observed 
using immortalised cells.  
 
5.2.3.4 D: The ability of primary murine hepatic endothelium to recruit 
leukocyte subsets from flow and under static conditions 
 
Preliminary experiments were carried out on primary mLSEC to assess total 
lymphocyte versus subset recruitment using LPS and TNF-α+IFN-γ, which induced 
the most adhesion in earlier studies. 
 
 
 
 
 
 
 
 
 222 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 12: Effect of LPS and TNF-α+IFN-γ on the adherence of total 
lymphocytes and subsets.  	  
CTG labelled murine splenocytes, CD4+ and CD8+ cells were isolated and perfused 
over IBIDI VI chambers containing mLSEC that had been stimulated with LPS 1µg/ml 
or TNF-α+IFN-γ 100U/ml for 4 hours. Video microscopic data was collected from 2 
functional flow experiments and analysed offline. Error bars represent mean +/- SEM 
n=3. Statistics were carried out using a two-way ANOVA and Bonferroni post-test 
against control. Cell Lines showed significant difference ***<0.001. 
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The recruitment of whole unfractionated lymphocytes was unaffected by cytokine 
treatment, however cell type had a significant effect on adhesion. CD4 cells bound in 
increased numbers relative to unfractionated cells and binding was modestly 
elevated by cytokine and LPS stimulation. Levels of CD8+ cell recruitment were 
similar to the unfractionated population but here there was a marked increase in 
adhesion following TNF-α+IFN-γ treatment (Fig. 5.12).  
 
In order to compare adhesion to all cell types in parallel and to make best use of the 
minimal yield of cells available after sorting, an alternative method for functional 
assessment of adhesion to endothelium was used. Instead of examining endothelial-
lymphocyte interactions under flow, labelled lymphocytes were added to stimulated 
EC monolayers in tissue culture plates. Static adhesion assays were carried out on 
all cell lines and primary mLSEC stimulated with LPS (1µg/ml) or TNF-α+IFN-γ 
(100U/ml) treatments, using the same lymphocytes. These treatments were selected 
due to their effect on recruitment in previous experiments (Fig. 5.13).  
 
 
 
 
 
 
 
 
 
 224 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. 13: Effect of LPS and TNF-α+IFN-γ on the lymphocyte recruitment in 
static assays.  	  
CTG labelled murine splenocytes were isolated and incubated with EC in 24-well 
culture plates stimulated with LPS 1µg/ml or TNF-α+IFN-γ 100U/ml for 24 hours. The 
number of adherent cells was counted in an average of 10 fields. Error bars 
represent mean +/- SEM n=5. Statistics were carried out using a two-way ANOVA 
and Bonferroni post-test to control. *<0.05, **<0.01 and ***<0.001. 
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The relative levels and pattern of adhesion to all cell types was generally similar to 
that observed in flow based assays although adhesion to non-mUCEC endothelium 
was slightly higher in the static system.  Both cell type and treatment had significant 
effects on adhesion but was not dependent on each other. As before the high levels 
of adhesion to mUCEC were minimally altered by cytokine stimulation. However 
adhesion to the other endothelial cell types was elevated in response to both TNF-
α+IFN-γ and LPS stimulation to a degree more pronounced than that observed in the 
flow assays particularly in b.End.5 cells were increases in adhesion were significant. 
 
5.2.4 Modulation of the ability of endothelium to recruit leukocytes by shear 
conditioning 
 
Our next aim was to condition all our endothelial populations by exposure to 
continuous shear stress to determine the effects on recruitment capacity. We were 
unable to perform these studies in the time available but did manage some proof of 
concept pilot studies. 
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Figure 5. 14: The effect of shear conditioning on the total number of adherent 
neutrophils (A), the percentage of adherent neutrophils that adhered (B) and 
the velocities of rolling neutrophils (C).  
Murine bone marrow neutrophils were isolated and perfused over glass microslides 
containing cultured mUCEC-1. Endothelial cell monolayers were stimulated with 
either 5x10-9 g/ml of IL-1β or 1000U/ml TNF-α for 4 hours prior to perfusion of 
neutrophils. Error bars represent the standard deviation between bolus and wash 
samples in Fig 5.15-C. 
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Here mUCEC-1 grown in microslides were preconditioned in shear stresses of 2.0Pa 
and stimulated with TNF-α (1000U/ml) or IL-1β (5x10-9 g/ml). We then performed 
standard flow assays using freshly isolated bone marrow neutrophils. Fig. 5.14 
shows that cells exposed to culture under static or continuous flow conditions 
responded appropriately to cytokine stimulation which resulted in elevated total 
neutrophil adhesion, rolling adhesion and in general in an increase in transmigration. 
The number of adherent neutrophils was higher in the Il-1β-stimulated groups than 
the TNF-α-treated groups. Interestingly we observed an increase in total adhesion to 
IL-1β-stimulated EC under continuous flow compared to static conditions, which was 
not the case for TNF-α stimulation.  However the percentage of cells that rolled was 
higher after continuous exposure to flow for both cytokine treatments. However it 
appeared that exposure to continuous flow had little effect on the number of 
transmigrating cells after cytokine treatments, but did reduce the proportion of cells, 
which transmigrated across ‘unstimulated’ endothelium. In addition the high dose of 
TNF-α could have impacted upon the integrity of the endothelium.  
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Figure 5. 15: The effect of increasing concentrations of TNF-α  on the number of 
adherent lymphocytes. 	  
A mixed lymphocyte population from murine spleens were perfused over glass 
microslides containing cultured mUCEC-1 cells. Endothelial cell monolayers were 
stimulated with increasing doses of TNF-α for 24 hours prior to perfusion of 
lymphocytes. Error bars represent +/- SEM. One-way ANOVA was performed with 
Dunnets post-test but no data was significant. 	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Additional experiments examined the effect of increasing doses of TNF-α on the 
adhesion of mixed lymphocytes (Fig.5.15). Levels of adhesion increased above 
control up to 500U/ml after which adhesion was adversely affected, with levels 
dropping to below control values at 10,000U/ml. 
 
5. Discussion 
 
The aim of functional studies was to determine if there were differences in the ability 
of tissue specific endothelial cell populations to recruit various leukocyte subsets 
under static and flow conditions. We isolated a high yield of mixed lymphocyte 
populations and CD4+ and CD8+ subsets from murine spleens in addition to murine 
bone marrow neutrophils to relatively high purity. Experiments using purified proteins 
showed that neutrophils could adhere to E-Selectin under physiologically relevant 
shear stresses and that some cells rolled on the protein substrate. These 
experiments lead to further studies to examine the behaviour of leukocytes in 
endothelial cell systems using immortalised cell lines and primary mLSEC. The 
specific murine flow system we developed has not been previously used. Neutrophils 
have previously been isolated from murine bone marrow (Zollner et al.	  1997) but their 
functional responses under flow have yet to be reported. There is little literature 
available on the behaviour of murine endothelial cells under flow. Lim et al (Lim, et al.	  
2003) have cultured primary aortic and lung endothelial cells and examined their 
ability to recruit T-cells. This group has also isolated peripheral blood neutrophils 
from MMP-9 KO mice and examined their behaviour under flow (Allport et al.	  2002). 
Previously published studies similar to those carried out in this project involve 
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examining leukocyte adherence under static conditions (Barkalow et al.	  1996) or 
using different flow methods such as parallel plate flow chambers. A number of 
experiments have been carried out in vivo using intravital microscopy (Mayadas et al.	  
1993), as the parameters being tested have not yet been manipulated in vitro.  
 
5.1 Optimisation of leukocyte isolation. 
 
There are a number of different sources from which neutrophils and lymphocytes can 
be isolated; bone marrow, secondary lymphoid tissues, peripheral blood and whole 
blood. The total blood volume of a mouse is ~2ml, of which between 05-1ml can be 
removed. The yield of neutrophils from peripheral blood is low as circulating numbers 
are low. Therefore the bone marrow is a more ideal source of neutrophils as it 
contains a large neutrophil pool (Pallister 1998). It must be considered however that 
not all of the neutrophils here will have reached maturity. The bone marrow isolates 
used for functional flow experiments were ~70-75% pure as assessed by examining 
the cellular morphology. Ideally sample purity should be examined using a more 
quantitative method such as flow cytometry utilising a neutrophil specific mAb, such 
as murine GR-1. It has also been demonstrated by other groups that neutrophil purity 
in excess of 90% can be achieved by the inclusion of a B-Cell depletion step using a 
magnetically activated cell sorting kit. Nevertheless visual observation of our flow 
assay experiments allowed us to selectively score neutrophil adhesion in our 
experiments on the occasions where purity was less than ideal. 
 
A mixed lymphocyte population can be isolated from whole murine spleens, which is 
rich in T and B-Cells. Spleens are disaggregated and contaminating red blood cells 
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lysed and removed. The remaining lymphocytes can be used whole or sorted to 
isolate high purity CD4+ and CD8+ cells. Subsets can also be obtained using 
magnetic bead isolation methods but MoFlo cell sorting was found to be more 
appropriate for functional experiments. Our MoFlo data confirmed that the 
populations used were over 90 % pure after being 42.92% (CD4+) and 19.82% 
(CD8+) of the whole spleen prior to sorting. Therefore we are confident that cells 
used in flow assays were selective for the population in question. 
 
5.2 Neutrophil adherence to purified E-Selectin 
 
In order to characterise the behaviour of murine bone marrow neutrophils under flow 
conditions we carried out initial experiments using purified E-selectin coated 
microslides. We examined the effect of both increasing shear and E-selectin 
concentration on the number of neutrophils adhering to the microslide surface, the 
percentage of adherent neutrophils rolling and rolling velocities. Bone marrow 
neutrophils did adhere to the E-selectin coated surface and were found to 
spontaneously activate, even in the absence of a chemotactic stimulus. As the 
shear rate increased all three parameters decreased. Increasing the concentration of 
E-selectin in the initial shear experiments did not seem to have any effect. A broader 
range of E-selectin concentration was tested, to find the optimal concentration to use 
for further flow experiments.  It was found that, as the concentration increased there 
was a dose dependent increase in the number of adherent neutrophils and decrease 
in rolling velocity. This observed trend could be explained as an increase in the 
number of receptor-ligand interactions between the neutrophil and E-selectin with 
increasing protein concentration, resulting in increased avidity to the microslide 
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surface and decreased rolling velocity. These experiments have not previously been 
carried out using murine neutrophils though in similar human experiments, 
neutrophils did adhere to purified E-selectin (Lawrence et al. 1994; Reinhardt et al. 
1998). Whole blood was perfused over E-selectin coated coverslips at different 
concentrations and shear stresses, it was found that at the highest shear (4Pa) that 
neutrophils were the only leukocytes that adhered and all leukocyte adhesion was 
inhibited with an anti-E-selectin blocking antibody (Lawrence et al.1994; Reinhardt et 
al. 1998). Lawrence et al (Lawrence et al. 1994) showed that L-selectin was also 
required for neutrophils to adhere to an E-selectin surface under flow conditions and 
could be a ligand here. This could be confirmed using blocking antibodies to further 
dissect exact mechanisms involved.  Our conclusions from these studies were that 
our murine cell-based assay was working appropriately, we were able to isolate 
resting populations of murine neutrophils and that the cells responded as expected in 
the flow assay. Thus we moved on to experiments using endothelial monolayers. 
 
5.3 Effect of TNF-α on neutrophil recruitment  
 
Functional studies to examine the effect of TNF-α on neutrophil recruitment in the 
mUCEC-1 system showed that TNF-α elicited a dose dependent increase in the 
number of leukocytes adhering to the mUCEC-1. In addition the rolling velocities of 
adherent neutrophils decreased as TNFα concentration increased, and in general 
adhesion was higher than we noted in the purified E-selectin experiments. This fits 
with an increased density of multiple ligands being expressed on cytokine-stimulated 
endothelium.  We noted greater variability in neutrophil adhesion, rolling velocity and 
migration in the endothelial system. This may relate to the fact that the bone marrow 
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does not contain a homogenous population of neutrophils. As a site of neutrophil 
haemopoesis, the neutrophils, which we isolate, could be at any stage of 
development and may not all express the appropriate adhesion molecules at 
sufficient level to adhere, roll and transmigrate through endothelial cells (Adams et al.  
2005;Pallister 1998). Additionally it is likely that the endothelial surface, even of a cell 
line, does not uniformly express receptors between experiments which may add to 
potential variability. However these pilot studies with neutrophils satisfied us that our 
murine endothelial adhesion systems worked well enough to move onto comparisons 
between endothelial cell types in the context of lymphocyte adhesion. 
 
5.4 Characterisation of murine lymphocyte adhesion to immortalised cell lines 
under flow. 
 
Here we examined the effects of a number of different pro-inflammatory cytokines 
and endotoxins on the ability of mUCEC-1, s.END, b.End.5 and mLSEC to recruit 
lymphocytes. In order to visualise the adherent cells lymphocytes were fluorescently 
labelled with cell tracker green. Previous studies examined the toxicity of first 
generation fluorescent labels such as cell tracker orange and bisbenzamide and 
found that they effected the ability of human neutrophils to adhere and migrate to 
HUVEC (Smith et al. 2006) or P-Selectin (Abbitt et al. 2000). More recently 
developed dyes such as cell tracker green and CFSE are designed specifically for 
functional assays and have been optimised to have minimal detrimental effects on 
loaded cells. In agreement, our pilot experiments determined that CTG had no effect 
on the recruitment of murine lymphocytes to mUCEC-1 and s.END cytokine 
stimulated monolayers.  
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The majority of functional studies were carried out by culturing EC in glass capillary 
microslides, a technique pioneered in Birmingham (Buttrum et al. 1993). Towards the 
end of my studies an alternative method became commercially available. IBIDI VI 
chambers enable culture of EC in gas permeable chambers negating the need for 
complex flow-culture apparatus used previously. Endothelial cells populations 
cultured in IBIDI VI chambers appeared morphologically representative of healthy EC 
populations. Pilot experiments indicated that EC cultured in chambers recruited 
smaller numbers of lymphocytes and exhibited less of a response to stimuli 
compared to microslides in all cell lines in particular mUCEC-1. However, EC 
cultured in chambers exhibited normal adhesive properties and response to stimuli in 
a more stable state, providing reliable representative data. This altered expression 
profile could be due to the larger depth of IBIDI VI chambers compared to microslides 
(HxWxD: 17x3.8x0.4 compared to 50x3x0.3 mm). In addition smaller volumes of 
cytokine are used in IBIDI VI chambers and this could be impacting upon adhesion.  
 
Functional studies to examine the effects of pro-inflammatory stimuli on leukocyte 
recruitment in immortalised EC systems revealed differences in EC derived from 
different tissues. In mUCEC-1 cells TNF-α, LPS and IL-1β elicited the highest levels 
of adhesion after a short 4-hour exposure. Prolonged exposure for 24 hours resulted 
in decreased adhesion in particular to IFN-γ alone and in combination with TNF-α. 
This reduction could be due to deleterious effects of over exposure on the integrity of 
the EC monolayer. Certainly we noted that endothelial cells in these samples were 
stressed and granular in appearance, but this was surprising since cell lines often 
require higher doses of cytokines to yield a similar response to that seen in primary 
cell isolates (Proudfoot et al. 2001). It is possible that prolonged exposure to IFN-γ 
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may be effecting the growth of mUCEC-1 as the producers of this cell line published 
that IFN-γ in conjunction with incubation at 33°C was required to switch cells into 
growth phase by activating an H2-K promoter linked to the SV40 large Tag. Thus 
whilst proliferating in response to high doses of IFN-γ, it is plausible that the cells did 
not produce all the relevant surface markers present in normal culture conditions 
(Lidington et al. 2002).  
 
In comparison, although global levels of adhesion were lower, s.END cells were more 
responsive to stimulation after 4 hours. Treatment with LPS, TNF-α+IFN-γ and IL-1β 
had most effect with up to 50% increase above control. A similar response was 
observed at 24 hours with a reduction in adhesion. s.END cells are an immortalised 
murine skin endothelioma cell line isolated from mice infected with a polyoma midde 
T oncogene and have been previously shown to retain functional properties of normal 
endothelial cells; uptake of acLDL, expression of CD31, VCAM-1, and E/P-Selectin, 
production of chemokines and response to TNF-α and IL-1β (Bussolino et al.1991). 
Physiologically, leukocyte recruitment in the skin involves ICAM-1 and LFA-1 
interactions in particular (Iwata et al.1996), which fits with our observations following 
TNF-α and IFN-γ-treatment here.  
 
The b.End.5 cells are immortalised using the same method as s.END cells. Both 
endothelioma cell lines exhibited similar levels of basal adhesion, but with the 
exception of LPS, 4 hours cytokine treatment had little effect on adhesion to these 
cells. However, modest increases in adhesion were noted after most stimuli following 
24-hours stimulation. Interestingly b.End.5 cells have previously been used to study 
the barrier role of the BBB and the role of VCAM-1, ICAM-1 and ICAM-2 in adhesion 
 236 
within the brain. In comparative studies with primary mBMEC, b.End.5 expressed 
similar levels of IL-6, PCA and PAF in response to IL-1, LPS and TNF-α stimulation 
for 4hrs (Bussolino et al. 1991). In addition other groups stimulated b.End.5 with 5nM 
TNF-α for 16 hours to examine CXCR-2 mediated adhesion (Frommhold et al.  
2008). The function of ICAM-1/VCAM-1 interactions has been demonstrated on 
cytokine stimulated mouse, rat and human BMEC and in models of EAE (Lee et al.  
1999) however data is limited on b.End.5 cells. Our data suggests that ICAM-2, 
CD31 and CD34 were expressed on b.End.5 cells but VCAM-1 was absent from 
whole tissue and b.End.5 by immunohistochemistry. Low levels were present in 
b.End.5 cells via ELISA in particular in the presence of high doses of TNF-α and 
TNF-α+IFN-γ. Due to the number of adhesion molecules expressed b.End.5 were 
able to recruit leukocytes from the circulation but the induction adhesion molecules 
produced in response to stimuli was limited.  
 
We also looked at the effect of PT treatment on lymphocyte adhesion and 
recruitment. Pertussis toxin blocks Gi-protein linked signalling and therefore inhibits 
signals generated when leukocyte borne chemokine receptors interact with their 
ligand, inhibiting leukocyte adhesion and transmigration. Treatment with PT 
adversely affected adherence to both TNF-α stimulated and unstimulated monolayers 
of mUCEC-1 and s.END cells suggesting a role for chemokines in both settings. In 
both cell lines a number of different chemokines were constitutively expressed in all 
conditions, however it must be considered that the possible toxicity of pertussis toxin 
could be contributing to this effect.  
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5.5 Characterisation of murine lymphocyte adhesion to primary EC under flow. 
 
Immortalised EC lines were used to set up functional assays and we obtained data 
highlighting the phenotypic and functional differences between tissue specific EC in 
terms of cell surface marker expression, response to cytokines and ability to recruit 
lymphocytes. However the main aim of this project was to isolate and characterise 
primary liver endothelial cell populations. Pure populations of mLSEC were isolated 
from whole Balb/c livers and used at P0, one-day post isolation. Liver sinusoidal 
endothelial cells were exposed to a panel of pro-inflammatory stimuli for 4 or 24 
hours and their ability to recruit lymphocytes were assessed. After 4 hours the 
majority of treatments increased adhesion, with the exception of IL-1β. An additive 
effect of TNF-α+IFN-γ was apparent inducing the highest levels of adhesion along 
with LPS. After 24 hours stimulation, adhesion remained above control levels, but 
was generally not as elevated as after 4 hours treatment. This was in contrast to our 
cell lines where prolonged cytokine exposure produced a global decrease in 
adhesion.  
 
Much previous published research has examined the functional capabilities of 
cultured human LSEC and their ability to recruit subsets of immune cells (et al.  
2009;Curbishley et al. 2005). Similarly murine intravital studies have addressed 
leukocyte recruitment to the liver sinusoids in vivo, such as the role of selectins in 
endotoxaemic mice (Klintman et al. 2002).  However, whilst mLSEC have been 
isolated by a number of different groups to study, endocytosis and immunological 
function (Knolle et al. 2001;Smedsrod et al. 2004) the ability of mLSEC to recruit 
leukocytes from the circulation in flow-based models has not been studied. Thus we 
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investigated the ability of mLSEC to recruit different lymphocyte populations following 
cytokine treatment. 
 
5.6 Isolation and recruitment of lymphocyte subsets 
 
Single positive CD4+ and CD8+ lymphocytes were isolated from murine spleens. 
Global levels of adhesion in response to treatment were similar or lower than that 
seen in other assays. All EC were cultured in IBIDI VI chambers, which were shown 
to recruit smaller numbers of lymphocytes unlike microslides used in other assays 
where adhesion was higher in particular with mUCEC-1 cells. Studies on subset 
recruitment to each of the different tissues examined, heart, brain, skin and liver 
focus on leukocytes recruited or present during injury, inflammation and disease. 
 
In the brain, recruitment in murine model of MS, EAE is a Th1 mediated disease 
(Luster et al. 2005). Ghirnikar et al (Ghirnikar et al. 1998) found that injury to the CNS 
as a result of stab injury of the cortex initiated the innate immune response leading to 
recruitment of macrophages (12-24 post injury) followed by T-Cells (up to 8 days) 
and TNF-α, IL-1β and CCL2 were thought to be involved. Yilmaz et al (Yilmaz et al.) 
found that both CD4+/CD8+ cells in addition to platelets were recruited to the 
cerebral microvasculature in response to I/R injury and suggested a role for 
regulatory T-Cells in mediating inflammation. Subset recruitment to b.End.5 resulted 
in responses to LPS and TNF-α+IFN-γ indicating that b.End.5 had the ability to 
recruit both CD4+ and CD8+ cells. 
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Liver resident lymphocytes are skewed towards CD8+ cells (Golden-Mason et al. 
2004) and a number of activated CD8+ T-Cells are recruited and eliminated as part 
of the immune response (Petri et al. 2008). In inflammation however, the type and 
distribution of infiltrating inflammatory cells due to expression of combinations of 
chemokines and adhesion molecules determines the type of disease. A large 
proportion of liver resident lymphocytes are CD45RA+ (effector T-Cells) and are 
thought to be involved in local immune surveillance (Lalor et al. 2002b). Experiments 
using primary mLSEC were limited due to cell availability. However recruitment and 
adhesion of CD4+ cells was marked in comparison to CD8+ cells and mixed 
populations from the same tissue. Stimulation resulted in small responses with CD4+ 
responsive to LPS in comparison with CD8+ where TNF-α+IFN-γ caused most 
adhesion. The combination of TNF-α+IFN-γ elicited the highest levels of recruitment, 
in keeping with human studies, which have shown that this regime induces the 
interferon inducible chemokines that bind CXCR3 in inflamed hHSEC (Curbishley, et 
al. 2005). Knolle et al have done much work on the role of CD8+ cells in murine 
livers, for example demonstrating that the antigen specific CD8+ T-Cells are retained 
as a result of antigen cross presentation (von Andrian et al. 2008).  
 
Several models of inflammatory skin diseases are available including psoriasis, 
scleroderma and atopic dermatitis. Zhou et al showed that CD4+ cells are recruited 
and important in scleroderma (Zhou et al. 2006). In support of this s.END cells, which 
exhibited the most typical ‘endothelial-like’ profile of receptor expression recruited low 
levels of both CD4+ and CD8+ cells with a preponderance to recruit CD4+ T-Cells 
from flow. 
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I have previously covered mechanisms of recruitment involved in inflammation in the 
heart.  Whilst cardiac EC recruited the highest number of leukocytes from flow they 
may not possess the most physiological receptor expression as s.END were found to 
be more ‘endothelial-like’, in addition expression of VCAM-1 was unusually high. 
Nevertheless recruitment of subsets was apparent and responded well to cytokine 
treatment. We found that TNF-α and TNF-α+IFN-γ induced the largest responses in 
mUCEC-1 cells, IFN-α alone had less of an effect suggesting response was largely 
due to TNF-α.  In a model of rat cardiac allograft rejection the infiltration of leukocytes 
was assessed histologically implicating T-Helper cells and macrophages in 
progression of graft rejection (Forbes et al. 1983). 
 
5.7 Static adhesion 
 
Ideally parallel experiments using different EC types with the same isolates of 
leukocytes would have been performed to directly compare the adhesive capacities 
of all our endothelial cells under flow. This proved to be too logistically difficult given 
the availability of LSEC and thus we chose to perform static adhesion assays to 
maximise the use of both endothelial and leukocyte isolates. A select few stimulatory 
treatments were chosen, which had induced responses in previous experiments 
under flow conditions. Global levels of adhesion were much higher than that seen in 
flow experiments as lymphocytes are incubated with the EC monolayers for 2 hours 
in the absence of any flow conditions permitting more efficient interactions between 
cell types. We were pleased to note that the tissue specific differences observed 
previously were confirmed in these static assays. Levels of adhesion were highest in 
mUCEC-1 followed by b.End.5. s.END and then mLSEC. Stimulation with LPS and 
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TNF-α+IFN-γ both induced increased adhesion in all cell types with TNF-α+IFN-γ 
having most effect. Adhesion to mLSEC was lower than other cell types concurrent 
with additional adhesion assays. This could be a result of in vitro culture, tolerance to 
LPS or however mLSEC do respond to TNF-α+IFN-γ an important mechanism in 
hLSEC (Curbishley et al.	  2005).  
 
5.8 Continuous Flow 
 
We tested the effect of TNF-α and IL-1β used under ‘static’ conditions to examine 
what effect they would have on neutrophil recruitment to mUCEC-1 conditioned by 
continuous flow. TNF-α appeared to have more of an effect than IL-1β on the 
percentage of adherent neutrophils rolling. Whereas, IL-1β had a more marked effect 
than TNF-α on the number of adherent neutrophils and the percentage 
transmigrating. All the cytokine treatments were higher than the control for all 
parameters tested. Whilst these results are interesting, our limited number of repeats 
means ideally we repeat this experiment several times more to assess with 
confidence the significance of the effects TNF-α and IL-1β on neutrophil behaviour.  
 
A static control was also included in each continuous flow experiment. This was used 
to compare the effects of static versus continuous flow culture as continuous 
exposure to shear is thought to condition endothelial cells (Sheikh et al. 2003). Both 
the number of adherent neutrophils and the percentage of adherent neutrophils 
rolling were higher and the rolling velocities were lower in treatment groups exposed 
to continuous flow. There was no real difference in the percentage of neutrophils 
transmigrating through the monolayer, but as we have mentioned previously the 
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proportion of neutrophils transmigrating was much lower than expected. The 
Birmingham group led by Professor Nash has been the driving force in studying is 
the combined effect of shear and cytokines on neutrophil recruitment (Sheikh et al. 
2003;Sheikh et al. 2005). Previous results show that HUVEC conditioned by 0.3Pa of 
shear 4, 8 and 24 hrs after which HUVEC were stimulated with TNF-α at 100U/ml for 
the last 4 hours of the experiment resulted in the progressive reduction in the 
proportion of adherent neutrophils that transmigrated through the EC (Sheikh et al.  
2003). We found that exposure to shear, in contrast increased levels of adhesion in 
response to TNF-α and IL-1β. However these experiments have not previously been 
carried out on mUCEC-1 cells. Altered responses could be an artefact of 
immortalisation, tissue specificity or vascular location.  
 
The natural physiochemical environment of EC is exposure to continuous flow at 
varied shear stresses depending on the tissue and branch of the vasculature in which 
they are resident. Matharu et al (Matharu et al. 2006) reported that the higher the 
shear stress to which EC are exposed the less likely they are to respond to pro-
inflammatory cytokines (Matharu et al. 2006;Sheikh et al. 2003;Sheikh et al. 2005). 
We found that exposure to shear induced higher levels of neutrophil adhesion and 
transmigration in mUCEC-1 cells. mUCEC-1 originated from whole murine hearts 
where the aorta and major pulmonary veins had been removed, even though cells 
are from cardiac capillaries the heart is exposed to high levels of shear supporting 
the theory of shear exposure relating to cytokine responsiveness (Lidington et al. 
2002). The inability of HUVEC exposed to flow to capture flowing neutrophils was 
thought to be attributed to inhibition of TNF-α induced up regulation of E-Selectin 
mRNA (Sheikh et al. 2003). Impaired neutrophil transmigration was thought to be due 
to the altered expression of chemokines GRO-α and IL-8 required for successful 
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transmigration through the EC’s (Sheikh et al. 2003;Sheikh et al. 2005). We found 
that mUCEC-1 induced neutrophil transmigration despite the absence of IL-8 (KC), 
suggesting that alternate chemokines which may be unaffected by shear conditioning 
may be involved here. The cells do however express low levels of E-Selectin. Thus 
molecules other than E-selectin may contribute to capture after conditioning or it is 
possible that mUCEC do not regulate selectin expression in response to shear in the 
same way as HUVEC. 
 
It is thought that EC are conditioned by the physiochemical environment they are 
exposed to resulting in an altered and stable phenotype (Sheikh et al. 2003;Sheikh et 
al. 2005). The EC phenotype produced by the conditioning effects of shear is still 
somewhat controversial. Other groups have examined the effect of shear in HUVEC 
and murine lymph nodes (LN). Neutrophil adhesion to HUVEC was shown to 
increase in shear conditioned samples, compared to static controls and this was 
attributed to an upregulation of ICAM-1 (Tzima et al. 2002). In murine LN, culture 
under flow for 24-hrs was shown to downregulated VCAM-1 and abrogate neutrophil 
adhesion (Ando et al. 1994). This suggests that responses to shear vary with 
endothelial origin (e.g. macro vs. microvascular or lymphatic), whether the cells are 
additionally stimulated and what with (i.e. which cytokine is used) and depend on 
which target molecule you are studying. For example E and P-Selectin supported 
neutrophil adherence when HUVEC were stimulated with TNF-α but in IL-1β 
stimulated samples additional receptors were involved. This may explain why our 
responses using mUCEC-1 differ from HUVEC as the expression profile of adhesion 
molecules varies from EC derived from different locations in the vasculature. In 
particular VCAM-1 expression is particularly high.  No phenotypic data is available on 
shear-conditioned mUCEC-1 in contrast with that seen in HUVEC discussed above. 
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Immortalized EC are exposed to limited shear stress in flow chambers to examine 
leukocyte recruitment, as outlined in this thesis and much research from this group. 
However, EC populations can be sheared to model systems, for example human 
brain EC (HCMEC/D3) have been used to model the BBB and were exposed to 
pulsatile flow between 1-200 dyn/cm but leukocyte recruitment was not assessed 
(Cucullo et al. 2007). Due to the low shear environment in which mLSEC normally 
occupy in the liver sinusoid one would expect that they would be less responsive to 
cytokine and that exposure to shear would downregulate responses, as seen in 
HUVEC. However, we saw upregulation of adhesion in response to stimuli in 
conditioned mUCEC-1. In addition epigenetic changes induced by the environment 
could alter the responsiveness and the functional ability of mLSEC.  
 
Such differences in responses to shear have been attributed to downstream 
signalling or gene transcription pathways activated after cytokines ligate their 
cognate receptors (Matharu et al. 2006). A number of shear conditioned genes exist, 
gene expression profiles of HUVEC exposed to laminar shear stresses (10dyn/cm2) 
compared to static cultures showed that there were 107 differentially expressed 
shear-responsive genes (2-fold) after 24-hour exposure, including transcription 
factors, cell cycle regulators and antioxidants a relatively small proportion of the 
endothelial transcriptome (Wasserman et al. 2002). 
 
EC from heart, brain, skin and liver are all exposed to varying shear stresses due to 
their physiological location. EC in the heart and brain are exposed to high levels of 
shear stress (2.0Pa) compared to low shear seen in post-capillary venules and liver 
sinusoids (0.05Pa). It would be interesting to see whether the phenotype and function 
of EC can be altered if the physiochemical and shear environment was altered 
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(possible epigenetic modifications), i.e. can a sinusoidal EC behave like cardiac EC if 
exposed to high shear stress? Does this exposure to shear modulate the unique 
immunological functions of mLSEC? Cultured EC are removed from the physiological 
environment and external stimuli including shear forces that may affect their 
phenotype and function. In addition there is evidence to suggest that EC can detect 
differences in forces to which they are exposed. Andersson et al (Andersson et al. 
2005) showed that HUVEC expressed different sets of genes in response to shear 
stress and intraluminal pressure. Haemodynamics and shear stress can play a role in 
disease pathology; one of particular relevance is atherosclerosis. EC exposed to 
laminar shear stress or turbulent flow showed differential expression of 
atheroprotective genes that were antioxidant, anticoagulant and antiadhesive 
important for disease prevention (Topper et al. 1996). In liver injury or disease where 
fibrosis and consequent cirrhosis develop an increase in portal pressure and 
sinusoidal blood flow is seen, leading to EC capillarisation. Shear could be detected 
by EC leading to changes in gene expression or phenotype, conditioning the 
endothelium leading to transient epigenetic modifications or causing the disease to 
persist.  
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6. DNA MICROARRAY ANALYSIS OF ENDOTHELIAL POPULATIONS. 
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6.1 Introduction 
 
The advent of genomic technologies, our ability to map the genomes of several 
organisms and the availability of data from DNA sequencing projects has impacted 
highly upon scientific research. Arrays can be used to detect pathogens, perform 
expression profiling, and genotype organisms to name a few applications. Previous 
studies tended to apply a ‘reductive’ approach by examining how genes, protein 
structure and function or regulons impact on the behaviour of organisms. However, 
the new ‘genomic’ trend has permitted examination of whole organism biology, to 
facilitate understanding how multiple elements interact to produce responses 
(Twyman 2004). 
 
These experimental tools have provided new insights into areas such as proteomics, 
metabolomics and gene regulation. The most important of which in this context is the 
array, a powerful high-throughput, parallel assay used to study interactions between 
biological molecules (Hobman et al. 2007). These assays can use RNA, DNA, 
proteins or carbohydrates deposited in an ordered arrangement onto a planar solid 
surface. Each coordinate on the substrate represents a single gene, protein or 
molecule. Two types of DNA microarray formats exist; microarrays constructed and 
printed ‘in house’ (Schena et al. 1995) or manufactured arrays offered by companies 
such as Affymetrix, Agilent, and Nimblegen. In addition to the method of production 
microarrays also differ in the form of the nucleic acid printed onto the surface 
including, PCR products, cDNA and expressed sequence tags (EST’s). The 
microarray data outlined in my study was obtained using Agilent Oligo arrays, 
composed of oligonucleotides up to 60 bases long printed onto glass slides which 
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include intergenic regions and open reading frames, allowing greater flexibility 
(Hobman et al. 2007). 
 
6.1.2 How do arrays work? 
 
DNA array technology relies on detecting interactions between molecules 
immobilised on the array surface with molecules present in a complex solution added 
to the substratum. This is possible due to the ability of nucleic acids to bind 
complementary sequences under favourable temperatures and salt concentrations 
(Stoughton 2005). The nucleic acid immobilised to the solid surface (probe) 
hybridizes with nucleic acids labelled with a radioactive isotype, chemical or dye 
(target) (Phimister 1999). These interactions can then be quantified.  
 
Arrays can be used to assess the differences between the transcriptional profiles of 
two samples, for example, stressed versus control cells (Type 1 experiment) (DeRisi 
et al. 1997). In addition, competitive hybridisation can be used to allow direct 
comparisons within a single array. Here cDNA from both sources is labelled with a 
different dye and added to the same array. cDNA from each sample competes for 
binding to the DNA probes, and the reliability  of the data can be assessed  as control 
and test samples  have the opportunity to interact with the test probes under similar 
conditions. Type 2 experiments compare a number of parameters by using an 
invariant control such as genomic DNA (Yang et al. 2002). 
 
As mentioned previously, there are several different types of microarrays. The first 
microarray probes consisted of PCR products with primers designed to hybridise 
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towards the 3’ to 5’ end of genes of interest. The majority of arrays now utilise 
oligonucleotides designed from entire genomes or specific groups of genes, which 
are only as good as the reference gene from which they are designed. 
Oligonucleotide arrays are less problematic than unreliable PCR products. However, 
arrays need to be redesigned as new genes emerge to prevent false-positive results. 
Multiple spots of each gene/probe are printed on each array to increase the reliability 
and statistical power of the data generated. 
 
6.1.3 Microarray analysis procedure 
 
The specified microarray required is printed or purchased from a manufacturer. The 
slide is uniformly treated with the nucleic acid of choice, which is crosslinked to the 
solid surface using UV light or by baking at 80°C. Total RNA is extracted from 
samples using phenol-chloroform or Qiagen columns and must be of sufficient purity, 
stability and concentration. RNA quality can be assessed by examining ribosomal 
RNA (18S/28S) degradation by RNAses using a Bioanalyser (Agilent Technologies). 
The Bioanalyser uses a RNA electrophoresis chip to measure RNA integrity.  
 
The resulting RNA is then converted to cDNA and directly or indirectly labelled using 
fluorescent dyes. Direct labelling involves inserting a dye labelled nucleotide directly 
into the cDNA with reverse transcriptase. For indirect labelling, reverse transcriptase 
inserts amino-allyl UTP instead of dTTP into the cDNA. This cDNA is then reacted 
with alkaline NHS esters of CyDyes. The complex solution of target nucleic acids is 
then added to the array. Slides are subjected to a number of different solutions to 
reduce autofluorescence, reduce non-specific hybridisation and maximise 
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interactions between the probe and target. Slides are then washed to remove 
unbound target, dried and scanned to capture images of where cDNA has hybridised 
with the test probes. Acquiring high quality images of microarrays is important as this 
impacts upon any further analysis. Each spot on the array represents one gene and 
thus the image analysis software must be able to determine between the background 
signal and the millions of individual spots thus requiring high-resolution power. In 
addition to detection, the image acquisition must be highly sensitive as different 
genes are expressed at varying levels. Microarrays can be measured using scanners 
with narrowband illumination or imagers, which use wideband illumination detected 
by photomultiplier tubes or charge-coupled devices respectively (Ahmed et al. 2004). 
Several problems with image acquisition exist, particularly when using fluorescently 
conjugated nucleotides, and these include photobleaching and bleed through 
(overlap of fluorophore spectrum). 
 
6.1.4 Data Acquisition 
 
Images captured by scanning an array indicate the amount of labelled cDNA bound 
to each gene probe, and thus give a representation of the level of transcription of that 
gene. In the case of a Type 1 experiment i.e treatment versus control; outliers are 
removed to identify differentially transcribed genes (DeRisi et al. 1997). Data for each 
gene is used to generate an average, geometric mean and standard deviation. 
Genes within a quoted log ratio away from the mean are considered outliers (Loos et 
al. 2001). These genes are then further selected on the basis of a fixed fold-change 
(in this study a fold change of 2) however important genes might be below this 
threshold so stringency can be altered by manipulating this parameter (Yang et al. 
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2002). Data is then subjected to statistical analysis by t-test, significance analysis of 
microarrays (SAM) or ANOVA to generate reliable gene lists (Zheng, et al. 2007). 
These gene lists can be used to generate graphical representations of expression in 
order to highlight differences between populations or treatment groups. 
 
6.1.5 Applications of DNA microarrays in research. 
 
Genome wide analysis can provide useful insights into whole systems biology or in 
conjunction with more detailed gene lists direct research in a specific area, such as 
inflammation. Mouse models have been widely used to examine many diseases 
afflicting humans, and murine microarrays have been used to research multiple 
sclerosis (C.Lu et al. 2008), scleroderma (Zhou et al. 2006), psoriasis (Wolfram et al. 
2009) and atherosclerosis (Yuan et al. 2009). In addition microarray analysis of 
endothelial cell populations has provided useful insights into the non-inflammatory 
effects of shear (Chen et al. 2001) effects of VEGF on angiogenesis (Weston et al. 
2002) and responses to bacterial products (Zhao et al. 2001). The use of such 
experimental tools may identify useful therapeutic targets and provide information on 
molecular pathways important for disease pathology allowing research to progress at 
a faster rate than was previously possible.  The aim of our DNA analysis was to 
highlight tissue specific variation of endothelial cell populations, in addition to 
confirming expression of endothelial specific genes and particularly those involved in 
inflammation and leukocyte recruitment.  
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6.2 Results 
 
RNA samples were extracted from mUCEC-1 and s.END cells stimulated with pro-
inflammatory treatments (IFN-γ, TNF-α, LPS and combination of TNF-α+IFN-γ) for 24 
hours with an aim to see variation in areas of gene expression associated to 
endothelial cell function, inflammation and recruitment in response to  pro-
inflammatory treatments. Samples were assessed for RNA purity and integrity using 
an Agilent Bioanalyser, cDNA was generated and hybridised to Agilent murine oligo 
arrays. Differentially expressed genes were analysed using GeneSpring GX 7.3.1. 
Software and Heatmaps were generated from genes 50% present or marginal 
(significant probes above baseline gene expression determined from several spots of 
each probe on the array). More specific gene lists reflecting proteins of interest to the 
current investigation were generated for each treatment group and cell line. 
IngenuityTM Pathway Analysis 3.0 (IngenuityTM Systems, CA, USA) was utilised to 
assemble information on functional networks and pathways of interacting proteins. 
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Figure 6. 1: Sample of Bioanalyzer data. Representative images of RNA sample 
purity obtained from Bioanalyzer.  	  
A representative sample of bioanlayzer data from mUCEC-1 and s.END cell samples 
sent for microarray. The peaks (A) and gel bands (B) represent ribosomal RNA 
subunits at 18S and 28S the most conserved gene in eukaryotes. The Agilent 
Bioanalyzer quantifies the amount of RNA and assesses purity and integrity. The RIN 
Number (C) or RNA Integrity Number ranges from 1-10 with 10 being RNA of the 
highest quality. 
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We began by assessing the integrity of RNA samples to be used for microarray 
analysis using the Agilent Bioanalyzer. The images presented in Fig. 6.1 show a 
representative section of RNA samples. The Bioanalyzer generates spectra of 
ribosomal RNA subunits at 18S and 28S (Fig 6.1-A). In addition a pseudo-gel image 
indicates whether any RNA degradation is apparent in the sample (Fig 6.1-B). These 
two measures and the RNA Integrity Number (RIN) allow the researcher to be 
confident in the quality of the RNA (Fig. 6.1-C). All samples run on Agilent Mouse 
Oligo Arrays were of sufficient quality (Fig. 6.1).  
 
Several heatmaps of microarray data were then generated. Heatmaps are graphical 
representations of gene expression under a number of different conditions where 
data in a 2-D map are represented as colours. The values displayed are normalised 
signal values as log ratios (Log Ratio of 0= Genes with a ratio of 1-Genes 
unchanged). The key indicates gene intensity and ‘trust’ i.e the degree of 
reproducibility between spots (probes) for each gene in the array. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 255 
 
 
 
 
 
 
 
 
 
 
Figure 6.2: Heatmap of all genes present or marginal (50%) in mUCEC-1 and 
s.END cells in all treatments examined. 	  
 Each line represents one gene and each column represents the average of 3 spots 
for each probe. EC were cultured and treated with pro-inflammatory substances for 
24 hours prior to RNA isolation with Qiagen RNAeasy columns. Samples were 
assessed for purity and integrity using Agilent Bioanalyzer and run on Agilent mouse 
oligo arrays. Extracted data was analysed using GeneSpring GX 7.3.1 software. 
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Figure 6.3: Heatmap of gene variation. Graph representing genes present in 
mUCEC-1 and s.END cells.  	  
EC were cultured and treated with pr-inflammatory substances for 24 hours prior to 
RNA isolation with Qiagen RNAeasy columns. Samples were assessed for purity and 
integrity using Agilent Bioanalyzer and run on Agilent mouse oligo arrays. Extracted 
data was analysed using GeneSpring GX 7.3.1 software. 
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Figure 6.4: Baseline gene expression. Image represents genes expressed in 
mUCEC-1 and s.END cells treated with control media.  	  
Each column represents one spot of the same gene probe, I,e all replicates of 
samples n=3. EC were cultured and treated with control TCM prior to RNA isolation 
with Qiagen RNAeasy columns. Samples were assessed for purity and integrity using 
Agilent Bioanalyzer and run on Agilent mouse oligo arrays. Extracted data was 
analysed using GeneSpring GX 7.3.1 software. 
 
 
 
 
 
 
 
 
 
 
 
 258 
 
The heatmaps in Fig. 6.2/3 show the variation in gene expression in mUCEC-1 and 
s.END cells when stimulated with a variety of pro-inflammatory stimuli for 24 hours. 
Each line represents a single gene that was present or marginal (arbitrary levels 
(flags) of expression generated by the analysis software) in all samples. Fig. 6.2 
shows that there were global differences in total gene expression in different cell 
lines and that whilst expression of individual genes was altered following different 
treatment strategies the two cell lines maintained their individuality (i.e. global gene 
expression patterns were still maintained). This is demonstrated in a different format 
in Fig. 6.3 where global gene expression is again represented but individual gene 
expression changes in response to treatment are indicated by single lines. Here it is 
clear that again each cell has a distinctive gene expression profile and that the 
s.END cells have a greater variability in degrees of expression (the chart is spread 
more than the samples from the mUCEC cell line). However when the data is 
expressed in this format it is clear that there are some groups of genes, which show 
large fold-changes in expression in response to cytokine treatment. The data 
represented by these heatmaps is based upon expression values generated from the 
average of 3 spots for each probe/gene. The degree of ‘trust’ or confidence in the 
data is based on the reproducibility between these spots and is represented by the 
degree of grey shading on the gene data in Fig. 6.2 and 6.4. This is confirmed in Fig. 
6.4 which shows genes expressed in control untreated samples; each of the three 
columns represents one spot of each probe indicating that variation between spots 
was minimal in representative control samples from each cell line. 
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6.2.1 Analysis of expression of key genes of interest using microarrays. 
 
Whilst the heatmap figures for total gene expression data are useful to show global 
patterns of gene expression between cell types or in response to treatment they are 
not particularly informative in the context of identifying changes in specific genes. 
Thus in order to examine gene expression in more detail and to compare the 
phenotype of cell lines in respect of the data obtained in previous chapters, 
comprehensive gene lists were generated for specific sets of molecules in the 
context of endothelial phenotypic markers, inflammation and leukocyte recruitment. 
As before the specific gene data is shown in colour and positive fold change is 
indicated by blue, where gene expression is higher than for those genes in yellow 
(with a fold-change less than 1 compared to normalised expression level of the 44K 
genes on the array chip set by software). The darker the gene colour (ie the greyness 
of the bar) the less reliable the expression profile is (Trust). As was noted for global 
gene expression, our key genes differed vastly in expression between mUCEC-1 and 
s.END cells (Fig. 6.5 – 6.11).  
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Figure 6.5: Expression of endothelial cell markers.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pr-inflammatory substances for 24 hours prior to RNA isolation with Qiagen RNAeasy 
columns. Samples were assessed for purity and integrity using Agilent Bioanalyzer 
and run on Agilent mouse oligo arrays. Extracted data was analysed using 
GeneSpring GX 7.3.1 software. 
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The expression patterns of a number of endothelial cell markers were investigated on 
EC and once again opposing gene expression patterns were apparent between cell 
lines (Fig 6.5). Interestingly vWF considered a general marker of endothelial cells 
was absent from both EC from heart and skin. In s.END cells VEGF-B/C and 
Claudin-3 were highly expressed, whereas mUCEC-1 cells expressed GP38 and 
VEGF-A. Little variation in expression patterns was seen in response to stimuli.  
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Figure 6.6: Expression of adhesion molecules.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pr-inflammatory substances for 24 hours prior to RNA isolation with Qiagen RNAeasy 
columns. Samples were assessed for purity and integrity using Agilent Bioanalyzer 
and run on Agilent mouse oligo arrays. Extracted data was analysed using 
GeneSpring GX 7.3.1 software. 
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Analysis of adhesion molecule expression under basal or cytokine-stimulated 
conditions (Fig. 6.6) shows that if genes were considered to be present and 
expressed when coloured blue (i.e. fold gene expression was equivalent to, or above 
that of the majority of genes expressed in the array used to set the normalisation-
percentile shift algorithm set at 75%) the sEND cell line had a more characteristic 
‘endothelial’ pattern of expression with P-Selectin, E-selectin, CD31, ICAM-2, CD34 
and endoglin all significantly expressed. In contrast unstimulated mUCEC cells had a 
more restricted basal expression of P-Selectin, JAM-1, JAM-2 and VCAM-1. For most 
of these genes in either cell line, expression was minimally altered by cytokine 
treatment (gene fold- expression colour remain similar across the rows). However 
there were notable exceptions. ICAM-1 was upregulated by IFNγ and in combination 
with TNFα in both cell types. In addition this treatment regime induced expression of 
CD44 in s.END cells. Whereas it appeared that P-Selectin may be downregulated by 
these cytokines, there also appeared to be a downregulation of P-Selectin in the 
presence of IFNγ. Interestingly however levels of P-selectin increased in response to 
LPS stimulation. Neither cell expressed JAM-1, PSGL-1, VAP-1 or LYVE-1.  
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Figure 6.7: Expression of CCL Chemokines.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pro-inflammatory substances for 24 hours prior to RNA isolation with Qiagen 
RNAeasy columns. Samples were assessed for purity and integrity using Agilent 
Bioanalyzer and run on Agilent mouse oligo arrays. Extracted data was analysed 
using GeneSpring GX 7.3.1 software. 
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Chemokines and their cognate receptors are integral to leukocyte recruitment. We 
examined the expression of all groups of chemokine ligands and receptors 
(Fig.6.7/8). mUCEC-1 and s.END cells express a small number of CC ligands. 
mUCEC-1 particularly expressed TECK, TARC and MCP-2. Stimulation with IFN-γ , 
TNF-α+IFN-γ and LPS in mUCEC-1 cells increased expression of these chemokines 
in addition to MCP-3. RANTES expression was induced by TNF-α, LPS and TNF-
α+IFN-γ but absent in IFN-γ treated samples.  In contrast s.END cells expressed a 
more restricted profile including MIP-1β and MCP-1. Interestingly, MCP-3 increased 
when exposed to LPS and a similar pattern was seen in mUCEC-1 cells. 
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Figure 6.8: Expression of CXCL Chemokines.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pro-inflammatory substances for 24 hours prior to RNA isolation with Qiagen 
RNAeasy columns. Samples were assessed for purity and integrity using Agilent 
Bioanalyzer and run on Agilent mouse oligo arrays. Extracted data was analysed 
using GeneSpring GX 7.3.1 software. 
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CXC Ligand expression was globally higher in mUCEC-1 cells including SDF-1, MIP-
2γ, CXCL16 and IP-10.  In addition MIG was induced in response to IFN-γ and TNF-
α+IFN-γ in both cell types. IP-10 was increased in all treatments above control. The 
addition of LPS induced expression of CXCL5 and KC in both cell types. The 
expression of chemokine receptors was minimal on endothelial cells as these 
molecules are generally expressed on leukocytes mediating interactions between 
leukocytes and the endothelium. Small amounts of CXCR3 are apparent on s.END 
cells, expression of which has previously been indentified in populations of human 
microvascular endothelial cells (Romagnani et al. 2001) and CCR9/10 in mUCEC-1 
cells. CXCR4 has been shown to be expressed on HUVEC and play a role in 
transendothelial migration (Murdoch et al. 2000). 
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Figure 6.9: Expression of chemokine receptors.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pr-inflammatory substances for 24 hours prior to RNA isolation with Qiagen RNAeasy 
columns. Samples were assessed for purity and integrity using Agilent Bioanalyzer 
and run on Agilent mouse oligo arrays. Extracted data was analysed using 
GeneSpring GX 7.3.1 software.  
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Figure 6.10: Expression of interleukins and Receptors.  	  
Heatmap of adhesion molecule gene expression in mUCEC-1 and s.END cell lines 
treated with pro-inflammatory stimuli for 24 hours. EC were cultured and treated with 
pr-inflammatory substances for 24 hours prior to RNA isolation with Qiagen RNAeasy 
columns. Samples were assessed for purity and integrity using Agilent Bioanalyzer 
and run on Agilent mouse oligo arrays. Extracted data was analysed using 
GeneSpring GX 7.3.1 software. 
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Interleukins are a group of cytokines initially discovered on leukocytes as a method of 
communication between different leukocyte populations. Produced by and acting 
upon leukocytes they induce activation and are involved in development of T, B and 
haematopoetic cells. Both cell types expressed a limited number of interleukins and 
receptors and expression levels varied. The majority of markers were absent shown 
by grey (low trust) s.END cells were found to express IL-6 and lower levels of IL-13 
and little change was observed with treatment. mUCEC-1 cells expressed TNFR6 
and expression was higher in all treatments above control. CSFM expression was 
induced in response to IFN-γ and in combination with TNF-α (Fig. 6.10). 
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6.2.2 Ingenuity Analysis: Pathways 
 
Ingenuity Pathway Analysis can be used to analyse how gene expression and protein 
interactions identified by microarray analysis interrelate to each other and impact 
upon each other’s function to contribute to changes in cell phenotype or function. We 
identified differentially expressed genes from our microarray analysis (66 probes in 
s.END cells and 330 probes in mUCEC-1 cells classified as significantly differentially 
expressed after treatment via statistical analysis) and used pathway analysis to 
identify the main biological processes in which these genes are involved. Two sets of 
pathway analysis were obtained from the microarray data, core and canonical 
pathways. Core analysis allows rapid assessment of the signalling and metabolic 
pathways most significantly different between the cell populations. Whereas 
canonical analysis examines pathways related to each other reduced to the simplest 
form. Histograms represent the highest rated maps/pathways, which have a 
significance level that pass the threshold and p-value set. Canonical ratio value is 
determined by the number of molecules in a given pathway that meet cut off criteria 
over the total number of molecules that make up that pathway. Ingenuity analysis 
was limited to samples stimulated with IFN-γ or TNF-α+IFN-γ as these stimuli 
induced the largest responses and greatest numbers of differentially expressed 
genes. 
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Figure 6.12: Canonical pathways in s.END Cells.  	  
Comparison of pathways in which 66 significant probes present in s.END cells 
treated with IFN or TNF+IFN for 24 hours are present. P-Values set at <0.05. Data 
analysed using IngenuityTM Pathway Analysis 3.0  
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Figure 6.13: Core pathway analysis in s.END Cells.  	  
Ingenuity analysis of core pathways associated with 66 significant probes present in 
s.END cells treated with TNF+IFN for 24 hours. P-Values set at <0.05. Ratio, is the 
number of genes from experimental list compared to total number of genes in that 
pathway. Data analysed using IngenuityTM Pathway Analysis 3.0 . 
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Figure 6.14: Canonical pathways in mUCEC-1 Cells.  	  
Comparison of pathways in which 330 significant probes present in mUCEC-1 cells 
treated with IFN or TNF+IFN for 24 hours are present. P-Values set at <0.05. Data 
analysed using IngenuityTM Pathway Analysis 3.0  
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Figure 6.15: Core pathway analysis in mUCEC-1 Cells.  	  
Ingenuity analysis of core pathways associated with 330 significant probes present in 
mUCEC-1 cells treated with TNF+IFN for 24 hours. P-Values set at <0.05. Ratio, is 
the number of genes from experimental list compared to total number of genes in that 
pathway. Data analysed using IngenuityTM Pathway Analysis 3.0  
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Both canonical and core analysis indicated that a majority of the significantly 
differently expressed genes in s.END cells were associated with immune and 
endothelial cell functions such as, antigen presentation, endocytosis and recognition 
of pattern recognition receptors (PRR’s) (Fig. 6.12 and 6.13) and that responses to 
IFNγ were very similar to those elicited in response to the combination of TNFα plus 
IFNγ. The response of mUCEC-1 was similar (although a greater number of genes 
was involved), however reassuringly the interferon-signalling pathway was also 
significantly altered in response to treatment of these cells. The ratio value is the 
number of molecules in a given pathway that meet cut criteria over the total number 
of molecules that make up that pathway.  
 
6.2.3 Validation of gene expression using qPCR 
 
In order to confirm expression of differentially expressed genes and to check the 
validity of our microarray data a number of random genes were additionally analysed 
using quantitative real-time SYBR® Green PCR (qPCR). Comparisons were made 
between the fold changes seen in arrays and by qPCR. Fig. 6.16-6.17 show that the 
validation in both cell lines was successful and the qPCR data supported conclusions 
drawn from the microarray data. We examined whether the trends in fold changes 
were similar between microarray and qPCR as they are normalised in different ways 
so absolute values will differ. The rationale behind this is that Genespring filters data 
based on p<0.05 so 5% of the gene list could be false positives. A multiple testing 
correction is then applied to reduce this but false positives could still exist so qPCR is 
used to validate true positives. Negative fold changes are not considered significant 
as they are less than the fold change defined by arrays (2) and wouldn’t have been 
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considered significant. Of note, one of the genes chosen for the validation, Perp, was 
absent from s.END cells in both arrays and qPCR hence no values are present for 
fold expression changes. 
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Figure 6.16: qPCR Validation in mUCEC-1 cells. 	  
The expression of selected genes was examined using SYBR® Green qPCR. Fold 
change increase/decrease from control treated samples were compared to data 
obtained from Gene Arrays. 
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Figure 6.17: qPCR Validation in s.END cells.  	  
The expression of selected genes was examined using SYBR® Green qPCR. Fold 
change increase/decrease from control treated samples were compared to data 
obtained from Gene Arrays. 
 
 
 
 
 
 
 
 
 
 
	  
 280 
6.3 Discussion 
 
Microarray analysis, database mining and transcriptional profiling have been used to 
expand insights into endothelial gene expression and endothelial cell biology (Ho et 
al.	   2003). Novel endothelial cell specific genes have been discovered using arrays. 
Pai et al showed that freshly isolated EC from lung and kidney expressed 350 genes 
at higher levels than surrounding parenchymal cells and that 200 were potentially 
novel (Pai et al.	  2005). Tissue specific differences were also apparent with genes 
encoding ephrin signalling highly expressed in lung. In addition, Ho et al examined 
gene expression in EC from four vascular sources (including lung, heart, and 
umbilical vein) and five non-endothelial cell types (including astrocytes, keratinocytes 
and mammary epithelial cells). They found 64 pan-endothelial markers differentially 
expressed with a minimum of three fold differences such as VE-Cadherin and 
Endothelial Cell Specific Molecule-1 (ESM-1) (Ho et al.	   2003). Interestingly matrix 
gla protein, a gene encoding bone development was discovered in murine aortic 
endothelial cells where it may regulate calcification a causative factor of vascular 
disease (Yuan et al.	  2009). 
 
6.3.1 Gene Expression Patterns in mUCEC-1 Cells 
 
The gene expression patterns of mUCEC-1 cells in response to stimuli have not 
previously been reported, and thus the gene array data obtained in this investigation 
provides novel insights into responses of cardiac endothelial cells to inflammatory 
insult, and in particular to molecules associated with inflammation. Expression of EC 
markers and adhesion molecules had been previously studied in additional chapters. 
Reassuringly our microarray data was concurrent with phenotypic data obtained with 
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other techniques (IHC, cell based ELISA). For example, mUCEC-1 cells expressed 
high levels of VCAM-1, JAM-2 and Endoglin by all detection methods. Interestingly 
chemokine and chemokine receptor expression was minimal with TARC (CCR4) and 
Monocyte chemoattractant protein-2 (MCP-2) present on the mUCEC-1 cells in all 
treatments and control. 
 
We also demonstrated that these cardiac endothelial cells express scavenger 
receptors including VLDLR and CD36. Our functional observations that TNFα 
induced adhesion of leukocytes to mUCEC were supported by demonstration of 
receptors such as TNFR-6 thus conferring the ability to respond to this cytokine. 
 
Ingenuity analysis on mUCEC-1 cells stimulated with combinations of TNF-α and 
IFN-γ showed as expected that significantly different probes were often involved in 
immune functions such as antigen presentation and interferon signalling. Given the 
nature of the immortalisation of these cells and their propensity to proliferate in the 
presence of IFN-γ it is perhaps not surprising that gene expression is sensitive to the 
presence of this cytokine. 
 
6.3.2 Gene Expression Patterns in s.END Cells 
 
Although several murine models of skin diseases exist including dermatitis, psoriasis 
and scleroderma, and sEND cells have been used as model skin endothelial cells in 
vitro, the gene expression profile of s.End cells in response to pro-inflammatory 
stimuli has not previously been published. The data in this chapter, in conjunction 
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with previously obtained phenotypic data, confirms that s.END cells express CD31 
and ICAM-2. E-Selectin is also expressed although fold change data from the gene 
arrays in response to treatment suggest higher changes at the gene level compared 
to protein level. The array data suggested that chemokine expression was more 
pronounced in skin EC compared to cardiac EC, and included Monocyte 
Chemoattractant Protein-1 (MCP-1) and Macrophage Inflammatory Protein 1-β (MIP-
1β). Studies in the CD18 hypomorphic (CD18hypo) PL/J mouse model of psoriasis 
showed that MCP-1 expression was enhanced in the lesions of affected CD18hypo 
mice  (Wang et al. 2006). Additionally injection of recombinant murine MCP-1 in 
conjunction with TNF-α induced psoriasiform skin inflammation around the injection 
sites with recruitment and activation of macrophages. Our array data also shows 
induction of MCP-1 expression by our skin cells suggesting it may contribute to the 
lymphocyte recruitment we noted in vitro as well as promoting inflammation in vivo. 
 
Genome wide analysis enabled Zhou et al to identify early markers of scleroderma 
using a murine sclerodermatous graft-versus-host disease model.  Scleroderma 
affects the dermal arterioles leading to degradation of EC and subsequent fibrosis 
accompanied by an infiltration of CD4+ T-Cells (also required in the development of 
psoriasis). Samples of skin were taken from diseased and control mice 3-5 weeks 
after administration of bone marrow and spleen cells from B10.D2 and syngeneic 
Balb/c mice respectively. Consistent differences were found for chemokines 
(including CCL2,5,17, MIG, IP-10 and ITAC) in conjuction with growth factors (PDGF-
C, FGF-1, VEGFα) and adhesion molecules (E,P,L-Selectin and VCAM-1) consistent 
with inflammatory diseases in particular fibrosing autoimmune conditions (Zhou et al. 
2006). Interestingly, we found that s.END cells (originating from dermal 
haemangiomas) expressed low levels of CXCR3, receptor for ligands MIG, ITAC and 
 283 
IP-10 involved in fibrosis. E-Selectin and P-Selectin (in some treatment) were also 
expressed in addition to a number of EC markers including VEGF B and C. Pathway 
analysis produced similar results to mUCEC-1 with significant probes involved in 
endocytosis and recognition of PRR’s. Thus it appears that the skin cell line used in 
vitro exhibits phenotypic similarity with cells in vivo and responds similarly to 
inflammatory insult. Thus in contrast to the mUCEC cells, this line represents a 
realistic model in which to study organ-specific recruitment of leukocytes in vitro. 
 
6.3.3 Further investigations of EC phenotype with microarray technologies 
 
In previous chapters in addition to EC from heart, skin and liver, the phenotype and 
function of brain microvascular endothelial cells (b.End.5) was examined. Our 
investigations of available literature suggest that comprehensive expression profiling 
of these cells has been carried out, and that such array analysis would generate 
interesting, novel data. Much research with primary brain microvascular endothelial 
cells has investigated the role of the blood brain barrier (BBB). Lu et al showed that 
pertussis toxin (PTX) increases BBB permeability. Mice were treated with PT, which 
induces experimental autoimmune encephalitis (EAE) and brain microvascular 
endothelial cells were subsequently isolated and analysed using a cDNA microarray. 
They found 34 genes that were differentially expressed in response to PT, one third 
of which were involved in angiogenesis. Further experiments blocking signal 
transduction pathways were consistent with the concept of PT alteration of BBB due 
to adverse effects on angiogenesis and tube formation (Lu et al. 2008). It would be 
interesting to see whether our cell line responded similarly to treatment in vitro, and 
also to see whether this cell line exhibits appropriate angiogenic reponses in assays 
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such as matrigel invasion and scratch wound repair. Such data would indicate 
whether these cells are indeed a good model of brain endothelium. 
 
Gene array analysis can also be used to identify a specific population of cells or to 
confirm a successful isolation. Microarrays would have been a useful tool for 
analysing the primary mLSEC obtained using αCD146 method outlined in Chapter 1. 
Kobayashi et al used DNA microarray analysis to confirm the isolation of aortic 
endothelial cells and smooth muscle cells from murine aortas (Kobayashi et al. 
2005). In conjunction with morphological and immunocytochemical analysis EC were 
found to specifically express CD31 whereas SMC expressed smooth muscle actin. 
These observations could be extended to include the full panel of phenotypic 
markers we identified in our staining studies.  
 
To date limited gene array analysis has been performed on mLSEC and we hope to 
generate more data from our cells in the future. Serial analysis of gene expression 
(SAGE) has been carried out on RNA isolated from normal and CCl4 damaged 
mLSEC. Nonaka et al discovered 6011 unique transcripts expressed in response to 
injury. CCl4 treatment induced upregulation of genes associated with cell growth and 
differentiation (Cdkn1a, Irf1) and downregulated genes related to protein 
transportation (Kdr, Ap1b1). In addition they discovered 23 mLSEC specific genes 
not found in other mouse tissues or cell lines including Stabilin-2 (Nonaka et al. 
2004), which interestingly we found on immortalised cardiac endothelial cells 
(mUCEC-1). The limited array data included here (Fig. 6.18-9) showed that human 
LSEC expressed a number of markers associated with sinusoidal endothelial cells 
including scavenger receptors, EC markers and growth factors. It would be 
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interesting to see whether this pattern of expression translated into mice and whether 
more specific analysis could highlight more interesting differences or similarities 
between human and murine systems and EC from different vascular beds and 
tissues. 
 
Macroarrays have also been used to examine the effect of shear stress on the 
development of cardiac tissue in mES cells. Shear is thought to induce epigenetic 
modifications of histones activating transcription of VEGF receptor-2 promoter and 
early induction of cardiovascular markers (Illi et al. 2005).  
 
DNA technology as an experimental tool has unlimited potential with increasingly 
complex formats and resources are available the challenge is mining the large 
amounts of data generated by such methods and using it as a basis for more in 
depth studies into mechanisms responsible for physiological responses. In this 
chapter we have used DNA microarray technology to highlight differences in tissue 
specific endothelial populations in particular relation to the functional capacity of EC 
particularly their role in leukocyte recruitment. Array data was used to support 
previous analysis and to make connections between phenotypic differences and 
functional responses, perhaps shedding light on the role of particular chemokines or 
adhesion molecules. 
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Endothelial cells are an essential part of the human body and play a vital role in 
many processes. We examined in particular their role in leukocyte recruitment. The 
recruitment of leukocytes into tissues as a part of immune surveillance and response 
to inflammation is an essential process. Alterations in the expression of adhesion 
molecules and chemokines present on the surface of EC in different tissues enables 
site specific recruitment of subsets of leukocytes dependent on the unique 
combination of molecules and receptors present. 
 
A general paradigm of leukocyte recruitment exists, the individual steps of this 
sequential generic model are widely accepted, but published research and data 
presented in this thesis have highlighted the specialisation of underlying molecular 
mechanisms present in different tissues and physiochemical environments. Much 
previous research has focussed on HUVEC due in part to the ease of access of 
tissue and simple isolation methodology. However a number of additional endothelial 
cell sources have been used from both humans and mice. We wanted to know how 
the tissue origin of endothelium can impact upon and regulate leukocyte recruitment, 
and in particular how recruitment to the liver microcirculation varies from other sites. 
Such information can be of use in the investigation of conditions where the host’s 
immune system causes pathology for example in autoimmune or alcohol induced 
liver injury. 
 
7.1  Isolation of primary murine endothelial cells. 
 
The isolation and successful culture of primary murine endothelial cells, in particular 
liver sinusoidal endothelial cells, was of particular interest here as mEC can be used 
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in vitro as a model of human systems. Murine tissue is often more readily available 
than human samples and murine systems are more amenable to manipulation, be it 
alterations in shear exposure or inflammatory insult, use of intravital microscopy or 
genetic alterations in knockout mice or models of human disease. However, primary 
EC are notoriously difficult to isolate. In addition to the challenge of isolating small 
number of cells from whole tissues (in particular mLSEC which constitute ~10% of 
whole liver cell population) it is difficult to maintain the EC in a state that recreates 
their physiological environment, as a result of which EC tend to dedifferentiate in 
culture.  Steps can be taken to attempt to recapitulate the natural physiochemical 
environment with the addition of growth factors (HGF, astrocyte conditioned 
medium), autologous serum and appropriate oxygen tensions (Martinez et al. 2008) 
as well as coculture with proximal cell populations (Alabraba et al. 2007). Despite 
such difficulties, the isolation of a number of human EC populations has been 
successfully achieved, in particular HUVEC (macrovascular) and hLSEC 
(microvascular). The majority of methods involve dissociation of the tissue (Knolle et 
al. 1999) on the basis of size or buoyant density using gradient materials and 
differential centrifugation. In addition selection beads can be used to isolate specific 
subsets of cells on the basis of expression of certain molecules (CD31, HEA125, 
CD146). 
 
In contrast to the human situation, fewer studies have utilised cultured primary 
murine cells, and often rather than isolating primary cells, studies are performed in 
the whole animal system. Although this has obvious advantages in terms of 
maintenance of correct endothelial phenotype, the technical complexity of such 
systems and the potential for contribution of multiple cells and mediators to test 
responses means that more simplified ex-vivo experiments are of value. Thus, 
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several groups have looked at isolating primary murine EC from brain (Wu et al. 
2003), lung, heart (Marelli-Berg et al. 2000), skin and liver (Katz et al. 2004) to 
examine immunological functions, expression of adhesion molecules, generation of 
immortalised cell lines (Magid et al. 2003) and purely to achieve successful isolation 
protocols (Marelli-Berg et al. 2000).  
 
We attempted to isolate EC from murine brain and liver to assess expression of EC 
markers and adhesion molecules and how the phenotype of these EC populations 
affected the functional ability to recruit leukocytes under flow conditions. The most 
successful isolation methodology in our hands utilised αCD146 magnetic beads to 
isolate mLSEC. The gold standard method for isolation of mLSEC from whole liver 
involves in situ perfusion of the organ as reported by Smedsrod et al. (Smedsrod et 
al. 1985). Perfusing the organ allows a more delicate and comprehensive tissue 
dissociation but is a complex procedure requiring specialist equipment.  Knolle et al 
use this method in combination with CD146 selection to obtain pure populations of 
mLSEC. However, many problems were encountered when we attempted to recreate 
this methodology in Birmingham. These issues included availability of the more 
complicated elements of apparatus, methods available for killing the animal and 
clotting in the portal vein hindering sufficient perfusion. None of these problems 
would be impossible to rectify in the longer term, however magnetic bead isolation 
methods were used in the current studies to permit easy selection of CD146 positive 
EC with the available resources.  
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7.1.1 Characterisation of mLSEC. 
 
When isolating primary cell populations it is crucial to be able to identify and 
phenotype them in order to confirm cell identity and purity. EC characteristics often 
used for such purposes include expression of CD31, CD34, vWF, uptake of acLDL, 
binding of lectins and formation of tubes in matrigel (angiogenesis assay). However, 
at present no single marker or characteristic is sufficient to confirm the identity of 
murine liver sinusoidal endothelial cells unlike the human counterparts where 
expression of L-SIGN and DC-SIGN can be used (Shetty et al. 2008).  
 
Molecule IHC 
CD31 +++ 
ICAM-2 - 
JAM-2 + 
VCAM-1 - 
CD34 ++ 
VAP-1 ++ 
Endoglin ++ 
E-Selectin - 
LYVE-1 ++ 
 
Table 7. 1: Table summarising expression profile of endothelial markers and 
adhesion molecules of primary mLSEC cells. 
Expression of phenotypic markers was assessed using IHC methods. Expression 
levels were compared to CD31 positive control in each experiment. 
 
Isolation of mLSEC using αCD146 beads yielded populations with the characteristic 
‘endothelial-like’ cobblestone morphology, which stained positive for CD31, ICAM-2, 
CD34, VAP-1, LYVE-1 and Endoglin using immunohistochemical techniques (See 
Table 7.1). However these cells did not proliferate in culture, even in the presence of 
HGF and VEGF. Interestingly Rainger et al (personal communications) have found 
that primary EC isolated from fat pads and vessels from younger/neonatal animals 
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tended to proliferate more in culture compared to those isolated from older mice. This 
reduced propensity of cells from adult mice to proliferate could be due to a finite 
number of cell divisions relating to animal lifespan. Certainly the activity of 
telomerase has been shown to impact on angiogenesis in mice by mediating 
responses to VEGF (Zaccagnini et al. 2005) but limited data is available for in vitro 
cultures of murine EC.  Several other groups have also examined the phenotype of 
murine liver endothelium. mLSEC isolated by collagenase perfusion express LYVE-1, 
Stabilin-2 (Nonaka et al. 2007), Endoglin (Onoe et al. 2005), ICAM-1, VCAM-1 and 
CD31 (Do et al. 1999). In contrast, limited phenotypic analysis is available for 
CD146-selected mLSEC, however in the paper describing this method, Schrage et al 
(Schrage et al. 2008) found that mLSEC expressed the endothelial markers CD31, 
CD146, VE-Cadherin and Meca-32 (Hallman et al. 1995). None of these markers are 
sinusoidal specific to the hepatic sinusoid however. Many of the markers examined 
are expressed in additional locations, for example LYVE-1 in the lymphatics, CD31 
on lymphocytes (Lalor et al. 2002b) and VE-Cadherin is a component of intercellular 
junctions found in many cell types. CD146 and Meca-32 are more endothelial specific 
but not mLSEC specific. Thus to date identification of mLSEC depends upon 
expression of a number of phenotypic indicators and morphological characterisation 
(fenestrations, cobblestone morphology).  In the future more detailed array analysis 
(similar to that we currently have in progress) will contribute to this area of research 
and could identify specific markers or patterns of expression in mLSEC. However, 
the limited phenotypic analysis obtained in this thesis is concurrent with that found by 
other research groups.  
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7.1.2 Functional analysis of mLSEC behaviour in vitro 	  
Currently much of the available data for assessment of the immunological function of 
mLSEC is focussed on their role in antigen presentation (Knolle et al. 2001) and 
innate immunity (Elvevold et al. 2008). In contrast, our functional experiments using 
mLSEC examined the ability of stimulated cells to recruit mixed lymphocytes from 
whole spleens and isolated subsets of CD4+/CD8+ cells. We found that after both 4 
and 24 hours the majority of treatments increased total levels of adhesion above that 
of the unstimulated control, with the exception of IL-1β at 4 hrs. The combination of 
TNF-α+IFN-γ and LPS induced the highest levels of adhesion and these treatments 
were carried over to ‘static’ adhesion assays where similar results were observed.  
Although limited research data is available on the response of mLSEC to these 
treatments, LPS and TNF-α have previously been reported to play a role in liver 
injury (Jirillo et al. 2002;Lalor et al. 2002a). The regulation of inflammation in the liver 
is complex as the liver is constantly exposed to gut-derived food antigens and has 
evolved mechanisms to suppress immune responses to harmless antigens whilst 
maintaining the capacity to respond to infections (Oo et al. 2009). Uhrig et al (Uhrig 
et al. 2005) showed that mLSEC can be tolerant to LPS and this can subsequently 
lead to cross-tolerance to IFN-γ stimulation. LPS tolerance resulted in decreased 
leukocyte adhesion due to down regulated ICAM-1 expression on the endothelial 
surface. It may be that if LPS primed mLSEC in our system were subsequently 
challenged they would also demonstrate this tolerance. Nevertheless we did note an 
increase in adhesion in response to short exposure to LPS alone (albeit a small one) 
suggesting cells can respond to an initial stimulus.  
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The combination of TNF-α+IFN-γ induces the expression of CXCR3 ligands, CXCL9, 
CXCL10 and CXCL11, involved in mediating liver inflammation and infiltration of 
lymphocytes (Curbishley et al. 2005). We confirmed that we saw a modest increase 
in adhesion of lymphocytes to mLSEC in response to these cytokines, and that the 
mLSEC supported adhesion of both CD4+ and CD8+ cells. There was a suggestion 
that proportionally, we saw a greater increase in CD8 cell recruitment in response to 
stimulation with these cytokines. In vivo studies of the proportions of lymphocytes 
resident in normal and inflamed livers suggest a bias towards CD8 recruitment into 
the liver. In response to inflammation or liver injury mLSEC express additional 
adhesion molecules and chemokines such as VCAM-1 and E-Selectin permitting 
recruitment and retention of effector T-Cell populations. For example CD8+ 
CD45RO+ cells in livers infected with hepatitis C (Lalor et al. 2002b). This selective 
recruitment relates to differential chemokine receptor expression. In humans CD8+ 
cells express CXCR3/6 and CCR5 as do CD4+ Th1 cells and in contrast, CD4+ Th2 
cells express CCR4 and 8. Specialised subsets of CD4+ T-Cells such as Th17 cells 
and Treg express CCR4, 6, CXCR3, 6 and CCR4, 5 and 8 respectively. Generally in 
hepatic inflammation leukocytes recruited into the liver are CXCR3/6, CCR1/5 
positive (Kunkel et al. 2002;Shields et al. 1999) which fits with the expression of 
ligands for these receptors during human inflammation (Curbishley et al. 2005).  Our 
preliminary data also suggests the same trends for inflamed mLSEC in vitro.  
 
7.2 Use of immortalised endothelial cell lines 
 
The ideal methods for investigating diverse endothelial functions would focus upon 
studies of the cells in vivo in a physiologically relevant environment.  Indeed, with the 
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advent of techniques such as intravital microscopy, and whole animal imaging 
facilities researchers are able to examine processes such as leukocyte recruitment in 
the whole animal. Although these studies are tremendously important it remains 
difficult to manipulate certain parameters such as shear stress and to hone in on 
particular molecular interactions between cell types in a whole animal system. 
Similarly, at least in the UK, studies are limited by the necessity to obtain Home 
Office licenses to perform any in vivo work. As a result in vitro systems can be a 
valuable alternative, ideally with primary cell isolates, since they enable the 
researcher to obtain the most representative impression of the in vivo situation. 
However, as previously discussed, the challenges isolating primary cell populations 
from whole tissue are complicated by the difficulty in isolating homogenous 
populations of cells. However, EC and epithelial cells have been isolated from some 
tissues, such as the lymphatics (Ager 1987) and gastrointestinal system (Whitehead 
et al. 2009) respectively. Again due to availability of tissue in some institutions, 
immortalised cell lines have been developed to allow further research and 
understanding of EC function.  
 
Cell lines originate from a primary cell population and are often conditionally 
immortalised with viral mechanisms to prevent senescence. However generation of 
cell lines has uncovered many issues warranting consideration such as altered gene 
expression compared to the in vivo situation and phenotypic drift in culture. These 
cells can be continually subcultured to high passage generally maintaining a stable 
phenotype. Several comparisons have been made between primary cells and 
immortalised cells from the same cell source in order to validate them as a reliable 
and functionally representative. For example HMEC-1 (Human microvascular 
endothelial cells) originates from human dermal endothelial cells transfected with 
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SV40 (Ades et al. 1992). HMEC-1 cells were originally shown to form tubules in vitro, 
and exhibit many phenotypic markers characteristic of endothelium. However 12 
years after they were originally isolated these cells have now lost this ability (Nisato 
et al.  2004), illustrating the ‘phenotypic drift’ which can occur with prolonged culture. 
In addition Lidington et al (Lidington et al. 1998) compared several EC cell lines to 
HUVEC and examined expression of CD31, ICAM-1, VCAM-1, E-Selectin, MHC, 
CD40, CD95 and LFA-3 in response to TNF-α and IFN-γ stimulation and static 
transmigration assays with PBMC. The most striking differences between HUVEC 
and cell lines were the induction of VCAM-1 and E-Selectin in response to TNF-α 
and MHC in response to IFN-γ. Levels of leukocyte transmigration on immortalised 
cells were also reduced in comparison to HUVEC however this may be due to 
immortalisation or variation in the vascular beds from which EC were derived. 
However, experiments by Sahota et al (Sahota et al. 2004) in models of tissue-
engineered skin found no difference in the ability of primary small vessel dermal 
endothelial cells (HuDMEC) and HMEC-1 to respond to angiogenic factors 
(VEGF/FGF) and penetrate the dermis. Thus it seems that at least in some model 
systems, and with careful interpretation, cell lines can be used as good replacement 
models for primary endothelium. Thus with an appreciation of the limitations of 
research using cell lines we decided to utilise them as a comparator in our research 
in order to determine the key experiments to take forward with primary murine EC 
populations.  
 
A murine immortalised liver sinusoidal endothelial cell line has been reported (M1), 
and was immortalised with an SV40 construct similar to mUCEC-1 (Saito et al. 2007). 
These cells have been cultured in 3D bioreactors in an attempt to reconstruct liver 
tissue in vitro. However limited subsequent data is available on this cell type, which 
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suggests it, may not be representative of this specific vascular bed. Certainly In our 
laboratory historical attempts at immortalisation of hLSEC with SV40 were 
unsuccessful and resulted in cell senescence (unpublished data).  
 
7.2.1 Characterisation of mUCEC-1 cells. 
 
mUCEC-1, a cardiac EC population, was isolated from the H-2KB-tsA58 
immortomouse expressing a thermolabile strain of the simian virus (SV40) large T-
Antigen linked to an inducible major histocompatibility complex H2-K promoter. EC 
from the immortomouse have been isolated from lung, colon, kidney, heart and brain 
(Langley et al. 2003). In addition s.END and b.End.5 cells were isolated from 
hemangiomas generated by a retroviral construct encoding polyoma middle-sized T-
Antigen from skin and brain respectively (Bussolino et al. 1991).  
 
mUCEC-1 have previously been shown to express CD31, Endoglin, ICAM-1/2 and 
VCAM-1 and respond to growth factors and cytokines (TNF-α, IL-1β and LPS).  
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Molecule IHC ELISA 
(4hrs) 
ELISA 
(24hrs) 
Microarray 
CD31 + + + ++ 
ICAM-2 + + + + 
JAM-2 ++ ++ ++ +++ 
VCAM-1 + +++ +++ +++ 
CD34 + + ++ + 
VAP-1 - + + - 
Endoglin + + ++ + 
E-Selectin - + + ++ 
LYVE-1 - + + - 
 
Table 7. 2: Table summarising expression profile of endothelial markers and 
adhesion molecules of mUCEC-1 cells.  
Expression of phenotypic markers was assessed using several different methods 
including, IHC, cell-based ELISA and microarray. Expression levels were compared 
to CD31 positive control in each experiment. 
 
Our phenotypic studies confirmed expression of all of the molecules mentioned and 
in addition JAM-2, E-Selectin and CD34 by immunohistochemistry, ELISA and gene 
array (Table 7.2). Interestingly there was limited response to pro-inflammatory insult. 
The global heatmap data comparison with sEND cells suggested that the mUCEC 
genes varied less in response to cytokine stimulation on the whole. Relative 
expression levels of individual genes were corroborated by each technique used and 
were concurrent with reported data involving leukocyte recruitment to the heart. 
Endothelial expression of VCAM-1, CD34 and CD31 has previously been 
demonstrated in inflamed heart valves. ICAM-1 and VCAM-1 have also been 
implicated in the infiltration of CD8+ cells into cardiac tissue of patients with severe 
cardiomyopathy (Soderquist et al. 1999). An interesting exception is the lack of E-
selectin expression in mUCEC-1 by IHC methods in vitro, which has been postulated 
to be relative to the degree of vascular injury in vivo (Bussolino et al. 1991;Haverslag 
et al. 2008).  
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One clear difference in expression between cardiac EC in situ and our cell line was 
the unusually high expression of VCAM-1 even in the absence of stimulation. This 
clearly impacted on the functional responses of mUCEC-1 to inflammatory insult and 
to high basal levels of adhesion. Levels of adhesion increased in response to short 
exposure to TNF-α and Il-1β, which carried through into subset experiments. After 
prolonged exposure to these cytokines in addition to LPS, which induced a significant 
increase in leukocyte adhesion. However, there was a tendency to see a reduction in 
lymphocyte adhesion in response to cytokine after prolonged exposure for 24 hours, 
as demonstrated by Matharu et al in the case of selectins (Matharu 2006). 
Physiologically these EC are derived from the microvasculature of the heart (with 
some contamination from the myocardium) the high expression of VCAM-1 could be 
an adaptation to the high levels of shear stress in the physiochemical environment of 
the heart. The higher the levels of VCAM-1 present on the endothelium may increase 
the likelihood of interactions with fast flowing leukocytes in the circulation. mUCEC-1 
contain a temperature sensitive  interferon inducible promoter as part of the 
immortalisation process. However, the presence of IFN-γ in cultures could have led to 
the high constitutive expression of VCAM-1. Investigations by the same group that 
generated the cell line showed that VCAM-1 was induced in response to TNF-α and 
IL-1β (Singh et al. 2005). 
 
It is likely that the high constitutive expression of VCAM-1 on these cells explains our 
observation that recruitment of lymphocyte subsets was high in comparison to all 
other cell types. Recruitment of subsets was high in comparison to all other cell types 
and recruitment was skewed towards CD4+ cells. We also observed that treatment of 
lymphocytes with pertussis toxin lead to a reduction in adhesion to both TNF-α 
stimulated and unstimulated endothelium suggesting a role for chemokines in 
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adhesion to this cell type. In support of this our whole genome microarrays revealed 
expression of a variety of chemokines including MCP-2/3, TARC, SDF-1 and IP-10 
implicated in the recruitment of monocytes, subsets of T-Cells and activated 
leukocytes. SDF-1 was expressed in cells stimulated with LPS, TNF-α and IL-1β and 
CXCL16 in response to TNF-α+IFN-γ treatments where adhesion was increased in 
functional experiments. Interestingly we also noted expression of TARC by our 
cardiac EC line, which has previously been associated with macrophages present in 
atherosclerotic plaques (Ritter et al. 2005). 
 
7.2.2 Characterisation of s.END cells. 
 
The skin acts as a barrier from the external environment, combating toxins, 
pathogens and physical insult. As a result the skin contains a wide range of 
immunocompetent cells. ICAM-1 is particularly important in recruitment of leukocytes 
to the skin. It is constitutively expressed on skin EC and is upregulated in response to 
IL-1, TNF-α and IFN-γ (Iwata et al. 1996).  
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Molecule IHC ELISA 
(4hrs) 
ELISA 
(24hrs) 
Microarray 
CD31 ++ ++ +++ +++ 
ICAM-2 + + ++ +++ 
JAM-2 +++ + + ++ 
VCAM-1 + + + ++ 
CD34 +++ ++ ++ ++ 
VAP-1 + + - - 
Endoglin +++ +++ +++ +++ 
E-Selectin - + - ++ 
LYVE-1 ++ +++ ++ + 
 
Table 7. 3: Table summarising expression profile of endothelial markers and 
adhesion molecules of s.END cells. 
Expression of phenotypic markers was assessed using several different methods 
including, IHC analysis, cell-based ELISA and microarray. Expression levels were 
compared to CD31 positive control in each experiment. 
 
 Our data showed that ICAM-2 was also expressed on s.END, as is common on 
many endothelial types, and increased upon stimulation. We also demonstrated 
expression of E-Selectin which has been reported on dermal EC in vivo (Fuhlbrigge 
et al. 1997) and is particularly important for immune surveillance mediated by CLA+, 
skin-homing T cells (Clark et al. 2006). In addition s.END cells expressed CD31, 
VCAM-1, Endoglin, CD34, VAP-1 and LYVE-1. s.END cells have previously been 
used to investigate endothelial signalling pathways and cytokine/chemokine 
production (IL-6, KC, MCP-1 and GM-CSF) (Bussolino et al. 1992;Bussolino et al. 
1991)  and shown to express CD31, VCAM-1, E and P-Selectin, in agreement with 
our observations. However detailed gene expression patterns of for s.END have not 
previously been published. The results of our DNA microarrays suggested that 
s.END cells had a more characteristic ‘endothelial’ expression pattern compared to 
mUCEC. s.END cells are isolated from the microvasculature of the skin and 
expressed many of the phenotypic markers and adhesion molecules we were 
interested in, particularly CD31 and Endoglin. Although levels of E-Selectin protein 
expression were low as detected by ELISA , message was detected by gene array, 
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which may be more sensitive. However levels of mRNA are not always totally 
correlated to protein expression.  Interestingly a subset of s.END cells was positive 
for LYVE-1 which we detected in all our assays. LYVE-1 is a marker of lymphatic 
endothelium and due to the high density of lymphatics in the skin it is more than likely 
that the original cell isolate was contaminated with some lymphatic EC, which may be 
persisting in the immortalised culture.  
 
In functional experiments the levels of adhesion to both endothelioma cell lines were 
much lower than mUCEC-1 cells, which may in part relate to more appropriate 
expression of adhesion molecules such as VCAM-1. Adhesion molecules were 
expressed on s.END cells giving them the ability to recruit leukocytes from flow. 
However they were shown to be more responsive to cytokine treatment with all 
treatments increasing adhesion above the control at 4 hours. As with our other cell 
lines adhesion decreased after prolonged exposure but LPS and the combination of 
TNF-α and IFN-γ maintained levels of adhesion above control. When subset 
recruitment was examined both CD4+ and CD8+ cells were recruited in response to 
stimulation and as with all cell lines more CD4+ cells adhered to EC monolayers. 
Interestingly expression of chemokines by s.END cells was limited, stimulation with 
LPS induced expression of KC (murine Il-8) and CXCL5 (ENA-78), a neutrophil 
chemoattractant with angiogenic potential (Persson et al. 2003). In vivo CCL27 is 
known to be involved in leukocyte homing to skin. In models of psoriatic skin 
inflammation MIP1α, MIP1β and RANTES are thought to be important (de Groot et 
al. 2007) however these chemokines were not expressed in s.END cells. Similarly 
Giustizieri et al  (Giustizieri et al. 2001) showed that in keratinocytes from patients 
with atopic dermatitis and psoriasis IP-10 and IL-8 were upregulated in the epidermis 
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of patients with psoriasis in response to TNF-α and IFN-γ but not in the lesions of 
patients with dermatitis. 
 
Endothelial cells from haemangiomas have been shown to have an altered 
phenotypic, morphology and function. Zhang et al (Zhang et al. 2006) showed that 
cavernous hemangioma endothelial cells (CHECs) derived from the human liver 
expressed and released more VEGF-A in addition to other factors compared to 
primary hLSEC. In addition CHECs exhibited more active angiogenesis capacity and 
formed abnormal capillary-like structures in vitro. This increased angiogenic capacity 
in EC from haemangiomas could impact on the adhesive properties of both s.END 
and b.End.5 cells relative to stable or differentiated EC types.  Thus s.END cells may 
be of limited use in modelling skin inflammation in vitro. 
  
7.2.3 Characterisation of b.End.5 cells. 
 
Recruitment to the brain microvasculature, like the liver sinusoids differs in 
comparison to most other vascular beds. Brain EC are exposed to high shear 
stresses and are in close contact with astrocytes. Leukocytes entering cerebral 
tissues have to overcome the tightly regulated and restrictive blood brain barrier in 
order to combat detrimental, unwanted inflammation in the CNS. A number of 
different adhesion molecules are involved in recruitment including ICAM-1, VCAM-1 
and CD31 (Engelhardt et al. 1995). The importance of ICAM-1/VCAM-1 has been 
shown in cytokine stimulated primary mouse, rat and human BMEC. b.End.5 cells 
have been used to model the BBB and confirm the importance of VCAM-1/ICAM-
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1/ICAM-2 in the subsequent adhesion and migration of T-Cells into brain 
parenchyma (Etienne-Manneville et al. 1998;Etienne-Manneville et al. 2000).  
 
Molecule IHC ELISA 
(4hrs) 
ELISA 
(24hrs) 
CD31 +++ +++ +++ 
ICAM-2 ++ ++ ++ 
JAM-2 + + + 
VCAM-1 - + + 
CD34 +++ +++ +++ 
VAP-1 - + + 
Endoglin ++ + + 
E-Selectin - + + 
LYVE-1 ++ + ++ 
 
Table 7. 4: Table summarising expression profile of endothelial markers and 
adhesion molecules of b.End.5 cells. 
Expression of phenotypic markers was assessed using several different methods 
including, IHC analysis and cell-based ELISA. Expression levels were compared to 
CD31 positive control in each experiment. 
 
We found b.End.5 expressed appropriate molecules examined in particular CD31, 
CD34, Endoglin and ICAM-2 concurrent with the previously reported importance and 
expression of ICAM and CD31 within the brain microenvironment (Table 7.4). 
 
Functional experiments assessing responses of b.End.5 confirmed that lymphocyte 
adhesion was higher to these cells than that of s.END cells and that 4 hours cytokine 
stimulation induced highest levels of adhesion compared to 24 hours with LPS and 
IL-1β inducing adhesion above control treatment. Both CD4+ and CD8+ cells were 
recruited and no bias was observed and as with basal adhesion data LPS produced 
higher levels of adhesion compared to other pro-inflammatory treatments that may be 
due to the privileged isolation of the CNS from the bloodstream and the ratrity and 
danger of bacterial infections in this site. This is supported by previous experiments 
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by Yilmaz et al (Yilmaz et al.) showing that brain endothelial cells can recruit both 
CD4+ and CD8+ cells. Several chemokines have been found in the brain in vivo in 
response to injury. Using a rat stab wound model of brain injury Berman et al 
(Berman et al. 1996) have shown MCP-1 to be present. In addition Ghirnika et al 
(Ghirnikar et al. 1998) showed RANTES and MIP-1β were present in astrocytes of 
injured brain tissue. Omari et al (Omari et al. 2004) stimulated primary cultures of 
human microvascular EC from patients with CNS inflammation and demonstrated 
MCP-1 expression. They also suggested that T-Cells expressing CD40L could 
regulate the production of RANTES thus permitting further recruitment of leukocytes 
across the BBB. It will be interesting to see if the expression of these chemokines 
and related molecules is seen in the whole genome microarray data for this cell line. 
In addition, since the integrity of the BBB is essential for its function analysis of 
expression and regulation of junctional proteins in stimulated b.End.5 could shed 
more light on this issue. 
 
7.3 Variation in endothelial gene expression 
 
It is widely accepted that EC play an integral role in a number of different biological 
processes including vascular specialisation and physiology and that EC phenotype 
varies throughout the vasculature and in different tissues. However understanding of 
this diversity is limited. Chi et al (Chi et al. 2003) sought to investigate this diversity 
and specialisation by analysing the gene expression of 53 different EC types. These 
included macro and microvascular EC from the aorta, iliac artery (Arterial), HUVEC, 
saphenous vein (Venular), skin and intestine (microvasculature) but not liver. They 
discovered not only characteristic differences in expression in arterial EC and the 
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microvasculature but also distinct tissue specific variation of gene expression in 
microvascular EC from varying tissue beds. Importantly these differences persisted in 
in vitro culture. Gene expressions in distinct organs were found to form discrete 
clusters when displayed in hierarchical maps. 
 
521 arterial specific genes were discovered compared to 2521 microvascular genes 
involved in diverse roles in EC biology including migration and angiogenesis. For 
example arterial EC were found to express Hey2 a human homologue of the 
zebrafish gene ‘gridlock’ which is responsible for inducing expression of additional 
arterial specific genes. Gene expression could also be linked to functionality at 
different sites since, for example fibronectin and osteonectin involved in ECM 
biosynthesis were found in arterial EC, which could be related to the thick vascular 
walls found in large vessels. Venous EC were found to express genes involved in 
internal symmetry suggesting a coordinated role for vascular development and the 
generation of a body plan. Microvascular EC expressed many genes associated with 
basement membrane generation (Collagen, CD36) possibly due to the close 
interaction with EC and basement membrane in microvascular structures. In addition 
genes involved in lipid metabolism (ApoD, ApoL) were expressed implicating EC 
from small vessels in this process. 
 
This distinct and significant variation in marker expression by different EC types is 
also supported by our microarray analysis on mUCEC-1 (from a high shear 
environment) and s.END (from a low shear environment) cell lines, where large 
global differences in gene expression were found even under pro-inflammatory 
conditions. We found variation in expression of endothelial markers, chemokines and 
adhesion molecules, which could impact on the functional properties of the EC. 
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Future work could examine more extensive gene lists to look at comparisons 
between the genes examined by Chi et al.   
 
It is important to culture isolated cells in an environment that most physiologically 
resembles the in vivo situation, which may be difficult to recapitulate in vitro. The 
microenvironment in which cells are cultured has a distinct effect on endothelial 
function. For example Wick et al (Wick et al. 2007) carried out transcriptional 
comparisons of human dermal lymphatic endothelial cells ex vivo and in vitro. They 
examined the expression of 159 genes that were differentially expressed compared 
to vascular EC. In cultured cells 19 of these genes were retained and 27 newly 
induced. These new genes were involved in cell turnover and cell metabolism and 
downregulated genes were components of ECM and those involved in signalling 
pathways associated with CCL21. Thus it is probable that further changes in gene 
expression would be apparent in our chosen cell lines should we culture them in 
conditions more representative of their environment in vivo.  
 
In pilot studies we found that exposure to shear, did indeed condition EC leading to 
decreased functional responses to cytokine treatment. Shear stress is an important 
component of the physiochemical environment in vivo impacting upon EC phenotype 
and subsequent function and varies throughout the vasculature. A number of 
different shear conditioned genes have been reported (Wasserman et al. 2002) 
including transcriptions factors and cell cycle regulators. The application of fluid 
shear stress has been shown to induce changes to the actin cytoskeleton elongating 
EC in the direction of flow (Osborn et al. 2006). Endothelium in the brain is exposed 
to higher levels of shear stress than that of the microvasculature of the liver and high 
endothelial venules in the lymphatics. Exposure of these EC to differing shear 
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stresses could induce transient epigenetic modifications leading to altered function 
and responses to additional external stimuli. In liver injury EC of the sinusoids are 
exposed to higher shear stresses as a result of portal hypertension leading to 
capillarisation. For example in primary biliary cirrhosis, hLSEC have been shown to 
transform into a continuous vascular EC type, leading to loss of fenestrations, 
presence of tight junctions and deposition of basement membrane, all of which are 
important for disease progression (Xu et al.  2003). The transient loss of shear stress 
in the brain has been examined in the context of BBB integrity. As a result of post-
ischemic cerebral injury shear stress can be affected. Krizanac-Bengez et al 
(Krizanac-Bengez et al. 2003) showed in an in vitro model of the BBB with rBMEC 
and astrocytes that the loss of shear stress alone had no effect on the integrity of the 
BBB due to a protective cascade of mechanisms involving cytokines and nitric oxide. 
Further studies to examine the response of primary mLSEC or BMEC to alterations in 
shear stress are warranted. 
 
7.4 Summary and Future Work 	  
We examined the phenotype and function of a number of different EC populations 
from organs that varied physiochemically and immunologically. We found that tissue 
specific variations were apparent including LYVE-1/Endoglin expression in the skin, 
VCAM-1/JAM-2 in the heart, LYVE-1/VAP-1/Endoglin in the Liver and CD31/CD34 in 
the brain. In addition these differences impacted on the functional responses of 
tissue-specific EC to recruit different leukocyte subsets from flow and that there was 
a differential response to pro-inflammatory stimuli LPS, TNF-α and IL-1β. Importantly, 
this response to cytokine decreased after prolonged exposure and trends in levels of 
adhesion in each cell type were apparent throughout different functional experiments 
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(mUCEC<b.END<s.END<mLSEC). Much of this project focussed on the isolation 
and culture of primary murine endothelial cell populations. Several groups have 
strived to culture representative homogenous primary cells; the complexity of this is 
evidenced by the numerous immortalised cell lines have been generated as a 
replacement for primary isolates. We isolated a population of murine mLSEC using 
αCD146 magnetic beads after attempting to optimise several other methods. A 
number of cell lines were used in this project and were found to express tissue 
relevant adhesion molecules and markers of endothelial cells. Whole genome DNA 
microarray analysis was performed on mUCEC-1 and s.END cell lines to assess 
expression of EC markers, adhesion molecules, chemokines and scavenger 
receptors. 
 
Future work would utilise microarray analysis to examine differences in the remaining 
cell populations examined (b.End.5 and mLSEC) to further elucidate possible 
mechanisms of tissue specific recruitment and to corroborate data already obtained. 
Samples have been prepared in order to perform these experiments and the data is 
eagerly anticipated. In the context of this thesis, this data would be interesting to 
further dissect the mechanisms of recruitment, in particular the role of specific 
chemokines in recruitment to different tissues and whether this impacts upon subsets 
of leukocytes recruited to these tissues. In the liver particularly it would be interesting 
to see if unique mechanisms of recruitment and immune modulation seen in the 
human liver are conserved in murine systems. 
 
The isolation of the murine counterparts to the hLSEC, routinely isolated in our 
group, is an important future goal for the laboratory, and thus the data and 
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methodology contained in this thesis will help to drive this forward.  We have access 
to a number of knockout animals where key genes of interest have been deleted and 
thus cells from these animals can be compared to wild types for dissection of roles of 
key receptors in vitro. The differential response to cytokine could be investigated by 
using mLSEC from knockout mice to investigate the role of Toll Like Receptors (TLR) 
in immune tolerance and LPS sensitivity and dissect contribution of individual 
receptor bearing cells (i.e. EV versus KC). TLR9 has previously been shown to be 
present in mLSEC and play a role in receptor mediated endocytosis (Martin-Armas et 
al. 2006).  
 
Our group is using in vivo recruitment model systems where disease mechanisms 
may be linked to multiple cell types (EC, KC and stellate cells). The flexibility of 
supporting such systems with reductionist models using single cell populations in 
coculture in vitro will be very powerful. In murine models of liver disease, 
haemopoetic stem cells have been shown to migrate to injured liver and influence 
tissue repair via a VCAM-1 dependent process (Kavanagh et al. 2009). Chen et al 
(Chen et al. 2009) also showed that murine mesenchymal stem cells trafficked from 
the bone marrow to injured liver and CCR9, CXCR4 and c-Met were essential in 
directing this process. Given the therapeutic potential of infused stem cell populations 
in the context of human disease, and the need to specifically target infused cells to 
specific hepatic compartments, information on recruitment mechanisms gained 
through in vitro assays with mLSEC and mMSC will be invaluable.  
 
We have shown that the phenotype of cultured EC from different tissues varies, 
specifically the expression of EC specific markers and adhesion molecules and in 
addition the pro-inflammatory environment can also modulate this expression. We 
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optimised and phenotypically verified a method for isolation of murine liver sinusoidal 
endothelial cells to high purity. In addition to phenotypic analysis we examined how 
these cells recapitulate the functional capacity of EC to recruit mixed populations of 
leukocytes and lymphocyte subsets from flow. Finally we looked at whole genome 
microarrays of EC from heart and skin and found large global differences in gene 
expression, which supported both ours and others, phenotypic data. There were 
limitations to this research however, for example due to the difficulty of isolating 
primary cell populations conditionally immortalised EC lines were used on which 
there is confounding data on their suitability as a substitute for primary cells. As a 
consequence although we found phenotypic differences between EC populations 
from different tissues and vascular beds thus far there doesn’t appear to be a 
mechanism available to definitively link the EC specific phenotypes reported here to 
their function. In addition microarray analysis on the remaining EC populations is 
outstanding. Confirmation of the chemokine expression on primary mLSEC in 
response to stimuli would shed more light on the functional capacity of these cells to 
recruit specific leukocyte subsets. Nevertheless the data we have generated 
contributes to an ever-growing volume of research investigating the role of EC 
specific address codes in subset recruitment and disease pathologies where 
recruitment is dysregulated. 
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8. APPENDICES 
 
8.1 Solutions for in situ perfusion of murine liver 
 
Perfusion Buffer Concentrate 
 
103.75g NaCl 
6.35g KCl 
28.7g HEPES 
Dissolved in 300ml UHQ Water 
Add 74ml 1M NaOH 
Make up to final volume of 500ml with UHQ Water 
Aliquot into 40ml volumes 
Freeze -20°C 
 
1x Perfusion Buffer is: 40ml PBC + 960ml UHQ Water (Filter) 
 
CaCl2 
 
FW=147 476mM 
0.7g in 10ml UHQ Water, filter aliquot in 1ml volumes. 
Freeze -20°C 
 
Magnesium Chloride: Stock 500mM, working 5-10mM 
 
FW=95.22 0.5M/500mM 
0.476g in 10ml UHQ Water 
Filter aliquot in 1ml volumes 
Freeze at -20°C 
 
10x PBS 
 
25 Oxoid Tablets in 250mls dH2O 
 
Liberase Blenzyme 3 
 
Reconstitute 7mg vial of lyophilised enzyme with 1ml milli-Q-water 
Place on ice for 30 mins (10 mins still, 20 mins shaking) 
Stock 1mg/ml aliquot into 0.143ml (4 Wunsch Units) at -20°C 
 
Collagenase Buffer 
 
49.5ml 1x Perfusion Buffer 
0.5ml CaCl2 476mM 
2 tubes Liberase Blenzim-3 
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Preservation Buffer 
 
250ml 1x Perfusion Buffer 
2.5g BSA 
 
 
DNAse: Stock 3500U/ml Working 200-1000Uml 
 
Preservation Buffer 
 
 
  
 	   V	   MgCl2	   DNAse	  	   ml ml µl 
Cells 50 0.7 14.3 
Gradient 10 0.14 2.9 
Table 8. 1: Constituents of Preservation Buffer 
 
 
8.2 Gene lists for DNA Microarray Analysis 
 
Gene Entrez ID 
CLDN4 12740 
HGF 15234 
VEGFB 22340 
VEGFC 22341 
TLR 4 21898 
CD146 84004 
CLDN3 12739 
TAPA-1 12520 
VWF 22371 
CLDN5 12741 
EGF 13645 
GP38 14726 
OCLN 18260 
VEGFA 22339 
CLDN2 12738 
CD62P 20344 
JAM-3 83964 
CD44 12505 
PSGL-1 20345 
JAM-1 16456 
JAM-2 67374 
VCAM1 22329 
CD62E 20339 
PECAM1 18613 
LYVE-1 114332 
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ICAM2 15896 
CD34 12490 
Endoglin 13805 
ICAM1 15894 
AOC3 11754 
CXCR5 12145 
CCR9 12769 
CXCR2 12765 
CCR3 12771 
CXCR6 80901 
MIP-1 αR 12768 
CCR2 12772 
CCR7 12775 
CXCR4 12767 
CXCR1 227288 
CD195 12774 
CCR8 12776 
CCR4 12773 
CCR9 12769 
CCR10 12777 
CCR6 12458 
MPR46 622798 
LDLRAP1 100017 
LRP6 16974 
VLDLR 22359 
CD36 12491 
LRP1 16971 
IGF-1 16000 
LRP2 14725 
LDLR 16835 
DC-SIGN 170786 
STAB2 192188 
STAB1 192187 
CLEC4G 339390 
IL-2  16183 
IL-6  16193 
IFNγ 15978 
IL-13 16163 
IL-10 16153 
IL1-β  16176 
IL-1α 16175 
IL-5  16191 
IL-4  16189 
TNFα  21926 
IFNα  15964 
GM CSF  12981 
TNFR6 14102 
CSFM 12977 
CCL27 20301 
TECK 20300 
MCP-2 20307 
TARC 20295 
MIP-1B 238799 
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MCP-1 20296 
MCP-3 20306 
MIP-3 A 20297 
EOTAXIN  20292 
CCL22 20299 
MIP-1 A 20302 
CCL24 56221 
CCL1 20290 
RANTES  20304 
CCL28 56838 
SDF-1 20315 
MIP-2 G 55985 
CXCL16 66102 
IP-10  15945 
IP-9 56066 
MIG  17329 
CXCL5 20311 
BCA-1 55985 
PF4 56744 
MIP-2 20310 
 
Table 8. 2: PubMed Gene Identities for Microarray analysis 
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